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Abstract 
In spite of numerous quality improvement interventions, delayed recognition of inpatient deterioration is a significant 
cause of morbidity and mortality. Expert consensus suggests that continuous patient monitoring may have an important 
role in addressing the problem. The use of conventional bedside monitors for monitoring patients on general (Level 0 
and Level 1) wards is poorly tolerated by patients and staff alike. Recent advances in technology have led to the 
development of a wide range of wearable monitors. This thesis examines the feasibility and efficacy of using wearable 
monitors to monitor the vital signs of patients in a general ward setting. 
The feasibility of monitoring was evaluated in two studies. The first was a comparative evaluation of five monitors used 
to monitor patients for 24 hours. The second study evaluated the feasibility of recording the electrocardiogram (ECG) 
and photoplethysmogram (PPG) of patients following cardiac surgery for their entire stay on the cardiac surgery ward. 
Data capture rates in both studies were low overall. ECG was more reliably recorded than PPG. System maturity, 
patient acceptance and intervention design were identified as key determinant of monitoring success.  
Based on our experiences we identified a need for better evaluation and implementation tools to assist future studies. We 
developed and validated an acceptance questionnaire. We also proposed a framework which provides a systematic 
approach to the implementation and evaluation of wearable monitoring systems. 
In selecting which vital signs to monitor, there is a trade-off between what is desirable and what is comfortable for the 
wearer. Respiratory rate, although a sensitive marker of deterioration, was difficult to measure comfortably. Therefore, 
we undertook an systematic evaluation of algorithms to estimate respiratory rate from the ECG and PPG in order to 
identify algorithms which might be clinically useful. We identified 4 algorithms which were more accurate than 
electrical impedance pneumography when operating in ideal circumstances. Further work is required to determine 
whether performance will be maintained in a real-world context. 
Finally, we examined whether continuous monitoring offered any advantage over intermittent observations according 
standard ward practice. We concluded that although individual patients might have benefitted from continuous 
monitoring, at the population level the benefit was minimal and outweighed the cost of the false alerts. The principle 
reason for lack of benefit was the low prevalence of abnormal vital signs.  
Future work should continue to address the technical and practical issues surrounding the design and implementation of 
wearable monitoring systems. In parallel research needs to be undertaken to gain a better understanding of which care 
processes are failing, what should be monitored and how the data can be used to improve the reliability of existing care. 
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Avoidable inpatient deterioration, and the consequent harm, has been recognised as a problem for over a quarter of a 
century. In 1992 Silber coined the term Failure to Rescue (FTR) to describe this phenomenon.1 FTR may be caused by 
either failure to detect patient deterioration in a timely fashion, afferent limb failure, or failure to respond adequately, 
efferent limb failure.2 Figure 1.1 illustrates how these limbs map onto a standard hospital process for addressing clinical 
deterioration. 
 
Figure 1.1: The afferent and efferent limbs of a standard process for identifying and responding to clinical deterioration in hospitalised patients. 
(The terms doctor and nurse are used for simplicity but in reality the “nurse” could be any observer and the doctor could be any skilled decision-
maker.) 
FTR is an internationally recognised problem, leading to both morbidity and mortality.3  A study of all patient deaths in 
English hospitals reported to the National Reporting and Learning Service between 2010 and 2012 identified FTR as a 
problem in 35% of cases (705 deaths).4 An Australian study of cardiac arrests estimated that up to 77% were 
preventable.5 The majority of clinical deteriorations are preceded by abnormalities in patients’ vital signs and are 
therefore detectable.6-10 
Afferent limb failure is common. Vital signs may be recorded insufficiently frequently. This has been implicated as a 
cause of avoidable death in 31% of cases in English hospitals.11 Vital signs, notably respiratory rate, are often recorded 
inaccurately.12-14 Clinicians, both nurses and doctors, may fail to recognise the significance of vital sign changes in the 
early phases of deterioration.15 
In order to assist early recognition of deterioration, Morgan developed the first Early Warning Score (EWS) in 1997.16 
An EWS algorithm assigns an integer score to each vital sign based on its degree of abnormality. The EWS value is the 
sum of the scores for each vital sign. The simplicity and intuitive appeal of the EWS has led to widespread adoption 
internationally and the development of numerous EWS algorithms.17  
In 2007 NICE issued Clinical Guideline 5018 which mandated that all English hospitals establish local monitoring and 
escalation protocols, incorporating an EWS. However, the problems with the afferent limb still persist.19,20 Furthermore, 
numerous studies have identified errors in the calculation of EWS values.21 

























Chapter 1: Introduction 
 
 15 
Automation of the afferent limb has been suggested as a possible solution. In 2010 a group of experts in the afferent 
limb published consensus statement comprising of 14 statements covering reporting standards, routine clinical practice, 
research directions and required technological development.22 Three of the statements provide motivation for this 
thesis: 
1. Significant technological advances are required to improve patient comfort, the ease of use, and signal-to-noise 
ratio [of continuous patient monitoring]. 
2. Technologies should be developed into system packages that monitor, transfer data, store them, analyse them, 
provide decision support, and create graduated alerts. 
3. Research is required to establish the optimum frequency of monitoring and to demonstrate the presumed 
promise of continuous monitoring. 
Based upon these statements three questions arise: 
1. How can we improve the feasibility of continuous physiological monitoring? 
2. How do we build systems capable of not only passively alerting but also making the data available for both 
real-time computer-aided clinical decision support? 
3. What is the optimal manner in which to use the data from continuous monitoring to deliver patient benefit? 
These issues have been explored in the context of the Intensive Care Unit (ICU). Researchers in multiple centres have 
developed large semi-automated data collection systems for gathering physiological data from ICU monitors23-26 27,28 
and used these to develop novel alerting systems which are in routine clinical use. 29,30 
However, when previous trialled,31 the of use bedside monitors for continuous monitoring of ambulatory patients on 
general wards has been found to be poorly tolerated by both staff and patients alike. Furthermore, the use of fixed 
monitors inhibits mobilisation. Early mobilisation has been found to have a number of important benefits including 
reduced incidence of deep vein thrombosis, reduced length of stay, and minimisation of deconditioning.32 A possible 
approach to addressing these issues would be use wearable monitors to continuously monitor patients, streaming the 
data to remote viewing stations over a wireless network.  
The use of wearable monitors has been successfully trialled in multiple outpatient settings but the use of wearable 
monitors in hospitals has not been extensively investigated.33 The work described in this thesis was undertaken as part of 
the Hospital of the Future project. The project aim was to develop a system for monitoring patients in a general (Level 0 
or Level 134) ward setting comprising of wearable monitors, and “smart alerts” based on signal processing and machine 
learning (Figure 1.2). 





Figure 1.2: The monitoring system which the Hospital of the Future project aimed to develop 
The aim of this thesis is to investigate the feasibility and efficacy of using a system based upon wearable monitors to 
identify acutely deteriorating inpatients. 
The thesis is organised into two halves. In the first half we examine the feasibility of inpatient monitoring using wearable 
monitors. We start by considering the array of wearable monitors available, their capabilities and limitations. We 
continue with a scoping review of the existing evidence regarding the use of wearable monitors in a hospital setting and 
then describe a sequence of studies to evaluate the feasibility of use wearable monitors to monitor inpatients. We 
conclude with two chapters aimed at helping future researchers conduct clinical evaluations of these novel devices more 
efficiently and effectively. 
In the second half we investigate the how data from wearable monitors might be processed to generate alerts for 
deteriorating patients. Firstly we report a systematic algorithms for deriving respiratory rate from cardiac monitors and 
pulse oximeters in order to determine which, if any, provide accurate physiological information. Secondly we investigate 
whether continuously monitoring patients using conventional alerting algorithms provides benefit of standard ward 
practice.
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 Wearable Monitors 
2.1 Introduction 
The idea that wearable monitors might be useful tools in the provision of healthcare is over half a century old. In 1947 
Norman “Jeff” Holter conducted the first evaluations of a wearable device for recording ECG, a 38kg device worn as a 
backpack (Figure 2.1 left). Nine years later, following the invention of the transistor, Holter reported the performance of 
a more capable device, the size of a paperback book (Figure 2.1 right). Following further technological developments 
ambulatory ECG monitoring as a diagnostic tool has become part of routine medical practice. 
       
Figure 2.1: Left: The original Holter monitor being used whilst pedalling a fixed bicycle in a laboratory in 1948. Image credit: Gawloska et al35 Right: 
An updated version being used to monitor a man walking in the street in 1957. Image credit: Holter36 
Other established uses of wearable monitors for diagnostic purposes are ambulatory 24 hour blood pressure monitors, 
now the gold standard tool for diagnosing hypertension, and polysomnography systems for monitoring cardiorespiratory 
function during sleep. In hospital, wearable cardiac “telemetry” monitors are used for detection of arrhythmias in high 
risk patients but have not been successfully used outside this narrow remit.37 
During the 1990s advances in sensor technology, wireless networking and mobile computing platforms facilitated rapid 
development of wearable monitors. In parallel, the range of wearable monitors has expanded from devices targeted 
mainly at medical, military and aerospace applications to include low-cost devices targeted at consumers for fitness 
387
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was read by sound. Smooth humming sound meant
that it was sinus rhythm, whereas choppy sounds
were the markers of ventricular extrasystolic be-
ats. For a detailed look at the fragment of ECG that
“sounded bad”, it had to be stopped and played in
real time. In general, speeding it up saved much
time while recording cardiac activity during longer
periods of time gave the possibility to capture
a wider range of eventual abnormalities [7].
The technique of 24-hour ambulatory monito-
ring of ECG ha  evolved ver the years. The device
enabled to review 24 hour recording in an hour
(it played back fifty times in real times). Develop-
ment in technology resulted in miniaturized porta-
ble tape recorders, speed up, simplified analysis and
increased the number of channels to record and
analysis. Recorders which are available nowadays
support a solid state memory card (PCMCIA), mi-
niaturized hardware, compression software and
sophisticated analytic programs.
Holter monitoring is commonly used in every
cardiology ward all over the world, that entails the
fact that his name is still known from this device
by a few hundred thousand physicians and patients.
Once he said: “When my heart starts skipping,
they’ll have the longest normal base line in histo-
ry” [2]. Among Montana’s people Norman Holter
was claimed to be “Renaissance man”. Because he
always remained dedicated to his state and accor-
ding to his contribution to science, he received ho-
norary doctorate degrees from Carrol College and
Montana State University and there are numerous
landmarks around Helena named after him. In re-
cognition of his contributions to medical technolo-
gy, in 1979 he was awarded with the Association
for the Advancement of Medical Instrumentation
Foundation Laufman-Greatbatch Prize.
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Figure 1. The original Holter device from 1947, weighing
38 kg.
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monitoring and “wellness” applications. The technological improvements and decreased cost of wearables has led to 
increasing interest in their clinical utility (Figure 2.2). 
 
Figure 2.2: The number of PubMed search results for “wearable” by year 
Not all wearable monitors are suitable for timely detection of patient deterioration in hospitals. Existing review articles 
are either out of date38 or are intended to provide a general overview of the field and therefore lack detail.39-42 The aim 
of this chapter is to provide a broad understanding of wearable monitoring systems and the component technologies in 
order to inform subsequent discussion of their implementation and evaluation. A secondary aim is to provide a 
comprehensive list of references to review articles and notable monitors in order to assist future researchers who are 
trying to identify suitable technologies or systems for clinical use.  
This chapter is divided into three sections. In the first we provide an overview of the architecture of a wearable 
monitoring system. In the second we describe the key components of a wearable monitoring system and the range of 
technologies available. In the third and final section we provide an overview of the different types of wearable monitors 
which might be suitable for clinical use.  The rapid pace of technological change during the period of our research has 
resulted in multiple new wearable monitors becoming available. Our review has been updated to include these monitors 
in order to make our work as useful for the reader at the time of publication. 
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2.2 Definition and Architecture of a Wearable Monitoring System 
The overlapping terminologies used to describe monitors poses a barrier to newcomers to the field. In some contexts the 
terms “wearable monitor”, “wireless sensor”, “wireless health monitoring system” and “body sensor network” are used 
as synonyms. In other contexts they are used to imply subtle distinctions between closely related concepts. 
In this thesis we will use the terms sensor, monitoring and monitoring system to refer to distinct entities. A sensor is an 
apparatus for detecting or measuring a physical stimulus. A monitor is a device which comprises of one or more sensors as 
well as the necessary hardware for digitisation, signal processing and either data storage or onwards transmission. A 
monitoring system a combination of elements which function together in order to measure, digitise, transmit, store, analyse 
and display physiological data. It may comprise of one or more monitors. Figure 2.3 illustrates the various components 
of a monitoring system. 
 
Figure 2.3: The components of a wireless wearable monitor based upon a framework proposed by Pawar et al.43  
Monitors can be classified into different types according to four criteria, automation of measurement, wireless 
networking capability, automation of transmission and wearability (Table 2.1). Although not strictly accurate, the term 
wearable monitor is commonly used to imply both wearable and wireless capabilities. We will use the term in the capacity 
for the remainder of the thesis. 
Wearable (wireless) monitors are of two types, data logging devices where data is manually downloaded at the end of the 
recording session using the wireless radio for convenience, and telemetry monitors, where data is transmitted 
automatically during the recording session. This transmission may happen in real-time or at periodic intervals. Some 
monitors are capable of functioning in both modes, whereas others are restricted to only one form of operation. The 
research presented in this thesis is focused on wearable telemetry monitors.  
 
 
M-Health can be defined as the emerging mobile communications
and network technologies for healthcare systems.
However, this definition focuses more on mobile computing as
compared to mobility of persons involved in the healthcare system.
We propose a definition of m-Health as:
M-health is the application of mobile computing, wireless commu-
nications and network technologies to deliver or enhance diverse
healthcare services and functions in which the patient has a free-
dom to be mobile, perhaps within a limited area.
In this definition, we stress the mobility of the patient within
the healthcare system. The patient is a person who is receiving
medical care. Of course mobility of health professionals may also
be facilitated by m-Health systems, but we see patient mobility
as essential to he concept of m-Health.
The Medical Dictionary Online defines patient monitoring as the
continuous or frequent periodic measurement of physiological pro-
cesses such as blood pressure, heart rate or respiration rate of a pa-
tient. There exist a variety of terms for the use of ICT in patient
monitoring, e.g. telemonitoring, remote patient monitoring, wireless
patient monitoring and mobile patient monitoring.
The American Telemedicine Association defines telemonitoring
as the process of using audio, video and other telecommunications
and electronic information processing technologies to monitor the
health status of a patient from a distance. In the context of health-
care, the terms telemonitoring and remote patient monitoring are
synonymous [10]. In the current state of telemonitoring [10] it is
pointed out that apart from monitoring people who are ill (pa-
tients), telemonitoring may also refer to health monitoring of
healthy individuals such as athletes or astronauts.
We consider mobile patient monitoring to be a subclass of re-
mote patient monitoring, since with the latter all the associated
healthcare tasks could be conducted solely using wired communi-
cation links (thereby possibly restricting movements of the pa-
tient). For instance the digital electrocardiogram (ECG) system
described in [11] transmits a patient’s ECG to a remote cardiologist
using a fixed phone line modem, hence this is classed as remote
patient monitoring but not as mobile patient monitoring. In this
case the system enables home-based monitoring for example but
not monitoring of the mobile patient at any arbitrary time and
place. During mobile patient monitoring however, the patient is
able to move freely anywhere inside or outside the home. Hence
we define mobile patient monitoring as follows:
Mobile patient monitoring is the continuous or periodic measure-
ment and analysis of a mobile patient’s biosignals from a distance
by employing mobile computing, wireless communications and
networking technologies.
Wireless networking technologies, essential for monitoring the
mobile patient, can be broadly categorized as: (1) Wireless wide
area network (WWAN) technologies which provide low-band-
width and high-latency service over a wide geographic area; and
Table 1
Parameters for comparison of mobile patient monitoring systems.
Parameter Description
Architecture Architecture of a mobile patient monitoring
system according to the generic architecture
shown in Fig. 3
Sensor/actuator set Types of sensors/actuators/other BAN
devices used
Sensor front end Details of the sensor front end in terms of its
make/model, included features and
supported biosignal processing functions
MBU Features of the MBU, in terms of supported
applications, network interfaces and
biosignal processing functions
Intra-BAN communication ! Communication type (wired/wireless) for
communication between BAN devices and
MBU
! Biosignal processing along the
communication path and on the MBU
! QoS requirements for biosignal transfer
! Communication protocol used for
biosignal transfer
Extra-BAN communication ! Communication techniques for
communication between MBU and BESys
! Biosignal processing along the
communication path and on the BESys
! QoS requirements for biosignal transfer
! Communication protocol used for
biosignal transfer
BAN Back-End server and
supplementary
applications
! BAN Back-End server information such as
technology choices for its implementation
and deployment
! Supplementary applications which use
biosignal and other health related data
available at the BAN Back-End server
Clinical Back-End server and
supplementary
applications
! Clinical Back-End server information such
as technology choices for its
implementation and deployment
! Supplementary applications which use
biosignal and other health related data
available at the clinical Back-End server
Back-End System
communication
! Mechanisms for making data generated at
the Back-End servers available to the
supplementary applications
! Communication protocols and technology
choices for data transfer
Trial patient group Target patient groups which are intended to
be monitored by a mobile patient
monitoring system
Trial information Information about trials conducted to
validate a mobile patient monitoring system
with a focus on the number of patients and
duration of the trial
Reported findings/problems Information about significant technical
findings and problems reported during the
trial
Fig. 3. A generic architecture of mobile patient monitoring systems.
546 P. Pawar et al. / Journal of Biomedical Informatics 45 (2012) 544–556











Conventional (ward) spot 
check monitor 
No No No No 
Conventional (ICU) 
continuous monitor 
Yes No No No 
Wireless spot check 
monitor 
No Yes No No 
Data logger 
(Holter monitor) 
Yes No Yes No 
Wireless data logger Yes Yes Yes No 
Wearable telemetry 
monitor 
Yes Yes Yes Yes 
Table 2.1: A classification of monitor types. ICU = Intensive Care Unit 
2.3 Key Components of a Wearable Monitor 
Three key components of a wearable monitor determine its clinical utility; the sensors, the wireless transmission system 
and the signal processing engine. All three affect power consumption. Power consumption dictates the required battery 
capacity, which in turn affects the size and weight of the device and therefore the wearability of the monitor. In 
designing a wearable monitor engineers must trade off data quantity, data quality, transmission range, transmission 
frequency and battery life. An understanding  of the strengths and weaknesses of each option for the key components 
enables users to make better predictions regarding which device might perform best for a given application. 
2.3.1 Sensors 
The vital signs routinely measured in hospitals are temperature, heart rate (HR), blood pressure (BP), respiratory rate 
(RR), peripheral arterial oxygen saturation (SpO2) and level of consciousness. Sensors have been developed to measure 
all except level of consciousness.a However, not all are suitable for incorporation into wearable monitors.  
At least 17 sensors for measuring conventional vital signs have been incorporated into wearable monitors. For each vital 
sign multiple sensor options exist, differing according to power consumption, patient-sensor interface and body location 
where worn. Full details are provided in Table 2.2. 
The patient-sensor interface and body location where worn are important for two reasons. Firstly they affect comfort 
and acceptability to patients, both in physical and psychological terms. For instance, patients may be unwilling to wear 
face-mounted sensors in a social setting.  Secondly they affect the susceptibility of the sensor to artefact, most notably 
motion artefact. 
                                                        
a Bispectral index sensors have been developed to measure the depth of anaesthesia but depth of anaesthesia is not the same as level 
of consciousness. 
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2.3.1.1 Heart Rate Measurement 
Seven types of sensor are capable of measuring HR, five of which, measure another vital sign at the same time. 
Therefore, where multiparameter monitoring is desired, HR can be measured without incurring increased power 
consumption or discomfort. If only HR measurements are required it can be measured using ECG. ECG sensors 
require very little power, can be incorporated into unobtrusive sensors and ECG is reasonably robust to motion artefact.  
2.3.1.2 Respiratory Rate Measurement 
Nine types of respiratory rate sensor have been used in wearable monitors. However, there are not as many choices of 
sensor for daytime monitoring of ambulatory patients as this figure might suggest. Impedance, inductance and piezo-
electric strain plethysmography are variants of the same technique and can be considered equivalent.72 Methods of 
measuring oro-nasal airflow (differential pressure transducers, thermistors and thermocouples) require placement of 
sensors on the face and, to date, have only been used in monitors for nocturnal sleep studies. Therefore, for the purposes 
of real-time patient monitoring of patients in a ward environment, there are four classes of sensor for measuring 
respiratory rate: acoustic sensors attaching via adhesion, impedance pneumography using electrodes on the chest, 
plethysmography sensors and accelerometer-based sensors. 
Plethysmography sensors have an established role in respiratory rate monitoring during exercise and are more resistant 
to motion artefact than impedance pneumography89 but may be uncomfortable.90 Impedance pneumography sensors 
have the disadvantage of requiring current to be injected into the circuit, increasing battery consumption. Acoustic and 
accelerometer-based sensors have yet to be extensively tested in a ward environment. 
2.3.1.3 Measurement of Peripheral Arterial Oxygen Saturation 
Measurement of SpO2 is achieved by measuring the differential absorption of two wavelengths of light, classically red 
(600-660nm) and near-infra red (900-940nm). More modern sensors have started using green LEDs, which provide a 
better signal-to-noise ratio than infra-red light.91 The two variants of the technique, transmissive and reflectance 
photoplethysmography, differ with respect to the arrangement of the light emitting diodes (LEDs) and photosensors. 
Transmissive photoplethysmography is more commonly used in clinical practice and involves placing the LEDs and 
photosensors on the opposite sides of well vascularised tissue. In reflectance photoplethysmography LEDs and 
photosensors are placed side by side. Reflectance pulse oximetry is sensitive to sensor location and skin perfusion. 91 
Ambulatory monitoring of pulse oximetry poses two challenges. Firstly, the power consumption of the sensor is  high, at 
least two orders of magnitude greater than ECG. Secondly, measurement is highly affected by motion artefact.91 
Modern pulse oximeters incorporate motion-resistance algorithms but these are of limited effectiveness.92 
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2.3.1.4 Temperature Measurement 
Skin surface temperature can be measured comfortably using a very low power sensor. However, the relationship 
between skin surface temperature and core temperature is complex and dependent on sensor location, the degree of 
exercise and clothing.93 This being the case, it is unclear whether a skin-mounted sensor would provide data suitable for 
reliable clinical decision making. 
2.3.1.5 Blood Pressure Measurement 
Blood pressure may be measured by a oscillometric brachial cuff or using applanation tonometry. Blood pressure cuffs 
are noisy and may be poorly tolerated.94 Applanation tonometry requires the sensor to be tightly strapped over the 
radial artery to the point of indenting the skin. We are aware of only one manufacturer who makes a wearable 
incorporating a tonometric sensor.95 At the time of writing their software does not support real-time surveillance of 
multiple patients. 
2.3.1.6  Signal Processing 
Monitors incorporating the same type of sensor may provide different quality data depending their signal processing 
algorithms. Signal processing affects clinical utility in three ways. Firstly some monitors only provide derived numeric 
vital sign values (e.g. HR) rather than the signal waveform from which they are derived (e.g. ECG). Secondly, signal 
corruption, notably by measurement artefact, may make measurements inaccurate. Some monitors, such as modern 
pulse oximeters,92 incorporate artefact reduction algorithms. Thirdly additional parameters may be derived from signal 
processing. These may be estimates of conventional vital signs such as RR,96,97 surrogates for vital signs such as pulse 
transit time, which is a surrogate for BP,98 or novel metrics of physiological instability such as heart rate variability.99 
2.3.2 Wireless Data Transmission 
2.3.2.1 Hardware 
Wireless networks are commonly classified into four types according to the distance between communications nodes. 
Body Area Networks (BANs) are short range networks (0.5-2m) used for communication between different devices worn 
on the body. Personal Area Networks (PANs) are intermediate range networks (1-10m) used for communication 
between a monitor and a receiving device which is either carried by the wearer, such as a smartphone, or installed in 
close proximity to the wearer, e.g. bedside wireless router. Wireless Local Area Networks (WLANs) are networks which 
cover a building. Wireless Wide Area Networks (WWANs) are used for long range radio communications such as 
mobile phone networks and the tactical radio networks used by the police and armed forces. Different radio protocols 
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have been developed to address these different niches (Table 2.3). In general, the longer the range of a wireless radio, 
the greater the power consumption.  
Radio Protocol Network type Typical Indoor Range Power Consumption 
ANT BSN <5m 180 µW 
ZigBee PAN* 10-100m 3 mW 
Bluetooth PAN 10m 10-100 mW 
Bluetooth Low Energy (LE) BSN/PAN 10m 70µW 
Wi-Fi WLAN 50-100m 0.2-1W 
Table 2.3: Non-proprietary wireless transmission protocols used for wearable monitors. Bluetooth LE devices only became available in 2012. 
* Similar to Wi-Fi and unlike Bluetooth, multiple ZigBee access points can be installed form a mesh network, thereby giving the network range of a 
WLAN. 
Transmission of data direct to Wi-Fi would be the simplest and cheapest option in terms of installation of a monitoring 
system in hospital. Unfortunately the high power consumption of Wi-Fi precludes its use in most wearables, notably 
those powered by coin-cell batteries.100,101 Traditional cardiac telemetry monitors  and some novel wearables use 
proprietary wireless networks. Use of a custom networking protocol, such as the Telran radio used in the Sensium 
monitor, 102 may have advantages in terms of optimising power consumption and network functionality103 but this 
requires installation of the manufacturer’s proprietary access points. This may be expensive or impractical, limiting the 
area in which patients can be monitored. 
The majority of wearable monitors transmit data via Bluetooth to a smartphone, which is used as a network bridge and 
forwards the data to a remote server via Wi-Fi or a mobile phone network. From a manufacturer’s perspective his 
approach has multiple advantages. Firstly a low power radio can be used to transmit data from the monitor, minimising 
battery consumption and therefore allowing smaller, lighter monitor designs. Secondly, computationally expensive 
signal processing and data display can be offloaded on the smartphone, thereby reducing power consumption further. 
Thirdly, most wearable monitors are marketed to consumers as fitness trackers and therefore need to function in an 
outdoors setting where a Wi-Fi network may not be available. Use of a smartphone as an communications relay ensures 
that data can be transmitted to a remote server providing mobile network coverage is available. 
When using Bluetooth-based wearables in a hospital setting there are two theoretical networking options. The first is to 
ask users to carry a smartphone in addition to the monitor. The second, if supported by the manufacturer, is install 
multiple Bluetooth access points around the hospital. However, Bluetooth routers share all the disadvantages of 
proprietary network access points with none of the advantages. The cost and difficulty of installing Bluetooth routers is 
comparable to installing proprietary network access points but Bluetooth does not support roaming – the ability to 
maintain a network connection whilst moving between network access points. Therefore once the wearer moves out of 
the range of the access point with which their monitor is paired, network communication will be lost. In practice, 
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therefore, use of a wearable monitor which transmits data via Bluetooth necessitates that the patient is also assigned a 
smartphone or tablet computer. 
2.3.2.2 Software 
Not all wearable monitors which transmit data to a smartphone are suitable for real-time patient monitoring. Software 
support is required for automated data transmission both between monitor and phone and between phone and server. 
Table 2.4 lists monitors known to have software support for real-time remote monitoring of multiple wearers.  
Most consumer wearables are conceived as monitoring devices to be used by one individual for data logging. 
Consequently they are not provided with smartphone applications which support automated streaming of data from the 
phone to a remote server. Organisations such as the Personal Connected Health Alliance104 and IEEE are working to 
establish open standards, notably IEEE 11073,105 to improve interoperability and allow third party software developers 
to address this gap. 
Monitor Currently 
available 
Provider of Remote Real-Time Viewing 
Software 
Available in 2012 
Conventional hospital telemetry monitors – e.g. 
Philips Intellivue Trx 
Yes Manufacturer 
Cardiosafe Auricall106 No Manufacturer 
Hidalgo Equivital107 Yes Manufacturer 
Intelesens Vitalsens108 No Third Party  
Nonin WristOx2 3150109 Yes Third Party  
RS TechMedic Dyna-Vision DVM012S90 No Third Party 
Available after 2012 
Intelesens Aingeal v2 (PatientGuard 300)108 Yes Manufacturer 
Isansys LifeTouch and LifeTemp110 Yes Manufacturer 
Philips Cableless Measurements111 Yes Manufacturer 
Sensium Patch50 Yes Manufacturer 
Sotera Wireless VisiMobile112 No Manufacturer 
snap40113 Yes Manufacturer 
VitalConnect VitalPatch114 Yes Manufacturer 
Zephyr BioHarness76 Yes Manufacturer 
Table 2.4: Wearable monitors known to support real-time remote data viewing. 
In the interim co-operation of individual manufacturers is required to integrate their wearable monitors into a unified 
monitoring platform. Some manufacturers107,109,115make the specifications for their Application Programming Interfaces 
(APIs) publicly available. This allows third parties to build custom software to integrate with these monitors. 116 
2.4 Wearable Monitors 
In the vast majority of cases, clinical researchers seeking to monitor patients with a wearable monitor will not be able to 
design and manufacture their own wearable monitors. As such the scope of any planned intervention is limited by the 
capabilities of commercially available monitors. At the same time, through collaboration with manufacturers of 
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wearable monitors, it may be possible to adapt monitors designed for the outpatient or consumer markets in order to 
make them usable for inpatient monitoring. 
In this section we present a high level overview of the capabilities and maturity of wearable vital signs model based upon 
a review of the academic, grey and consumer literature. In selecting devices we have given priority to those who have 
been formally evaluated in a peer-reviewed journal and those with unique capabilities or designs. The focus of the 
review is on commercially-available sensors but we have included selected academic prototypes which illustrate the 
potential of future monitors. 
In order to make the review as useful to the reader as possible we have opted to focus on currently available monitors. 
The rapid pace of technological development means that many of these were not available at the time of the research 
studies described in this thesis. At the same time we have included notable examples of monitors available at the time 
our research, in order to provide context to our research. Some of these device will either have been retired or updated 
in the interim. 
2.4.1 Digital Patches 
The digital patch form factor consists of a lightweight, low profile monitor body which attaches to the monitor by a 
single adhesive patch (Error! Reference source not found.). Commercially available systems are capable of 
measuring HR, RR, skin surface temperature and motion. Many derive an estimate of RR from ECG-based 
measurements rather than measuring RR directly.  
Many digital patches marketed for clinical use are designed as replacements for Holter monitors, event recorders and 
implantable loop recorders, making them unsuitable for inpatient surveillance. Table 2.5 lists digital patches which 
contain unique sensors, unique design features or are designed for real-time patient monitoring.  
Monitor Body location Available in 2012 HR BP RR SpO2 Temp. Motion 
Commercial monitors 
Intelesens Aingeal108 Thorax Yes •  •  •  
Intelesens Vitalsens108 Thorax Yes •  •  •  
Proteus Raisin Patch117 Thorax or 
abdomen 
Yes •    • • 
Sensium118 Thorax Yes* •  •  •  
Acurable Acupebble119 Thorax No •  •    
Isansys LifeTemp110 Axilla No     •  
Isansys LifeTouch110 Thorax No •  (•)    
Philips Cableless 
Respiratory Pod111 
Thorax No   •    
Zephyr BioPatch120 Thorax No •  (•)  • • 
Academic prototypes 
Haahr et al77 Finger n/a    •   
Table 2.5: Digital patches. Brackets around the bullet point indicate that the RR is estimated rather than being measured with a dedicated sensor. 
*Early versions of the Sensium patch were available in 2012 (called the LifePebble) but they were considerably less mature than the current version.  




Figure 2.4: The Sensium monitor, an example of the digital patch form factor 
Two models of monitor have been manufactured by Intelesens, the Vitalsens and Aingeal, both of which are variants of 
the same design. The monitors are supplied with a pair of device-specific, large diameter, adhesive electrodes linked 
together by a fine cable. One of the electrodes has metal studs embedded within it, to which the main body of the 
monitor attaches magnetically. This allows the same monitor to be reused for multiple patients. 
The Aingeal has two advantages over the Vitalsens for hospital monitoring. Firstly, it is capable of monitoring RR via 
impedance pneumography and secondly it communicates via Wi-Fi rather than Bluetooth. Modern revisions of the 
Aingeal device are also provided with software for real-time monitoring of patients. This was not available at the time of 
our research. 
A number of conference proceedings, written by employees of the manufacturer, have described small scale trials of the 
Intelesens devices in the laboratory, clinic and hospital ward settings. The aim of the studies being either to demonstrate 
the feasibility of monitoring, of validate the sensor accuracy.69,121-123 However, there are no other reports, either 
academic or commercial, of the devices being used for clinical purposes. 
The Sensium patch has similar capabilities to the Aingeal in that it is aimed at inpatient monitoring and capable of 
monitoring HR, RR and skin surface temperature. It communicates using a custom, lower-power, short range radio 
protocol103 to bespoke access points which act as a bridge to a Wi-Fi network. The RR algorithm relies on a 
combination of impedance measurements and ECG-derived respiratory signals. Hence it is confounded in patients with 
arrhythmias.50 Beyond a measurement validation study, there is no literature describing the clinical use of the sensor. 
The LifeTouch and LifeTemp are HR and temperature sensors respectively. Original versions of the LifeTouch 
communicated using the ANT radio protocol. Later versions use the more widely available Bluetooth LE protocol. 
Unique features of the LifeTouch system are that it comes in three sizes, to facilitate monitoring children, and that the 
current version of the manufacturer-supplied software also allow inputs from third party devices, the Nonin WistOx2 
3150 pulse oximeter and a third party wireless (but not wearable) blood pressure monitor. According to an abstract the 
LifeTouch has been used to monitor children124 but full results of the trial are not yet available. 
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The Zephyr BioPatch is a small, rigid monitor receptacle which attaches to two standard ECG electrodes placed on 
either side of the sternum. The receptacle holds the Zephyr BioModule, a small circular monitor which can also be 
attached to a chest strap or connected to a sports vest. The system is an evolution of the Zephyr BioHarness, which is 
discussed in further detail below. 
The Philips Cableless Respiration pod measures RR using an accelerometer. It is part of the Philips Cableless range of 
sensors which all communicate via short range radio to Philips Intellivue MP5C bedside monitors, which act as bridges 
to a Wi-Fi network. Measurements are taken at periodic intervals rather than continuously. Data is sent to the Intellivue 
Guardian dashboard software, which automatically calculates an EWS based on the monitor readings and data entered 
by staff. The system has undergone a feasibility trial in an emergency department involving 230 patients who were 
either moderately unwell or in the waiting area. The study reported that the system worked well and was well tolerated 
by staff and patients. 125 
The remaining monitors listed in Table 2.5 are not designed for inpatient monitoring but are of interest due to their 
novel sensors. The Acupebble is an adhesive HR and RR monitor which is placed over the sternum and derives HR 
and RR from acoustic signals.62 An academic prototype has been tested in a sleep clinic to validate its accuracy in 
detecting sleep apnoea.63 The Raisin Patch is a low profile disposable sensor which has the unique ability of being able 
to monitor medication ingestion, providing tablets have an ingestible chip embedded within them. 126 Haahr et al have 
described a prototype reflectance pulse oximeter patch but this has not been developed into a commercial product.77 
2.4.2 Module-With-Leads Monitors 
The module-with-leads design consists of a central module, usually carried in a bag or on a belt holster, connected to 
multiple sensors via leads (Figure 2.5). In contrast to a digital patch, sensors can be placed at disparate locations around 
the body. A further advantage is that because the weight of the module is carried in a bag, the module can be larger and 
heavier than would be practical with a digital patch. This allows the use of larger capacity batteries and the attachment 
of a wide variety sensors. The disadvantage of this design is that it is more obtrusive than the other designs. 
The module with leads is the form factor adopted by conventional telemetry monitors such as the Philips Intellivue 
TRx+SpO2111 and their modern variants such as the Dyna-Vision DVM012S.90 It also commonly used by monitors 
designed for physiological recordings in the laboratory, such as the Great Lakes Neurotechnologies BioRadio and 
wearable polysomnography devices used for sleep studies. Device capabilities are summarised in Table 2.6 
An unusual variant of this design is the VisiMobile. It is unique among the monitors described in this review in being 
capable of monitoring of all common vital signs (except level of consciousness). The main body of the monitor is worn 
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on the wrist with leads going to a pulse oximeter probe worn at the base of the thumb, a blood pressure cuff on the arm, 
a skin surface temperature sensor on the chest and ECG electrodes. In order to fix sensor modules on the arm and chest 
small adhesive plastic cradles are first affixed to the patient to hold the modules in place. The monitor is also capable of 
beat-to-beat blood pressure estimation using pulse transit time. This must be periodically calibrated using the standard 
blood pressure cuff and is not certified by the manufacturer to be accurate while the patient is moving.127 The monitor 
transmits data via Wi-Fi and has monitoring software which is capable of integration with hospital electronic patient 
record systems. The system has been trialled in a small pilot study128 and used for prolonged periods in a number of 
centres in the United States.129-131 However, detailed reports of the reliability and effectiveness of the monitoring are 
lacking. 
    
Figure 2.5: Left: The VisiMobile monitor, an unusual example of the module-with-leads style of monitor. Right: The Dyna-Vision DVM012S a more 
conventional design. 




No •  • •  • 
RS TechMedic Dyna-
Vision DVM012S90 
Yes •  • •   
Sotera Wireless 
VisiMobile 
No • • • • • • 
Philips Intellivue 
TRx+SpO2111 Yes •   •   
Table 2.6: Examples of module-with-leads style monitors 
 
2.4.3 Armbands 
Armband designs are used either for brachial blood pressure cuffs, such as the Philips Cableless Measurements NIBP 
module,111 and reflectance pulse oximeters, such as the Everion133 and snap40113 monitors (Figure 2.6). The amount of 
constriction needed to keep the monitor in place is proportional to the weight of the monitor. Therefore the design is 
best suited to lightweight monitors. 
 
 





   
3-lead 5-lead 12-lead 
OTHER CONFIGURATIONS 
Other configurations are possible and should be based on the indication for using the device.   
CONNECTING THE CABLE TO THE DEVICE 
The cable has a metal plug. Insert the plug in the port at the top side of Dyna-Vision™. On the front 
side of the device you will find the indicators for the correct port.  
There is a red dot indicator on the plug that corresponds with a red dot on the connector in the 
device. The plug only fits in one direction. If inserting the plug does not go smoothly.  
 
Inserted ECG cable 
Note: do not force (!) the plug into the connector. Damage to the plug and/or the device may occur.  
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There is scant data publicly available on the performance or technical specifications of the Everion and the Snap40. 
According to their manufacturers, both devices are currently being used in clinical trials. However, at present, the 
feasibility of using these devices for inpatient monitoring is unknown.  
 
Figure 2.6: The Snap40 monitor, an example of the armband form factor 
Monitor Available in 2012 HR BP RR SpO2 Temp. Motion 




No  •     
snap40113 No •  (•) • • • 
Table 2.7: Armband-style monitors. The BioVotion and snap40 derive RR from the PPG waveform. 
 
2.4.4 Wrist-worn Monitors 
Wrist-worn wearables (Figure 2.7) have become more common with the advent of consumer smartwatches. The wrist-
worn location necessitates that the monitor is compact and lightweight. Large wrist-worn monitors are poorly tolerated 
as they interfere with activities of daily living.134 Wrist-worn devices include smartwatches incorporating HR monitors, 
such as the Apple Watch, pulse oximeters and blood pressure monitors. Noteworthy devices are listed in Table 2.8. 
           
Figure 2.7: Left: The Bpro, a blood pressure monitor. Right: The WristOx2 3150, a wrist-worn pulse oximeter 
Monitor Available in 2012 HR BP RR SpO2 Temp. Motion 
HealthStats Bpro95 No  •     
Nonin WristOx2 315079 Yes •   •   
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Oxitone 1000135 No •   •   
Omron Series 7 BP645136 No  •     
Table 2.8: Wrist-worn monitors 
The Bpro is a blood pressure monitor which measures BP via applanation tonometry. The technique requires precise 
placement of the sensor over the radial artery and the monitor strap must be tight enough to ensure that the sensor 
indents the wrist. The sensor is capable of outputting a peripheral arterial pressure waveform from which the monitor 
derives an estimate of central aortic systolic pressure.54 The monitor is primarily intended for 24 hour blood pressure 
monitoring and has been trialled to demonstrate its feasibility 137 and validity.138 
The WristOx2 3150 (Figure 2.7), a pulse oximeter which uses a finger probe and is capable of transmitting both 
numeric measurements and PPG waveform via Bluetooth. In addition to manufacturing its own pulse oximeters, Nonin 
provides pulse oximeter circuit boards and modules for inclusion in other wearable devices. All use the same publicly 
available data transmission format, making them easy to integrate into third party monitoring systems. At least three of 
the monitoring systems described in this review, the Isansys monitoring system, the Dyna-Vision and the Equivital EQ-
02, either incorporate Nonin sensors or have software compatibility with the Nonin WristOx2 3150. 
The WristOx2 3150 has been used in numerous trials varying from physiological studies of oxygenation in microgravity 
139 to home monitoring of patients with COPD140 and heart failure141 to monitoring of the physiology of pregnant 
women during outpatient visits.142 However, we are not aware of any studies where the WristOx2 3150 has been used 
for prolonged continuous monitoring. 
Other wrist worn devices are blood pressure cuffs and bracelet or watch-style PPG sensors. The majority of consumer 
smartwatches are only capable of measuring heart rate as they use single wavelength photosensors. However, a few 
recently released devices, such as the Oxitone 1000135 promise to provide SpO2 readings from the wrist, without 
requiring a conventional finger probe. The validity of the measurements from such sensors in a real-world environment 
has yet to be independently evaluated. 
2.4.5 Thoracic Bands 
Wearable monitors mounted on thoracic bands (Figure 2.8) have long been used for exercise tracking as they can 
incorporate respiratory rate sensors which are reasonably reliable even during motion. They have two practical 
disadvantages for prolonged hospital monitoring. Firstly, multiple sizes of thoracic band are needed to accommodate 
patients with different chest sizes. Secondly, the bands are not disposable, therefore they must be washed between uses. 
Two monitors based on a thoracic band form factor have been used published trials in a variety of settings, the Equivital 
EQ-02 and the Zephyr BioHarness. 




Figure 2.8: The Zephyr BioHarness, an example of the thoracic band form factor 
Monitor Available in 2012 HR BP RR SpO2 Temp. Motion 
Hidalgo Equivital  
EQ-02107 
Yes •  • • • • 
Zephyr BioHarness120 Yes* •  •  • • 
Table 2.9:Thoracic band monitors. *The version of the BioHarness available in 2012 was considerably less refined than the current version. 
The Equivital EQ-02 consists of a chest belt which incorporates fabric ECG electrodes and an respiratory inductance 
pneumography band. The main body of the sensor fits into a pocket on the band and contains an accelerometer, 
gyroscope, infra-red thermal sensor and thermistor. Optionally a pulse oximeter module can be attached, which can be 
used to measure SpO2 using conventional pulse oximeter probes. Core temperature can be measured using an ingestible 
sensor. The device records full waveform data, which can be transmitted in real-time via Bluetooth to a paired laptop 
directly or top a remote server via a smartphone. Data is simultaneously stored in the monitor’s flash memory so data 
can be retrospectively downloaded in the case of network failure. 
The monitor has been used successfully for a diverse range of studies, from monitoring of soldiers143 and footballers,144 
to validation trials in a laboratory setting51 and monitoring of patients on a renal dialysis unit.145 In all cases monitoring 
was conducted for a relatively short period. 
The BioHarness originally consisted of a monitor integrated into a chest strap. Over successive iterations it has evolved 
into a system comprising of a detachable monitor, the BioModule, which can be attached to either a small ECG patch, 
the BioPatch; a chest strap, the BioHarness; or a vest with integrated electrodes. The system can operate in holter 
monitor mode or transmit data via Bluetooth, a proprietary RF network or via long distance radios. The accompanying 
software allows multiple subjects to be simultaneously monitored but is tailored for monitoring of athletes rather than 
hospitalised patients. 
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Studies involving the BioHarness are similar to those of the Equivital. For instance it has been evaluated for exercise 
monitoring,146 laboratory environment147 and outpatient cardiovascular monitoring.116 As with the Equivital, all studies 
involved comparatively short periods of monitoring. 
2.4.6 Monitors Integrated Into Garments 
Sensors may be integrated into clothing either by providing special pouches to hold the sensor body and routing leads 
through the fabric or by weaving fabric-based sensors into the garment (Figure 2.9). The approach has the advantage of 
the flexibility afforded by the module-with-leads design but without the problems of lead management. The 
disadvantages are that multiple sizes are required and garments need washing. Numerous academic prototypes of this 
form factor have been proposed52,148,149 but few have become commercially available. Those which have, for example 
the VitalJacket150 are no longer available.  
 
Figure 2.9: The Hexoskin Smart Shirt. The main body of the monitor is housed in a laterally placed waist-level pocket 
A currently available example of this type of monitor is the Hexoskin Smart Shirt (Figure 2.9)115 Previously named 
AstroSkin, the system was originally designed for the monitoring of astronauts. The shirt integrates ECG electrodes and 
abdominal and thoracic respiratory impedance pneumography bands. The main monitor module is housed in a pocket 
in the shirt and includes an accelerometer. A cap incorporating a reflectance pulse oximeter to be placed on the 
forehead is also available as an optional sensor. The device has not been used for patient monitoring with the exception 
of a laboratory validation study of patients with COPD.151 
2.4.7 Ear-based Monitors 
Ear-based monitors (Figure 2.10) measure vital signs either in-ear, from the auricle or the post-auricular skin. The 
current commercially-available monitors are marketed as consumer-grade fitness trackers. Wearables with 
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interchangeable PPG probes (such as  the module-with-leads monitors) can also monitor SpO2 and HR from the ear 
with an ear clip pulse oximeter sensor. 
The CardioSafe Auricall was a pulse oximeter which was developed in a university, commercialised and used for 
monitoring of hospitalised patients in the centre where it was developed.106 It is no longer commercially available. There 
are a wide range of headphones, such as the Bose SoundSport Pulse152 which use single wavelength PPG sensors to 
detect HR for consumer fitness tracking. None of these have been used for clinical applications. 
 
Figure 2.10: Left: The Cardiosafe Auricall, an example of an ear-based monitor. Right: The Bose SoundSport Pulse, one of many headphones with a 
built-in heart rate monitor. 
Monitor Available in 2011 HR BP RR SpO2 Temp. Motion 
Bose SoundSport Pulse152 No •      
Cardiosafe Auricall153 Yes •   •   
Table 2.10: Ear-based monitors 
 
2.4.8 Other Form Factors 
Other notable wearable monitors are a pulse oximeter incorporated into a ring83, necklace-shaped monitors39 and 
sensors incorporated into tattoos.154 These remain academic prototypes currently but herald a future of less obtrusive 
wearable monitors. 
2.5 Conclusions 
In this chapter we provided an overview of the architecture of wearable monitoring systems, the key technologies 
incorporated into a wearable monitor and provided examples of different commercially available monitors. Although an 
initial market survey might suggest that there are a wide variety of systems which might be used for prolonged inpatient 
monitoring, constraints of comfort, data transmission, signal processing and commercial availability serve to limit the 
range of monitors which are practical to implement. There is relatively little published data describing the use of these 
monitors for clinical purposes. 
level of the ear lobe and allows the continuous recording of
transcutaneous SpO2 and HR. The data collected are sent via
Bluetooth® to a mobile telephone and from there via GPRS
(General Packet Radio Service) directly to a server. Treating
doctors have encrypted access to this server via the Internet
and are able to check current or past data. This device was
approved with the EC-certificate in the year 2004.
The Auricall® device was previously validated vs two
different widely used pulse oximetric devices (Hellige® and
Nellcor®) in 20 normal subjects, 20 heart surgery post-
operative inpatients and 20 post-oper tive outpatients [15].
This validation study, made according to the Lübeck
validation procedure [16,17] has shown that the measured
SpO2 and HR values were reliable [15]. On the basis of these
data it was shown that Auricall® is a reliable device for a
continuous monitoring of SpO2 and HR independently of the
patients' location (Fig. 2).
20 patients with chronic HF (clinical characteristics in
Table 1) and absence of previous diagnosis of SAS were
included in the study. In 13 patients the etiology of HF was
ischemic while in 7 patients it was due to a dilated
cardiomyopathy. All patients were treated with an optimal
state-of-the-art therapy (Table 2). The patients were
requested to carry the device for at least 36 h and to write
a diary during the recording time. The Ethical Committee
approved the study and every patient signed an informed
consent before participating.
The sensor was generally well tolerated over the recording
time. In 18 of 20 patients it was possible to obtain a satis-
factory recording of SpO2 and HR (mean time 33.8±11.2 h).
The range of observed average SpO2 was 90.1±3.8 to 99.8±
0.2%, the range of observed average HR was 47.5±10.6 to
97.1±5.3 b/min. In 9 out of 18 patients a significant periodic
change in SpO2 was observed (Fig. 2). The mean baseline
SpO2 measured by the Auricall® sensor in the patients
showing periodic change of SpO2 was 97.1±2% vs 97.2±1.6
in patients without periodic change of SpO2 ( p=ns).
Patients showing periodic changes were significantly
older (age: 55.7±9.8 years vs 45±15.6 years, pb0.05)
compared to the patients without periodic change in SpO2
and were characterized by lower mean HR (60.8±6.4 vs
76.3±9.4; pb0.05), probably due to the bradycardia that is
usually associated with apneic episodes [18]. Pulse oximetry
performed by the Auricall® device revealed a significant
higher number of desaturation events (i.e., SpO2 b90% for at
least 10 s) in those patients compared to the ones showing no
p riodic SpO2 ch nge ( pb0.05). All other characteristics
were similar in these two groups.
This study shows that Auricall® is a valuable instrument
for the evaluation of SpO2 and HR in patients with HF.
Moreover, in those patients Auricall®, due to a qualitative
Fig. 2. Original recordings of pulse oximetric saturation (SpO2), heart rate (HR) and quality index in a patient with heart failure obtained with Auricall® device.
These are typical examples of a tracing suggesting the presence of sleep breathing disorders. In fact the SpO2 trace shows repetitive episodes of periodic deep
desaturation those are accompanied by cyclic variations in the heart rate.
Fig. 1. Auricall® device.
142 I. Sudano et al. / International Journal of Cardiology 129 (2008) 141–143
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In describing commercially available monitors we have described the types of studies and contexts in which the 
monitors have been used. However, we have not provided a detailed description of the quality or quantity of evidence 
surrounding the use of wearable monitors for inpatient monitoring.  In the next chapter we report the results of a review 
of the literature regarding the feasibility and effectiveness of inpatient monitoring. 
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 The Use of Wearable Monitors in a Hospital 
Ward Environment: A Scoping Review 
3.1 Introduction 
In the last chapter we described the range of wearable monitors available and the diverse environments in which they 
have been deployed. Evidence of successful use of a monitor in an outpatient or non-clinical context does not necessarily 
imply that it will work equally well for monitoring hospital patients. We conducted a systematic literature review with 
the primary aim of describing what is known about the feasibility of monitoring patients’ vital signs on a general hospital 
ward using wearable monitors. Secondary aims were to identify which monitoring systems were used, which vital signs 
were most commonly recorded and which metrics were used to describe monitoring system performance. 
3.2 Methods 
We chose a scoping review as the most appropriate method of addressing our research questions. Scoping reviews are a 
type of systematic review155 that are recommended for emerging fields where the quality and sources of evidence are 
more heterogeneous that in established disciplines. They are more appropriate than classical systematic reviews for 
addressing the evidence surrounding intervention feasibility.156  
As scoping reviews are a relatively new form of literature review methodology, guidelines on best practice are still 
evolving. We followed the recommendations of Peters et al156 and The Joanna Briggs Institute 2015 guidelines written 
by the same authors.157 Where appropriate, reporting was conducted according to the PRISMA guidance.158 The 
PRISMA checklist is provided in Appendix B. 
3.2.1 Eligibility criteria 
3.2.1.1 Publication type 
Publications were restricted to those describing original research. Review articles were used to identify relevant 
publications but were not eligible for inclusion themselves. There were no language restrictions. Only articles published 
from 2000 onwards were included. 
In order to ensure that the information in this chapter is as up to date as possible we have chosen to include data from 
studies published after the studies reported in this thesis were commenced. The only exceptions to this rule being 
publications arising from our work. 




We included all studies which reported monitoring of patients who were conscious, capable of independent action and 
able to provide feedback. We included children aged 4 or above in this definition. Excluded participants were those who 
were sedated, anaesthetised or had cognitive disturbances which would have made it hard for them to provide feedback 
about the monitor. Studied which involved a mixture of eligible and ineligible patients were included. 
3.2.1.3 Concept 
We included studies which reported the use of a novel wearable monitor to record temperature, HR, BP, SpO2 or RR 
and where the monitoring was carried out in an unsupervised or lightly supervised fashion. Novelty was defined as the 
monitor having been developed from 1995 onwards, 5 years prior to the earliest eligible study. 
Studies describing monitors which only recorded metrics not included in a conventional EWS, such as mobility or 
actigraphy, were excluded. Also excluded were studies where measurements were either manually initiated or tightly 
supervised, such as might occur in a controlled validation study. 
In order to be eligible, publications needed to report at least one outcome measure which related to the feasibility, 
efficacy or effectiveness of the monitoring. Studies which only reported technical metrics, such as wireless monitor 
performance were excluded. 
3.2.1.4 Context 
In order to be eligible the study needed to be conducted within a hospital environment where patients might be free to 
ambulate. Studies conducted in the emergency department and general wards were included. Those conducted in the 
outpatient setting, pre-hospital environment, laboratories, clinic rooms, investigation suites, operating theatres, intensive 
care units or high dependency units were excluded. If a publication reported data from both ineligible and eligible 
environments separately then it was included but we only reported the data from the eligible environment. 
3.2.2 Search Strategy 
The literature search was conducted using the Medline, EMBASE, CINAHL and Institute of Electrical and Electronics 
Engineers (IEEE) Xplore databases. The search was conducted using the OVID interface for Medline and EMBASE, 
the EBSCO interface for CINAHL and the IEEE Xplore Command Search interface for IEEE Xplore. The terms used 
are shown in Table 3.1. Restrictions on the number of search terms imposed by the IEEE Xplore search interface 
meant that the search strategy was slightly different for IEEE Xplore.  
We supplemented the papers identified by searching the references and for citing articles using Google Scholar. We also 
used Google Scholar to search for the names of monitors and manufacturers mentioned in the studies or review articles 
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identified by our search. Finally we added papers from our own library. The final search was conducted on the 19th Dec 
2017. 
OVID Search (Medline and EMBASE) 
1. (wireless or wearable or radio or "body sensor network").ab,ti.  
2. (monitor* or sensor* or sensing).ab,ti.  
3. (hospital* or ward* or inpatient* or "emergency department").ab,ti.  
4. 1 and 2 and 3  
5. remove duplicates from 4  
6. limit 5 to human  
7. limit 6 to yr="2000 -Current" 
 
CINAHL Search 
1. (wireless or wearable or radio or "body sensor network").ab,ti.  
2. (monitor* or sensor* or sensing).ab,ti.  
3. (hospital* or ward* or inpatient* or "emergency department").ab,ti.  
4. 1 and 2 and 3   
5. limit 4 to yr="2000 -Current" 
 
IEEE Xplore Search 
("Abstract":"wireless"  OR "Abstract": "wearable" OR "Abstract": "body sensor network"  OR "Abstract": "radio")  
AND 
("Abstract":"monitor*"  OR "Abstract": "sensor*” OR "Abstract": "sensing") 
AND 
( "Abstract":"inpatient*" OR "Abstract":"ward*" OR "Abstract":"hospital*" OR "Abstract":"emergency department") 
 
Limits: Year = 2000 – 2017 
Limits: Publication type = conference publications, journals & magazines 
Table 3.1: Search terms used for the three different  
3.2.3 Data Management 
De-duplication of results was conducted by a three stage process. Medline and EMBASE duplicates were supressed 
using the functionality provided by OVID. Search results from all four databases were subsequently imported into 
Mendeley (v 1.17.12, Mendeley Ltd) and a further scan for duplicates was conducted using the application’s in-built 
function. Finally, search results were exported to Covidence (www.covidence.org) and a third de-duplication process 
was conducted using Covidence’s duplicate detection feature. 
3.2.4 Screening and Data Extraction 
Eligible publications were identified via a two-stage screening process. Titles and abstracts were screened against the 
inclusion criteria. Full text reports were obtained for all studies meeting the inclusion criteria or where there was any 
doubt. Screening and data extraction were conducted by a single author. 
In some cases the results of a study were published in multiple forms. However, if the results of study reported in letters, 
posters, abstracts or conference proceedings were subsequently more fully reported in another form then we only 
included the most informative publication(s). In line with recommended practice, the list of items for data extraction was 
developed iteratively. A formal assessment of study bias is not undertaken when conducted a scoping review on account 
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of the heterogeneity of the literature included. 156 However, we reported potential sources of bias where these were 
evident. 
3.3 Results 
After de-duplication 1660 papers were included in the screening process. From these 8 studies were selected from full-
text search. A further 11 papers were added following manual searching. In total 19 articles were included in the 
analysis. The literature selection flow diagram is shown in Figure 3.1. 
 
Figure 3.1: Literature search flow diagram 
Only 10 publications were journal articles. 6 were conference proceedings, 2 were abstracts, 1 was an IEEE magazine 
article. The majority of  publications reported the results of feasibility studies (n = 14) Of the remainder, 2 were 
retrospective analyses of data obtained from wearable monitors, 2 were validation studies and 1 was a review article. 
Full study details are provided in Table 3.2. 
10 out of the 19 articles were published in 2014 or later, two years after the start of our research. 7 of these were journal 







8 studies selected 
based on full-text 
review
1660 studies screened 
against title and 
abstract
50 studies assessed 
for full-text eligibility 41 studies excluded
   17  Wrong outcomes
   12  Wrong study design
   10  Wrong setting
     2  Wrong intervention
     1  Wrong patient population
119 duplicates removed
1610 studies excluded
11 additional papers identified 
from manual searching
19 studies included in 
analysis
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Author Year of publication Publication type Study type Authors were employed by 
manufacturer or designed monitor 
Published before or during 2012  
Curtis et al159 2008 Journal article Feasibility study Yes 
Orphanidou et al90 2009 Conference 
proceeding 
Feasibility study No 
Kisner et al106 2009 Journal article Retrospective database 
analysis 
No 
Pollack et al160 2009 Journal article Feasibility study Yes 
Harper et al123 2010 Conference 
proceeding 
Feasibility study Yes 
Chipara et al161 2010 Conference 
proceeding 
Feasibility study Yes 
Ko et al162 2010 IEEE Magazine 
article 
Feasibility study Yes 
Donnelly et al122 2012 Conference 
proceeding 
Feasibility study Yes 
Dor et al163 2012 Conference 
proceeding 
Feasibility study Yes 
Published after 2012 
Fule et al124 2014 Abstract Feasibility study No 
Hernandez-Silveiraet 
al50 
2015 Journal article Validation study Yes 
Donnelly et al121 2015 Conference 
proceeding 
Review article Yes 
Welch et al129 2015 Journal article Retrospective database 
analysis 
Yes 
Watkins et al130 2015 Journal article Feasibility study No 
Hubner et al125 2015 Journal article Feasibility study No (but study funded by 
manufacturer) 
Lin et al 164 2016 Abstract Feasibility study No 
Boatin et al165 2016 Journal article Validation study No 
Weenk et al128 2017 Journal article Feasibility study No 
Weller et al 131 2017 Journal article Prospective study of alarm 
thresholds 
No 
Table 3.2: Publication details.  
3.3.1 Monitors and Vital Signs 
17 monitors were evaluated across the 19 studies (Table 3.3). The VisiMobile (Sotera Wireless, San Diego, USA) and 
the ZephyrLife BioPatch (Medtronic, Minneapolis, Minnesota, United States) were the only monitors to be evaluated in 
multiple studies. Three conference proceedings described the testing of monitors manufactured by Intelesens which 
were evolutions of the same monitor design. Similarly, a group from Washington State University published two reports 
describing iterations of their pulse oximeter-based system.  
Heart rate was the most commonly monitored vital sign followed by SpO2. 11 monitors incorporated an ECG sensor, 9 
included a pulse oximeter. The remaining vital signs were far less commonly recorded. 6 systems measured respiratory 
rate, 4 measured skin surface temperature and 2 measured blood pressure. The earliest report of a wearable blood 
pressure monitor was published in 2015. The majority of systems incorporated more than one type of sensor. 5 included 
both HR and RR sensors, 4 included both ECG and PPG sensors. 
Chapter 3: The Use of Wearable Monitors in a Hospital Ward Environment: A Scoping Review 
 
 41 
The majority of monitors (n = 11, 64%) transmitted data via a Personal Area Network (PAN) to a relay device (Table 
3.3). The two variants of the Aingeal monitor and the VisiMobile were the only monitors capable of direct transmission 
to Wi-Fi. The two Washington State University prototypes and MEDSiN, another academic prototype, used mesh 
networks based upon a custom network protocol and ZigBee respectively. 
Author Monitor(s) Academic Prototype/ 
Commercially available 
Sensors Data transmission 
Published before or during 2012  
Curtis et al SMART Academic Prototype ECG 
Pulse oximeter 
Patients also wore an ultrasound-
based geolocation tag 
PAN: wired connection to HP 
iPaq PDA 
WLAN: Wi-Fi 
Orphanidou et al Dyna-Vision 
DVM012S 




PAN: Bluetooth (Windows 
CE Smartphone) 
WLAN: Wi-FI 
Kisner et al Auricall Commercially available Pulse oximeter PAN: Bluetooth to mobile 
phone 
WLAN: Mobile phone 
network 
Pollack at al NetGuard Commercially available ECG PAN: Proprietary RF network 
LAN: Access points 
connected via wired network 
Harper et al Vitalsens Commercially available ECG 
Thermistor 
PAN: Bluetooth (Laptop) 
WLAN: None 
Chipara et al Washington State 
prototype 
Academic Prototype  Pulse oximeter WLAN: 802.15.4 (Telos B 
motes) 
Ko et al MEDiSN Academic Prototype Pulse oximeter WLAN: ZigBee 





Dor et al Washington State 
prototype Mk2 
Academic Prototype Pulse oximeter WLAN: 802.15.4 (Telos B 
motes) 
Published after 2012 
Fule et al LifeTouch and 
WristOx2 










PAN: Bluetooth (Tablet) 
WLAN: Wi-Fi 
Hernandez-
Silveira at al 
Sensium patch Commercially available ECG 
Impedance Pneumography 
Accelerometer 
PAN: Proprietary RF network 
LAN: Access points 
connected via wired network 
Donnelly et al PatientGuard 300 
(Aingeal v2) 








Blood pressure cuff 
Accelerometer 
WLAN: Wi-Fi 




Blood pressure cuff 
Accelerometer 
WLAN: Wi-Fi 
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Author Monitor(s) Academic Prototype/ 
Commercially available 
Sensors Data transmission 
Hubner et al Philips Cableless 
Measurements 
Commercially available Pulse oximeter 
Blood Pressure 
Accelerometer for respiratory rate 
PAN: Proprietary RF network 
LAN: Access points 
connected via wired network 




(W)LAN: Not described 




(W)LAN: Not described 
Weenk et al VisiMobile and 
HealthPatch 














PAN: Bluetooth to 
smartphone 
WLAN: Wi-Fi 




Blood pressure cuff 
Accelerometer 
WLAN: Wi-Fi 
Table 3.3: Details of publication and monitors studied. 
*The Sensium patch uses both data from impedance and ECG sensors to estimate respiratory rate 
LAN = Local Area Network, PDA = Personal Digital Assistant, PAN = Personal Area Network, RF = Radio Frequency, WLAN = Wireless Local 
Area Network, 
3.3.2 Intervention Details 
The majority of studies (n = 13) were prospective assessments of the feasibility of monitoring. The studies conducted by 
Hernandez-Silveira et al50 and Boatin et al165 were predominantly validation studies conducted in a real-world 
environment, although the latter did also report wearer feedback. The primary aim of two studies of the VisiMobile 
monitor, one prospective by Weller et al131 and one retrospective by Welch et al,129 was to determine appropriate alarm 
limits to optimise sensitive and specificity of alerting. The study of the Auricall by Kisner et al106 was a retrospective 
analysis of the effectiveness of pulse oximeter monitoring in reducing the incidence of post-operative atrial fibrillation in 
cardiac surgery patients. 
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Studies were generally small (Table 3.4). The median number of patients per study was 44 (IQR: 29-140). Notable 
exceptions were two papers evaluated alarm limits based on data from the VisiMobile monitor. Welch et al129 reported 
that the VisiMobile had been used to collect data from 3430 patients from 10 hospitals but provided no further details 
about how these data were collected. Watkins et al131 described the results of analysis based upon data from 736 
patients. The paper provided a high level description of the implementation strategy but did not clearly report how 
many patients were monitored in total. 
Monitoring periods in most studies were short. Patients were monitored for less than 8 hours during 7 out of the 16 
studies that reported the duration of monitoring. The longest reported monitoring period was over 10 days which was 
achieved for 3 patients using the Vitalsens monitor (Intelesens, Belfast, UK).123 The two retrospective database analysis 
studies suggested that wearable monitors (the VisiMobile and Auricall) had been integrated into routine clinical practice 
but did not describe typical recording duration.106,129 
3.3.3 Reported Outcomes 
Five studies, with recording durations ranging from a 2 hours to 3 days, provided results regarding the reliability of data 
transmission (Table 3.4). System reliability was reported to be good in nearly all cases. Orphanidou et al90 reported that 
during 4 hour monitoring periods ECG was acquired for 97% of recording duration, respiratory impedance 
pneumography trace 96% and PPG for 88%. In their study of patients monitored with a pulse oximeter for a median of 
25 hours, Chipara et al161 found that data were successfully transmitted (median of 99.7% data transmitted per 
recording) but typically only 81% of vital signs values per recording were valid (range 0.5% – 98%). Dor et al163 
reported that an upgraded version of the same system was able to transmit at least 70% of readings for 86% of patients. 
Weenk et al128 reported that in their study, where recordings were typically 2 to 3 days in duration, 16% of the data 
from the VisiMobile and 13% of the data from the HealthPatch were affected by artefact. The least favourable results 
were from the study of paediatric monitoring conducted by Fule et al.124 In this study, 72% of HR values but only 9% of 
SpO2 values were transmitted accurately. The mean recording duration was 2.4 days. 
Eight studies reported feedback from staff, patients or both. In all studies the feedback from staff and patients was 
reported to be either positive or strongly positive. No study used a validated questionnaire and some of the questions 
may have been phrased in a leading manner. For instance, Watkins reported that “100% [of nurses] agreed the monitor 
provided valuable patient data that increased patient safety.” 
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The study by Weenk et al128 was the only to provide a comprehensive discussion of positive and negative feedback. 
Negative issues identified were the weight of the wrist-worn VisiMobile, patient dislike of multiple leads, the nursing 
workload imposed by frequent battery changes and the fact that adhesive patches were either itchy or became 
accidentally detached.  
Five studies described practical issues relevant to successful implementation of monitoring.  Three papers,159,161,163 noted 
the improved reliability achieved through redundancy in either sensing or communication. Curtis et al159 noted that 
feedback from medical staff and bioengineers during the initial testing of their prototype did not necessarily match that 
of the patients. The two papers from the Washington State University group161,163 noted that system reliability was not 
solely dependent on the monitor but also on the hospital infrastructure, IT policies and inadvertent tampering with 
equipment. For instance cleaners would unplug wireless base stations in order to power their equipment. Finally, Weenk 
et al128 described how eight recordings from the VisiMobile were accidentally deleted and two HealthPatch recordings 
were not transmitted on account of technical failures. 
In terms of study bias we have already noted the potential for bias through the use of non-validated feedback 
questionnaires. Additionally, we note that the detail regarding the nature of the interventions, wearer compliance and 
data analysis was generally poor. Furthermore, 10 out of the 19 included at least one author employed by the 
manufacturer or were funded by the monitor manufacturer. 
3.4 Discussion 
3.4.1 Feasibility 
To date there have been no well-reported, large scale evaluations of wearable monitors in a general ward environment. 
9 out of 19 publications were conference proceedings or abstracts which, by their nature, do not allow for detailed 
reporting of methods and results.  
The most encouraging evidence for the feasibility of wearable monitoring in a hospital setting comes from the large 
databases of wearable monitor data used for the retrospective analyses conducted by Kisner et al106 and Welch et al129 
and the service evaluation reported by Weller et al.131 In all three cases the focus of the paper was not on the feasibility 
of monitoring but on analysis of the data obtained from the monitors. Little detail is provided about monitor reliability, 
data quality or patient acceptance. The Auricall monitor is no longer available. 
In general studies suggested that monitoring was feasible and feedback from staff and patients was reported to be 
positive. However, there is a risk of bias towards optimistic reporting of outcomes in the literature reviewed. 
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Questionnaires used were of dubious validity, sample sizes were small, minimal detail was provided about the 
distribution of feedback. Over half the studies were either funded or co-authored by monitor designers or employees of 
the monitor manufacturers. 
Only two studies reported difficulties with data collection when conducted over 2 to 3 days. Both were by clinicians not 
involved with the monitor design or manufacture. Fule et al reported low reliability of SpOs monitoring of children with 
a wearable pulse oximeter. Weenk et al128 reported substantial data loss on account of user error.  
A further note of caution should be raised regarding the generalisability of the results reported. A large proportion of 
studies have only evaluated the feasibility of short-term patient monitoring. A system which is successfully able to 
monitor a small cohort of patients for a few hours may not necessarily perform equally well when used for 
simultaneously monitoring large numbers of patients for multiple days. 
3.4.2 Monitors and Vital Signs 
In descending order, HR, RR and SpO2 were the most commonly recorded vital signs. The most common 
combinations of vital signs recorded were HR and SpO2 (a pulse oximeter being capable of recording both), followed by 
HR and RR. 
As might be expected, the maturity of systems has evolved over time. 4 out of the 9 studies published in 2012 or before 
reported the evaluation of academic prototypes. Thereafter all the systems evaluated were commercially available.  
However, in the same time the capabilities of most systems has remained static. With the majority of monitors only 
recording one or two vital signs. Exceptions are the Philips Cableless measurements system, which could record HR, 
RR, SpO2 and BP, and the VisiMobile could record HR, RR, SpO2, BP, and skin surface temperature. These two 
systems are unique amongst all those tested in having all the components designed by a single manufacturer and being 
specifically targeted at inpatient monitoring.b 
3.4.3 Limitations 
Even accounting for the heterogeneity of the literature, the search terms chosen for the review did not perform well. 
1779 abstracts were screened to yield 8 studies. A further 11 were identified by manual searching. This is partly 
reflective of the heterogeneity of terms used to refer to wearable monitors. As discussed above not all wireless monitors 
are wearable, nevertheless “wireless health monitoring system” is a commonly used to describe wireless wearable 
monitors. MESH terms are intended to address this problem. Use of MESH terms in the search strategy may have 
                                                        
b The Isansys system mentioned in the abstract by Fule et al has evolved over time to become orientated towards hospital monitoring 
but consists of a mixture of bespoke and third party components. 
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improved the yield from the search. Future researchers can use the set of papers identified by our search to test the 
sensitivity and specificity of different search strategies. 
Further limitations are imposed by the search tools available. The search interface provided by IEEE Xplore is poorly 
adapted for conducting systematic reviews and there are limitations on the maximum number of search terms. Some 
mitigation is provided by the fact that many IEEE Xplore publications are also indexed in the MEDLINE database. 
3.5 Conclusions 
Our comprehensive literature review demonstrates that there is a limited evidence to describe whether it is feasible to 
use novel wearable monitors for prolonged inpatient monitoring in a general ward setting. The monitoring systems 
which have been used they are typically capable of monitoring only two or 3 vital signs. Therefore integration of 
additional digital data entry systems are required if the aim is to calculate a conventional EWS. 
The literature surrounding the evaluation of wearable monitors for inpatient monitoring is immature. Consequently is 
there is considerable heterogeneity regarding the design and reporting of studies. Further work is required to 
systematically evaluate the feasibility and effectiveness of wearable monitoring.  
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 Testing of Monitor Performance in a Hospital 
Setting  
4.1 Introduction 
The aim of our research was to describe the feasibility and effectiveness of using wearable monitors for inpatient 
monitoring. In addressing this question we faced two challenges. Firstly, we needed to select a wearable monitoring 
system to form the basis of our evaluation. Secondly, we needed to devise a testing protocol. As described in the 
previous chapters, there is dearth of high quality publications evaluating wearable monitors for prolonged inpatient 
monitoring.  
In order to address these issues we devised a monitor selection process followed by study comparing shortlisted 
monitoring systems. The primary aim of study was to identify a monitor to use in a subsequent study. Secondary aims 
were to identify factors influencing monitoring success and to pilot the implementation and evaluation approaches in 
order to determine how these might be improved.  
4.2 Monitor Selection 
4.2.1 Shortlisting Criteria 
 Essential Desirable 
Data Quality & Quantity 
Vital signs to be recorded HR and* SpO2 Temperature, HR, BP, SpO2 and RR 
Waveform data Waveform data for ECG and* SpO2 of 
sufficient fidelity to allow calculation of heart 
rate variability 
Waveform data for all signals recorded 
Recording frequency At least one segment of waveform/vital sign 
reading every 5 minutes 
Continuous recording 
Data Transmission   
Transmission frequency Capable of automated periodic data 
transmission during the recording period. 
Continuous, real-time wireless data 
transmission 
Network protocols No use of proprietary network protocols Transmission of data via Wi-Fi 
Data Viewing   
Software features Ability to export data for analysis Real-time remote view of incoming data 
Other   
Wearability Wearable Small and unobtrusive 
Regulatory compliance CE marked device  
Table 4.1: Shortlisting criteria for monitoring systems. *It was acceptable for an individual monitor to record only ECG or PPG but if it did so then it 
needed to be worn together with a second monitor to record the other signal. 
We created a set of shortlisting criteria  based upon our aims, a literature review and the advice of local experts in 
telehealth (Table 4.1). We decided to mandate collection of waveform data based upon two insights. Firstly, it would be 
theoretically possible to estimate RR from either the electrocardiogram (ECG) or photoplethysmogram (PPG) 
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waveforms if the monitor did not incorporate a respiratory rate sensor. Secondly, this would allow the derivation of 
extra metrics such as heart rate variability which are associated with physiological instability.166 Such metrics might 
improve the utility of monitoring systems given the technical barriers to monitoring all the conventional vital signs. 
4.2.2 Candidate Monitoring Systems 
Candidate devices were identified based from a search of trade literature and industry contacts of local telehealth 
researchers. Three suppliers were able to provide systems matching our specifications, OBS Medical, a manufacturer of 
inpatient monitoring software, Visensia,30 and two wearable monitor manufacturers, Proteus Digital Health and 
Hidalgo.  
Table 4.2: Monitor characteristics 
Proteus Digital Health and Hidalgo both supplied systems based on their wearable monitors, the RP2 and Equivital 
EQ-02 respectively. OBS Medical supplied the Visensia software and proposed a selection of monitors which were 
compatible with the Visensia software. These included two ECG monitors, Vitalsens (Intelesens, Belfast, UK), Aingeal 
(Intelesens, Belfast, UK);  a pulse oximeter, the WristOx2 3150 (Nonin Medical, Minnesota, USA); and a monitor 
Monitor Parameters recorded Waveform data Capable of  
continuous 
recording 





Heart rate (ECG) 
Respiratory rate (via 
impedance pneumography) 
Skin surface temperature  
Activity (tri-axial acceleration)  
 ECG No 
(Set to record 
90s of data 
every 5 minutes) 
Wi-Fi No 
RP2 
(Proteus Digital Health) 
Heart rate (ECG) 
Skin surface temperature  
Activity (tri-axial acceleration) 
Electrode impedance 
No 
Only provides the timing 
and amplitude of R wave 
peaks and S wave troughs 
No 
(Set to record 





Heart rate (ECG) 
Skin surface temperature 




Heart rate (derived from the 
PPG) 
SpO2 




Heart Rate (derived from 
both ECG and PPG) 
SpO2 




Yes Bluetooth No 
Equivital EQ-02 Heart Rate (ECG and PPG) 
Arterial oxygen saturation 
Skin surface temperature 
Respiratory rate (via 
impedance plethysmography) 
Activity (tri-axial acceleration) 
ECG 
PPG 
Yes Bluetooth Yes 
Chapter 4: Testing of Monitor Performance in a Hospital Setting 
 
 51 
capable of recording both ECG and PPG, the Dyna-Vision DVM 012S. A summary of monitor characteristics is 
provided in Table 4.2. Full descriptions of the individual systems are provided below. 
4.2.2.1 Aingeal 
     
Figure 4.1: The Aingeal monitor. Left: detached from the electrodes. Right: the monitor being worn  
The Aingeal (Intelesens, Belfast, UK) is a small ovoid monitor worn close to the cardiac apex. It attaches to one of two 
large adhesive electrodes using magnets. It is capable of recording heart rate via ECG, respiratory rate via transthoracic 
impedance and skin surface temperature using a thermometer embedded within one of the electrodes. The ECG and 
transthoracic impedance waveforms are recorded in segments of a configurable duration at configurable intervals. A 
single temperature value is given per recording segment. For the purposes of our study, the manufacturer configured the 
monitors to record 90s of ECG every 5 minutes. 
Data from the Aingeal is transmitted via Wi-Fi to a remote computer running the manufacturer’s Canberra software. 
The version tested (v 1.1) had two components, a logging component needed be installed on a computer running the 
Linux operating system and a web-based data viewing application which allows the user to view static segments of ECG 
and impedance pneumography waveform. In response to the problems identified in the previous, office-based testing, 
the manufacturer provided a software patch to correct the data corruption flaws. This was applied by researchers 
shortly before the start of testing. 
Data were stored in an encoded format in a MySQL database. The manufacturer-recommended process for data 
extraction required manually exporting data from the database using the phpMyAdmin database querying application. 
Recordings are not stored on the device. Therefore failure of transmission or data logging components results in data 
loss. 
OBS Medical liaised with the manufacturer to develop a solution, based on the Mirth Connect HL7 integration engine, 
to periodically poll the MySQL database and transmit the latest HR values for display in Visensia (v3.2). 
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4.2.2.2 Dyna-Vision DVM012S 
      
Figure 4.2: The Dyna-Vision monitor. Left: the main monitor module. Right: the monitor being worn. (Images courtesy of RS TechMedic) 
The Dyna-Vision DVM012S (RS TechMedic, Broek op Langedijk, The Netherlands) is a multi-parameter monitor 
worn in a belt holster or carried around the neck in a bag. It is capable of recording 3, 5 or 12 lead ECG using 
conventional ECGs attached to adhesive electrodes, respiratory rate using a respiratory inductance plethysmography 
band and PPG using integrated pulse oximetry circuitry developed by Nonin Medical. We did not use the inductance 
plethysmography band in our testing as previous testing had indicated that patients found it uncomfortable.90 
The monitor is capable of storing data on device or continuously transmitting via Bluetooth but cannot do both 
simultaneously. Therefore, when set to transmit data remotely any failure of transmission or logging systems results in 
data loss. The manufacturer did not supply software for remote real-time data viewing therefore OBS Medical 
developed a custom smartphone application, Bluetooth Forwarder, to receive data from Bluetooth-based monitors and 
retransmit it over a Wi-Fi network to a server running Visensia. 
Visensia was unique amongst all the data viewing applications in providing a remote automatically updating real-time 
view of both vital signs and waveform data. All data recorded by Visensia were stored in plain text log files. Waveform 
data in these files were encoded. The manufacturer did not supply any tools for data extraction therefore we were 
required to write a custom script in Matlab to decode the waveform data and make the log files tractable for analysis.  
4.2.2.3 Equivital EQ-02 
The Equivital EQ-02 (Hidalgo, Swavesey, UK)  is a monitor approximately the size of a credit card and 11mm thick. It 
is carried in the pocket of a belt worn around the thorax which incorporates dry ECG electrodes, a respiratory 
inductance pneumography sensor, and an accessory module connector for addition of further sensors such as the 
XPOD 3012LP (Nonin Medical) pulse oximeter used in our study. The monitor itself also incorporates an IR camera 
and thermistor for temperature measurements, an accelerometer and a radio for communication with an ingestible 
 
 






3-lead 5-lead 12-lead 
OTHER CONFIGURATIONS 
Other configurations are possible and should be based on the indication for using the device.   
CONNECTING THE CABLE TO THE DEVICE 
The cable has a metal plug. Insert the plug in the port at the top side of Dyna-Vision™. On the front 
side of the device you will find the indicators for the correct port.  
There is a red dot indicator on the plug that corresponds with a red dot on the connector in the 
device. The plug only fits in one direction. If inserting the plug does not go smoothly.  
 
Inserted ECG cable 
Note: do not force (!) the plug into the connector. Damage to the plug and/or the device may occur.  
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thermometer capsule. All parameters are measured continuously with waveform data being provided for the ECG, 
PPG, accelerometry and inductance plethysmography. 
     
Figure 4.3: Components of the Equivital EQ-02 monitoring system. Left: the main monitor module. Middle: the Nonin XPOD module (blue) 
connected to a conventional pulse oximeter probe. Right: the thoracic band. The grey pocket on the lateral aspect of the belt contained connectors for 
the monitor module and XPOD. Although it was only designed to hold the monitor module, we found the pocket was sufficiently large to hold the 
XPOD also. (Middle image courtesy of Nonin Medical. Right hand image courtesy of Hidalgo) 
All recorded data is logged on the on-board memory. Vital signs and waveform data may be simultaneously transmitted 
via Bluetooth to a paired laptop running the manufacturer’s EqView Professional viewing software (v 4.0.8). 
Alternatively a manufacturer-supplied smartphone application can be used to forward vital signs, but not waveform, to 
the EqView Professional installed on a remote computer. 
A data download tool with an intuitive graphical user interface is provided by the manufacturer for managing 
recordings stored on the monitor. This automates conversion of the data to the easily-parsed CSV format. 
4.2.2.4 RP2 
 
Figure 4.4: The RP2 monitor 
The RP2 (Proteus Digital Health, California, USA) is a single-use, disposable adhesive patch containing an ECG sensor, 
an internal thermometer, an accelerometer and an electrode impedance meter for measuring the quality of electrode 
contact with the skin. The monitor is only capable of intermittent recording and for the ECG R wave peaks and S wave 
troughs are recorded. The manufacturer advised us that the thermometer was more a measure of device temperature 
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than patient temperature and was affected by the amount of insulation around the sensor (e.g. clothing, whether the 
patient was under a blanket).  
Data from sensors are recorded sequentially. For the purposes of this study the manufacturer configured the RP2 to 
sample ECG for 16 seconds followed by 4 seconds of accelerometry and a single temperature measurement before the 
next ECG acquisition phase. 
Data are transmitted via Bluetooth to an Android smartphone running the mTiles software (v 2.0). This transmits data 
via Wi-Fi or cellular radio to a logging server hosted by the manufacturer. If connection between either the monitor and 
phone or phone and server is interrupted the software is capable of re-transmitting data retrospectively. This is carried 
out on an opportunistic basis. The user may also manually prompt data upload at any point. Following a recording 
session data could be retrieved from the device’s on-board memory. At the time of testing this required us to send the 
patch back to the manufacturer. 
A web-based application was provided by the manufacturer to view a summary of recorded HRs and download data. 
Like the Aingeal web-based viewer, the software required manual refreshing to provide an updated view of the latest 
data. 
4.2.2.5 Vitalsens 
     
Figure 4.5: The Vitalsens monitor. Left: The monitor itself. Right: The monitor being worn. 
The Vitalsens, developed by the same manufacturer as the Aingeal is an ECG monitor that shares many of the same 
features of the Aingeal monitor. Like the Aingeal it records ECG and skin surface temperature and magnetically 
attaches to adhesive electrodes placed on the wearer’s thorax. However, the device is not capable of recording 
respiratory rate. 
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Data transmission is via Bluetooth and the monitor has no on-board memory. The Bluetooth Forwarder application 
was used to transmit data to Visensia. Data viewing and analysis procedures were the same as for the other Visensia-
based systems. 
4.2.2.6 WristOx2 3150 
 
 
Figure 4.6: The WristOx2 3150 monitor 
The WristOx2 3150 (Nonin Medical, Minnesota, USA) is a pulse oximeter worn on the wrist which records data from a 
fingertip probe. It records and transmits data continuously. It was unique incorporating a digital display, which was 
used to showing the current vital sign values, the remaining battery charge  and whether the Bluetooth radio is active. It 
was also unique in being the only monitor with removable batteries (3x AAA). 
The manufacturer-supplied software is only capable of logging data sent directly via Bluetooth to a paired laptop. 
However, the Bluetooth Forwarder smartphone application supplied by OBS Medical was capable of transmitting 
waveform data to Visensia. The WristOx2 3150 has no on-board memory so failure of data transmission or logging 
causes data loss. 
4.2.3 Pre-study Shortlisting Process 
With the exception of the Equivital, which was only released shortly before the clinical study, systems were optimised 
based upon a three month troubleshooting study carried out in an office environment. Problems identified as a result of 
this process ranged from flaws in software and device firmware, to usability problems that caused errors in system use.  
Based on our findings we decided exclude the Vitalsens monitor from further evaluation on the basis that data 
transmission was significantly more unreliable than all other systems and no obvious mitigations could be identified. 
Also on the basis of poor reliability, we also decided to forgo the integration of the Aingeal with the Visensia system, 
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opting to use the manufacturer’s own software, Canberra, instead. Other notable issues identified and mitigations 
implemented are listed in Table 4.3. Following the troubleshooting phase the formal study commenced. 
Monitor Problems Identified Mitigation 
Aingeal  Software flaws causing corruption of recorded data Manufacturer to address flaws affecting  timestamps and 
corrupted data due to partial transmission and provide a newer 
version of the Canberra software 
Recordings not captured at the configured intervals Settings used for recording (40s of ECG every 60s) might be 
causing a malfunction. Maximum recommended intensity 
should be 90s of ECG every 5 minutes. 
Monitors to be sent back to manufacturers for investigation of 
whether there were any problems with system configuration 
and for input of new settings 
Device connection to server intermittently unreliable. 
No reproducible cause for failure identified. 
Rather than use the Canberra software running within a Linux 
virtual machine on a PC, use a dedicated laptop running Linux 
natively to minimise complexity of system setup 
Wearers found audible alarms intrusive Manufacturer to disable audible alarms 
High incidence of skin rash after removal. (Pads used an 
adhesive designed to bond strongly to skin for at least 48 
hours) 
No suggested mitigation for high incidence of skin rash after 
adhesive pad removal. Manufacturer unable to change the 
adhesive 
Under some circumstances charging status light 
suggested devices were fully charged when they were 
not. 
Creation of a charging Standard Operating Procedure (SOP) to 
ensure that devices were fully charged 
Dyna-Vision Unpredictable intermittent transmission failure which 
occasionally could not be rectified even by full system 
reset 
An older, more thoroughly tested, version of Bluetooth 
Forwarder to be used with Dyna-Vision. 
Troubleshooting SOP to systematically restart system 
components. 
Upgrade to a newer version of Visensia which had a more 
reliable system architecture 
Study protocol to allow exchange of monitors midway through 
a recording period if standard troubleshooting procedures 
failure to restart transmission 
Periodic checks of Visensia to ensure data transmission ongoing 
Flashing power light can indicate either: battery low, 
battery charging or charging complete. This can lead to 
mistaking a nearly depleted battery for a fully charged 
battery 
Creation of a charging SOP to ensure that devices were fully 
charged 
WristOx2 Bluetooth radio turned off if wearer accidentally pressed 
a button on the monitor 
Periodic checks of Visensia to ensure data transmission ongoing 
Bluetooth radio turned off automatically to conserve 
power if monitor lost Bluetooth connection with 
smartphone 
Periodic checks of Visensia to ensure data transmission ongoing 
Smartphone battery capacity insufficient for continuous 
transmission over 24 hours 
Connect smartphone to an external USB battery pack 
RP2 High incidence of skin rash after removal. (Pads used an 
adhesive designed to bond strongly to skin for 
prolonged periods) 
Adhesive on patch to be changed to reduce the incidence of 
rash on removal 
Common issues Poor routing of cables and wearing of device negatively 
impacted user acceptance 
Provision of an advice sheet to help wearers  wear devices 
optimally 
Preferences on how to wear the same monitor varied 
between individuals 
Allow wearers to choose between different bags styles for 
carrying monitors and associated equipment 
Pulse oximeter probes poorly tolerated Choice of silicone rubber probes as the best tolerated style of 
probe 
Table 4.3: Problems identified during troubleshooting and associated mitigation strategies 
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4.3 Formal Study Methods 
The study was a four-arm unblinded non-randomised trial. Ethical approval was obtained from the Research Ethics 
Committee for Wales (08/MRE09/50). The reporting of the study is in accordance with the TIDieR guidelines for the 
reporting of studies of interventions.167 The completed TIDieR checklist is provided in Appendix B. 
4.3.1 Participants & Setting 
We recruited adult inpatients admitted to the Acute General Medicine, Care of the Elderly and Acute General Surgery 
wards of the John Radcliffe Hospital. Exclusion criteria were confusion, an inability to speak or comprehend English 
fluently, an anticipated length of stay less than 2 days as judged by the patient’s care team, being continuously 
monitored using other monitors, significant on-going pain or psychological distress, any condition which might make 
wearing the equipment dangerous or impractical, and being bedbound. 
Screening was conducted by ward nurses. Eligibility was assessed by the researchers. Patients’ mobility was assessed by 
researchers at the time of recruitment and scored from 1 to 5, where 1 indicated that the patient was bed-bound and 5 
indicated that the patient was able to walk independently (Table 4.4). 
Score Mobility 
1 Bedbound 
2 Needs the aid of two people to mobilise 
3 Needs the aid of one person to mobilise 
4 Able to mobilise alone but with difficulties 
5 Able to mobilise independently 
 Table 4.4: Mobility score 
4.3.2 Equipment 
The WristOx2 3150 was paired with each of the ECG monitors, the Aingeal and the RP2, to form monitoring systems 
capable of recording both ECG and PPG (Figure 4.7). 
Third party software, Visensia (v. 3.2, OBS Medical, Abingdon, UK)  was used to log data from the WristOx2 and 
Dyna-vision. Smartphones running Bluetooth to Wi-Fi bridging software, Bluetooth Forwarder (OBS Medical, 
Abingdon, UK), were used to transmit data from the monitors to the Visensia monitoring station, which was located in 
a research office on the hospital site. All other monitors were used with the manufacturer’s own software. Data 
transmission pathways are summarised in Figure 4.7.  




Figure 4.7: Data transmission pathways for the four monitoring systems tested. The components of each monitoring system that were given to patients 
are contained within the grey boxes. With the exception of the Equivital, all  monitors transmitted data via the hospital Wi-Fi network, either directly, 
in the case of the Aingeal, or via a smartphone in the case of all other monitors. The Aingeal data was logged by the Canberra software. RP2 data was 
logged by the RaisinMed software. Dyna-Vision and WristOx2 data was logged using Visensia. Logging software was installed on dedicated servers in 
all cases. 
Data from the Equivital could only be viewed during the recording using a laptop at the patient bedside. The 
manufacturer had developed a smartphone application running on Blackberry smartphones for transmitting vital signs 
data to a remote viewing station but it was not capable of forwarding waveform data at the time of testing. At the time 
of testing a more full-featured version for Android smartphones was under development. Rather than invest in the soon-
to-be-obsolete Blackberry-based system we opted to forgo the use of the smartphone application, reasoning that we 
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4.3.3 Study Procedures 
Participants were asked to wear the monitors for at least 24 hours, temporarily removing them only if necessary for 
clinical or hygiene reasons. Unless the participant preferred to fit the monitors themselves, the monitors were fitted by a 
researcher. The manner in which the monitors were fitted was informed by the manufacturers’ instructions and the 
researchers’ own experience of wearing the equipment. Irrespective of whether the participant or the researcher fitted 
the monitor, the fit was verified by the researcher. This was especially important for the Equivital which required the 
correct sized belt to be selected from the 9 options available. 
For all systems except the Equivital, bags were provided to hold the smartphone and battery packs. Participants were 
given a choice of waist-worn or hand-carried bags. The standard method of fitting the monitors is illustrated in Figure 
4.8. Silicone rubber PPG probes (Purelight 8000SM-3, Nonin, Minnesota, USA) were used with all systems. 
Participants were provided with an advice sheet regarding the care and use of the equipment they were wearing, contact 
details for the research nurse and a form to log any events which they felt might have relevance to the study, such as 
periods during which they removed the monitor. 
A copy of the participant advice sheet was placed in the nursing folder and verbal advice was given to the nurse caring 
for the patient at the time of recruitment. At the end of the monitoring period the patients were examined for skin 
rashes caused by the devices and were asked to complete a short questionnaire after which an unstructured interview 
took place, regarding the experience of wearing the monitoring equipment. Interview notes were documented on the 
study case report form during or immediately after the interview by the interviewer.  
During the monitoring period researchers visited patients intermittently to ensure that monitoring was continuing 
successfully. Researcher visits were prompted by observing a gap in incoming data on the remote monitoring display, 
calls from the ward staff or could be unprompted. Researchers were not routinely available after 6pm. During working 
hours their ability to observe problems was limited by the time devoted to other study-related activities. Faults and the 
actions taken to rectify them were logged. Researchers were given the discretion to implement any reasonable solution 
to rectify equipment failure, including substitution of a failed monitor with a different one of the same type during the 
recording session. 
 




Figure 4.8: The manner in which the monitors were worn. a) Aingeal/WristOx2, b) Dyna-Vision, c) RP2/WristOx2, d) Equivital (pulse oximeter not 
shown). The waist-worn bag (required for all systems except the Equivital) contained the smartphone(s) and USB battery pack. Patients were advised 
to store the Dyna-Vision monitor in the bag as shown in b). The Equivital monitor and associated pulse oximetry module were stored in the silver 
pouch on the lateral aspect of the wearer’s chest. 
4.3.4 Personnel Delivering the Intervention 
The majority of study procedures were carried out by a research nurse, who had previously worked as an Operating 
Department Practitioner and was thus familiar with a wide range of conventional physiological monitoring equipment. 
Additionally the research nurse had used previously the Dyna-Vision to collect data from 18 elderly hospitalised patients 
in a previous study.90 Technical support and cover for exceptional circumstances was provided by a clinical research 
fellow  trained in Acute Internal Medicine and Intensive Care. Neither researcher had an experience of installing or 
using wearable monitors beyond the office-based troubleshooting already described. 
4.3.5 Outcome Measures 
In contrast to classical efficacy trials which require primary and secondary endpoints, the best design studies intended to 
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inputs into the decision regarding which device to select: system reliability, acceptability of the monitors to patients and 
the causes of failure. Understanding why systems failed allows judgements to be made regarding how easy the failures 
might be to mitigate in future studies. 
4.3.5.1 Measures of Reliability 
Overall reliability was summarised as the proportion of the intended monitoring time for which the wearable monitor 
simultaneously recorded ECG and PPG. We termed this metric the Data Capture Rate{ECG, PPG} (DCR{E,P}). Data 
capture rates were also calculated for ECG (DCRE) and PPG (DCRP) individually. The intended monitoring time was 
defined as the difference between the time the monitor was initially fitted and the time the researcher arrived at the 
patient bedside to remove the monitor. 
As defined here, overall reliability measures the effects of both technical failures, loss of battery power and patient 
removal. Of these three technical failures are potentially the hardest to mitigate. Therefore we also report the technical 
reliability, calculated as the DCRs of systems during the periods they were worn and had power. The times of battery 
failure or device removal were defined as the last recorded data point prior to an entry in the researcher fault logs 
indicating that a patient had removed the device or a flat battery was identified. 
4.3.5.2 Measures of Acceptability 
Quantitative measures of acceptability were the length of time patients accepted to wear the monitor, feedback 
questionnaire scores and the incidence of skin rash. Qualitative descriptors were provided by the summarised interview 
feedback. 
4.3.5.3 Causes of Failure 
Failure counts and types were collected from the research and participant event logs. Unlike the other systems, the 
Equivital and RP2 periodically reported battery voltage in their data files. For these devices the incidence of battery 
depletion was collected from the data files. 
4.3.6 Sample Size & Allocation Procedures 
A convenience sample of 48 patients, 12 per study arm, was chosen for the study. The sample size was primarily limited 
by the time and resource available to conduct the research. As the results of this study were primarily intended to inform 
a future feasibility study, we aimed to limit data collection to a 3 month period. Patients who wore the monitor for less 
than 20 hours on account of clinical reasons (such as being taken to theatre) were excluded from the study and another 
patient was recruited in their stead.  
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Participants were allocated to wear one of four sets of monitors; Aingeal/WristOx2, Dyna-Vision, Equivital, 
RP2/WristOx2. Allocation to the cohort was done according to a gender-specific precompiled lookup tables designed to 
ensure that each monitor was worn the same number of times by participants of each gender and that the sequential 
patients were not allocated the same system, so as to avoid equipment shortages. The tables were compiled manually. 
Recruitment of replacements was carried out at the end of the study. No precompiled tables existed for the recruitment 
of replacements. 
4.3.7 Data Handling 
Study data were recorded on paper case report forms which were subsequently transcribed into a Microsoft Excel 
spreadsheet. Incidents in the participant and researcher logs were classified on transcription using a predefined scheme. 
Microsoft Excel was used to analyse data from the case report forms. 
Recordings from the monitors were exported as CSV files. Recordings longer than 24 hours were truncated at 24 hours. 
Only ECG and PPG data were included in the analysis. Other physiological parameters such as skin surface 
temperature were not examined. Matlab (MathWorks, Natick, Massachusetts, USA) was used to inspect and analyse the 
recorded data. 
For both data from the case report forms and from the log files, summary data are given as medians followed by the 
interquartile range in brackets. 
4.3.8 Statistical Evaluation 
Formal statistical comparison between results pertaining to the four monitoring systems and five individual monitors 
was not attempted as the number of subjects relative to the number of comparisons was very small and so the chances of 
any difference reaching statistical significance were low. Unless otherwise specified, measures were summarised as 
medians followed by the interquartile range (IQR) in brackets. 
4.4 Results 
4.4.1 Recruitment 
In total 50 patients were enrolled in the trial between October and December 2011. Of these 6 were replacements for 
patients who withdrew early for clinical reasons. Recruitment of patients to the Aingeal/WristOx2 cohort was 
terminated early when it became apparent that the manufacturer’s software patch had been incorrectly applied, causing 
corruption of all data from the Aingeal. As the system failure was caused by a software installation error rather than an 
inherent problem with the Aingeal monitor data from the Aingeal cohort was excluded from subsequent analysis. 
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Following the exclusion of the patients who withdrew early for clinical reasons and the patients in the Aingeal cohort, 
data from 35 patients were analysed; 12 in each of the Equivital and RP2/WristOx2 cohorts and 11 in the Dyna-Vision 
cohort (dFigure 4.9). The Dyna-Vision cohort was short of one patient due to an error in recruitment. 
 
 
dFigure 4.9: CONSORT recruitment flow diagram 
There were notable differences in the cohort demographics. Patients in the Equivital cohort tended to be younger than 
in the other cohorts and there was a male preponderance. 75% of patients in the RP2 cohort were recruited from 
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358 Assessed for 
eligibility
8 excluded due to 
total failure of 
Aingeal
50 Recruited
8 allocated to 
Aingeal/WristOx
13 allocated to 
Dynavision
2 excluded due to 
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Equivital







     84 Anticipated discharge or
          transfer to theatre
     62 Confusion
     32 Distress 
     13 Unable to walk
     12 Palliation
     10 Ongoing monitoring
     4 Communication issues
     17 Other reason monitoring
          impractical
  74 Declined to participate
0 analysed 11 analysed 12 analysed 12 analysed
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5 (3-5) 5 (5-5) 4.5 (4-5) 
Table 4.5: Participant demographics. Figures for the gender and ward are the total number of subjects. The remaining figures are medians followed 
by the interquartile range in brackets 
4.4.2 Compliance with the Intervention 
The majority of patients in each cohort wore the assigned monitoring equipment for at least 24 hours with the exception 
of the Dyna-Vision cohort (Table 4.6). The most common reason for early removal was patient request. 
 
Dyna-Vision Equivital RP2 WristOx2 
Number of times worn for ≥24 hours 5 8 9 7 
Reasons for early removal 
    Clinical 0 2 0 0 
    Patient request 4 2 1 3 
    Accidentally detached 2 0 1 1 
    Unknown 0 0 1 1 










Table 4.6: Duration monitors worn and reasons for early removal 
During the study two of the Equivital’s pulse oximetry modules failed. 8 patients had non-functioning modules applied 
before the problem was detected. In order to give an indication of the performance of the system when all components 
were operational, results for the sub-cohort with fully functional pulse oximetry modules are reported separately in the 
results tables. 
4.4.3 System Reliability 
Irrespective of the monitoring system, there were few instances where PPG was recorded without simultaneous ECG. 
Therefore the data capture rate for simultaneous ECG and PPG was determined by the performance of the pulse 
oximeter component. The RP2/WristOx2 set of monitors was the most reliable overall with a data capture rate for both 
ECG and PPG of 55% (Table 4.6). The median data capture rates for the individual monitors were; RP2 94%, 
WristOx2 55%, Equivital ECG 52%, Equivital PPG 44% and Dyna-Vision 38% for both ECG and PPG. 
The largest cause of data loss was premature termination of recording. This was caused either by battery failure or early 
removal of the monitors. Across all 47 recordings made by the individual monitors (11 Dyna-Vision, 12 Equivital, 12 
RP2 and 12 WristOx2)  only 14 (30%) spanned 24 hours. 6 were made by the RP2, 5 by the WristOx2 and 3 by the 
Dyna-Vision (Table 4.7). Only 7 recordings (15%) spanned 24 hours and contained more than 90% data. 6 of these 
were RP2 recordings and 1 from the WristOx2. In the case of the three Dyna-Vision recordings, one of these recordings 
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only contained 4.2 hours of data and the remaining two recordings were achieved by swapping monitors mid-study 
when the initial monitors unexpectedly failed.  
From the perspective of technical reliability (the DCRs for the periods that the monitor was both powered and worn) he 
Equivital was the most reliable system overall, recording both ECG and PPG for a median of 94% of the time it was 
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Table 4.8: Technical reliability – data capture rates during the periods when the monitors were powered and being worn 
4.4.4 Causes of Failure 
A total of 82 failure events, which included early removal of equipment, were logged by researchers (46 events) and 
participants (36 events). Researchers identified issues with the Dyna-Vision 23 times, WristOx2 19 times, Equivital 4 
times and RP2 twice. 66 of the 82 events could be linked to gaps in the recorded data, accounting for 6% of all data lost. 
Thus the majority of data loss was caused by failures which were not observed during the study. The ratio of observed 
to unobserved data gaps was similar across all monitors. The failures identified from researcher and participant logs are 
summarised in Table 4.9. 
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With the exception of the RP2, battery failure affected the reliability of all monitors, either directly or indirectly. 
According to device log files, the Equivital battery failed early for all studies, with a median battery life of 12 hours when 
both ECG and PPG sensors were functional. The Dyna-Vision battery was noted to be depleted prior to the end of 
study on two occasions. As the monitor was frequently removed early or exchanged due to malfunction it may be that 
the other failures masked a inadequacy in the battery capacity.  
 Dyna-Vision Equivital RP2 WristOx2 Total 
Device removed early 
(excluding removal for clinical reasons) 
6 2 1 4 13 
    Not tolerated by patient 4 2 0 3 9 
    Accidentally detached and not re-fitted 2 0 1 1 4 
Temporary removal 16 6 0 17 39 
     Interfering with activities 15 4 0 11 30 
     Discomfort 1 2 0 0 3 
     Accidentally detached and re-fitted 0 0 0 6 6 
Data transmission errors observed 8 N/A 0 7 15 
Researcher unable to identify cause 8 N/A 0 2 10 
Bluetooth turned off 0 N/A 0 2 2 
Phone malfunction - all causes 0 N/A 0 3 3 
Phone Battery Depletion 0 0 0 3 3 
Monitor Battery Depletion 2     




0 0 0 
Table 4.9: Causes of device failure gathered from researcher and participant logs 
Battery failure also affected the Motorola FlipOut smartphones used with the WristOx2, which failed if the accessory 
battery pack became accidentally disconnected. Once this was identified as a recurrent problem phones were plugged 
into charge at the patient’s bedside, increasing the risk that they would be left behind when the patient moved away 
from their bed space. 
It is not clear whether the battery capacity of the WristOx2 itself was sufficient to allow recording for the full 24 hours. 
Unlike the Equivital and RP2 log files, battery status was not recorded in the WristOx2 log files. However, no recording 
contained 24 hours of data. The maximum amount of data captured in a single WristOx2 recording was 21.8 hours. 
WristOx2 recordings which spanned over 24 hours contained significant gaps. These may represent periods during 
which the device was temporarily turned off.  
Device removal, both permanent and temporary was a common cause of data loss, being observed on 42 occasions. 
Permanent removal was caused either due to patient discomfort or because the device accidentally became detached. 
The fact that patients did not seek to re-fit devices once they had become detached suggests that either they did not wish 
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to continue wearing them or that re-fitting was perceived to be too complex. The device most commonly removed 
before the end of the study was the Dyna-Vision, with 6 out of 11 recordings terminated due to early device removal, 
followed by the WristOx2 (4 out of 12 studies). The Equivital was removed early on 2 occasions and the RP2 fell off 
once when applied to a diaphoretic patient. The WristOx2 was the only monitor to repeatedly fall off accidentally. This 
was caused by a flaw in the design of the monitor’s Velcro wristband which predisposed it to catching on objects and 
becoming unravelled.  
Transmission failures were a frequent problem with the Visensia-based systems. Despite adopting a systematic 
troubleshooting approach, researchers were frequently unable to pinpoint the precise source of failure. This was more 
common with the Dyna-Vision and on two occasions the researcher needed to replace both monitor and smartphone 
before transmission could be resumed.  
Hardware failure affected the Equivital recordings. Internal breaks in the pulse oximetry module cable occurred where 
the cable was soldered to the connector. The connector had a retractable collar which needed to be disengaged before 
the connector could be unmated. This was not immediately obvious and it is likely that excessive force was applied to 
the connectors by either untrained or forgetful users when trying to remove the pulse oximeter module. 
4.4.5 Acceptability 
Questionnaire responses, giving ratings for discomfort, interference with activity and embarrassment caused by wearing 
the device are shown in Table 4.10. The RP2 was the best tolerated device and the Dyna-Vision the worst. However, 
although the Equivital scored better on the discomfort rating than the Dyna-Vision, more people said that they would 
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Median Discomfort Rating (IQR) 30 
(17 – 46) 
13 
(0 – 30) 
1 
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7 
(1.5 – 40) 
Median Interference Rating (IQR)  30 
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Median Embarrassment Rating (IQR) 0 
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Projected wearing time 
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Table 4.10: Questionnaire results .The range of values for the questions on discomfort, interference and embarrassment is 0-120, with a higher value 
indicating a more negative opinion. 
Interview feedback was reasonably consistent. Wearers of the Dyna-Vision highlighted the long wires (n=8) and the 
need to carry the monitor in a shoulder bag (n=5) as barriers to acceptability. 3 wearers of the Equivital described it as 
mildly uncomfortable due to constriction of the thorax by the belt. However, given the low projected wearing time given 
by most wearers, it is likely that the interviewees did not clearly express the full extent of the discomfort caused by the 
belt or there was another unexplored issue affecting tolerance. 11 out of the 12 wearers of the RP2 said that they forgot 
they were wearing it. In contrast to our previous office-based testing, no participants experienced a rash or pain on 
removal of the RP2. Recurrently highlighted problems with the WristOx2 were the strap coming undone (n=6) and 
interference with activities (n=4). 
4.5 Discussion 
None of the systems we tested reliably recorded both ECG and PPG for over 20 hours. Data loss was caused by a 
combination of the unreliability of the monitoring systems, poor patient acceptance, poor usability and flaws in the 
intervention design. The poor system reliability stands in contrast to the majority of the existing studies in the literature. 
However, they are concordant with reports by Fule et al who reported a 9% data capture rate for the PPG when using 
the WristOx2 3150 to monitor children.124 A notable exception to the poor system reliability observed in our testing was 
the RP2 which had a data capture rate of 95% and high user acceptance ratings. 
4.5.1 Reliability 
The Dyna-Vision was frequently affected by unexplained transmission failures. Given that the transmission failures are 
common to all Visensia-based systems it seems likely that either the Visensia software or the bridging software were at 
least partially responsible. The incidence of transmission failures with the WristOx2 3150 was lower than that of the 
Dyna-Vision therefore the Visensia software cannot be entirely responsible. The persistent unexplained issues with data 
transmission highlight the potential pitfalls inherent in assembling a monitoring system using multiple components from 
different manufacturers. 
The WristOx2 failures observed were primarily due to the device becoming detached or needing to be removed because 
of interference with patient activity. At least one third party has manufactured replacement wristbands for the 
WristOx2169 suggesting that others have also observed similar problems with accidental detachment. Interference with 
routine activities was a problem shared by the pulse oximeter probes of all the monitors but in the case of the WristOx2 
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3150 the issue was further compounded by the fact that or the fact that the device automatically powered down if the 
pulse oximeter probe became disconnected from the body of the device.  
When functioning normally, the Equivital, was the most reliable device, partly because it was not subject to data loss 
from transmission failures.c However, it was affected by two significant flaws, the failure of the pulse oximeters, and the 
early battery depletion. These issues were not identified until late in the study for three reasons, poor usability, poor 
visibility of failure and inadequately rigorous study procedures. 
The effect of seemingly small usability problems is well illustrated by the failure to detect the early battery failure of the 
Equivital monitors. Post hoc analysis revealed four separate usability flaws which acted in concert to conceal the fact 
that the batteries were being depleted mid study. Firstly, the power light on an operational monitor turned off 
automatically after 3 minutes to conserve battery. Thus at the end of the study a functional monitor had the same 
external appearance as one with a depleted battery. Secondly, although the power light was set to re-illuminate in the 
event of low battery charge it was hidden beneath the wearer’s clothing and the fabric of the belt pocket in which it was 
worn, making the chance of opportunistic detection of a failing battery was low. Thirdly, when the monitor was plugged 
into the computer at the end of the study the battery icon was initially displayed as having full charge due to a software 
bug, briefly updating to show the true status 5-10 seconds later before changing again to show an animated charging 
icon whose appearance gave no indication of current battery charge. In routine use of the software, users would 
normally switch to the download screen, hiding the battery icon before it had updated. As a result the three possible 
icon states were not observed until after two months of use. Finally the numerical display of battery status showed 
battery voltage. Knowing the voltage to be around 4300mV when the battery was fully charged and erroneously 
believing battery charge to be directly proportional to voltage, researchers were falsely reassured by seeing a residual 
charge of 3800mV when the devices were collected at the end of the study. Had the battery level been reported in a 
more familiar fashion, such as a percentage of total capacity, this error would not have been made. 
The relative unfamiliarity of the Equivital to the researchers provided a significant disadvantage in using it optimally. 
All other devices tested had been used by the researchers over a period of 3-6 months prior to this study. As a result 
multiple device-specific issues had been identified and the standard operating procedures had been written in the 
knowledge of these problems. The Equivital did not benefit from this process. Once identified, usability problems are 
often easy to mitigate. It is likely that had the study been repeated immediately following its completion the data capture 
rates for the Equivital would be significantly improved. 
                                                        
c Though even if data were being transmitted in real-time, the simultaneous storage of recordings in the device’s on-board memory 
would have mitigated data loss caused by transmission failure. 
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Another key principle illustrated by our findings is the importance of visibility of failure. Both the Equivital and Aingeal 
systems suffered from systematic failures which had a significant consequences in terms of data loss. As installed, neither 
of these systems benefited from data viewing software which made it easy to view incoming data remotely. The 
Canberra system had no live updating facility and had a cumbersome interface for manually reviewing the latest 
incoming data. In retrospect the decision not to use the Equivital smartphone system on the basis that it only 
transmitted a subset of the data required was flawed. The incoming vital sign values would have acted as a general 
status indicator that the system was functioning correctly. 
The one caveat to this observation is that if the monitoring system is sufficiently reliable then the added benefit of a real-
time status view is diminished. The RP2 had the most cumbersome interface for viewing data mid recording. As a result 
we only used it very infrequently. Nevertheless the DCRs for the RP2 far surpassed all the other monitors in this test. 
Three factors contributed to the high reliability of the RP2. Firstly, data were stored both on-device and transmitted 
remotely so in the worst case scenario data could be uploaded at the end of a recording session.d Secondly, the data 
transmission system was designed to be tolerant of failure and cached data until it could be transmitted. By contrast, the 
systems based on Bluetooth Forwarder lost data if the wireless connection was interrupted. Thirdly, the logging software 
was installed and maintained by the manufacturer’s technical team. 
4.5.2 Acceptability 
The Dyna-Vision was the largest and worst tolerated device. Being a module-with-leads style of monitor it suffered from 
both having multiple leads which interfered with daily activities and requiring a bag to carry it. The Equivital  was also 
poorly tolerated by patients, reflected in the low projected wearing times. This reinforces the findings from previous 
work which suggests that constrictive belts placed around the thorax are not well tolerated for prolonged monitoring.90 
170 The thoracic band was especially problematic for the surgical population, many of whom did not want to participate 
in the study because the band would impinge upon surgical scars. 
The disparity between the projected wearing times and comfort ratings might indicate that, although patients could 
tolerate the device for a comparatively short period, they did not enjoy it. However, in the absence of corroborating 
evidence this is only a hypothesis. In common with the studies described in the previous chapter, we used our own 
questionnaire. The disparity between item responses which one would expect to be concordant and the fact that all 
                                                        
d It is worth noting that this is a useful feature for a study where data are retrospectively analysed but less so if a real-time view of data 
is required, as with live patient monitoring. 
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devices scored similarly suggests that the questionnaire is a poor tool. Future studies should seek to use a better designed 
acceptance questionnaire. 
Leaving aside considerations of the monitors themselves, the other notable finding from the study is the high number of 
patients who were ineligible for monitoring. The exclusion criteria were pragmatic and would be broadly applicable to 
the suitability of monitoring, irrespective of whether in a research context or not. This emphasises the challenge of 
monitoring acutely unwell patients and the requirement for unobtrusive monitors for use in this population. 
4.5.3 Limitations of the Implementation and Evaluation Methodology 
One of the most striking findings from the study is the degree to which researcher actions influenced the failure rates 
observed. This stands in contrast to simpler interventions such as drug trials where the efficacy of a tablet, once 
administered, is unaffected by researcher behaviour. Similar issues with unintended data loss caused by user error were 
reported by Weenk et al in their comparison of two wearable monitoring systems.128 
In our study, the researchers’ familiarity with the systems varied widely. The research nurse had experience of using the 
Dyna-Vision DVM012S from two previous studies, whereas they had never previously used the Equivital EQ-02. This 
will undoubtedly have affected the results. Given the influence of user behaviour of system reliability, evaluations of 
wearable monitors would benefit from a formal assessment of system usability. Adopting a rigorous and systematic 
approach to anticipating the likely sources of failure prior to implementation is this likely to have the added benefit of 
providing a structured classification of failures for evaluation studies. Guidance on suitable methodologies is provided by 
the IEC 62366:2007 171 and ANSI/AAMI HE75:2009 172 standards, which are discussed in Chapter 7. 
A second significant influence on system reliability was the implementation design. The immaturity of the devices 
studied (in the sense that they had not been extensively tested in previous studies) meant that we were identifying faults 
which were new to both ourselves and the device manufacturers. With the exception of the RP2, the monitors tested 
had multiple poorly mitigated failure points. As such they were reliant on user intervention to periodically restore 
functioning during the course of the recording period. 
The need to spend a greater proportion of time monitoring and correcting system failures must be counterbalanced 
against the other tasks involved in conducting a trial. In this study the time spent on recruitment and other study 
procedures meant that less time was devoted to reviewing patients who were already being monitored. This was 
exacerbated by the geographical dispersion of patients in the study, making it time-consuming to routinely visit all 
patients in order to check that devices were functioning and were being worn correctly.  
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A final limitation of the study was the failure to characterise the performance of the Aingeal monitor. This was caused 
by corruption of all data by the manufacturer’s software patch. We checked the system was functional following 
application of the patch by verifying that data were being recorded in the logging database. However, this test was 
insufficient to detect the failure, which resulted in the data being incorrectedly encoded as hexadecimal strings. This 
problem could have been avoided by one of three solutions: a) having staff from the manufacturer apply and verify any 
changes to their software, b) automating this process using an installer and verification process as happens with 
consumer software, c) undertaking full formal system checks, including plotting of recorded data every time a system 
change is made. 
4.5.4 Comparison with Previous Studies 
Our findings provide a less positive view of the feasibility of using wearable monitors previously reported studies of 
inpatient monitoring. Three factors may account for this. Firstly, we monitored patients for longer periods than in many 
of the previous evaluations. Secondly, our patient population may have been older and more unwell than those involved 
in previous studies. Thirdly, we reported more detailed metrics regarding recording success and failure than in many of 
the previous studies. Reporting bias may have masked high failure rates in previous studies. Fourthly, many of the 
previous studies were carried out with close involvement of the manufacturers or monitor designers, who would have 
been more familiar with the idiosyncrasies of their equipment than we were and therefore less likely to make user errors. 
Finally, we conducted a head-to-head comparison of five different monitors, many of which were combined with 
bespoke smartphone applications and as third party data viewing platform. As such we had to identify the failure points 
of multiple different, relatively untested, systems in parallel. Had the evaluation been of only one system over the same 
period of time, it is possible that the results might have been more positive. 
4.6 Suitability for Use in Future Studies 
 Data Capture Rate Chief causes identified for 
data loss 
Definitive mitigation 
possible by the end user 
alone 
Other issues  
Dyna-Vision ECG + PPG: 38% 
 
Unpredictable failure to 
transmit data 
No None 
Poorly tolerated by 
patients due to bag and 
long wires 
No – although 
improvements to the bag 
might help 
Possibly short battery life Yes – routinely change 
monitor before battery 
runs out 
Equivital ECG + PPG: 44% 
(fully-working sub-group) 
Short battery life Yes – routinely change 
monitor before battery 
runs out 
9 sizes of belt to be 
stocked. 
Limited belt sizes 
Likely to be poorly 
tolerated over multiple 
days due to constriction of 
chest 
No 
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Hardware failure Yes – better checking of 
hardware before applying 
it to patients 
RP2/WristOx2 ECG + PPG: 55% 
ECG only (RP2): 94% 




No Cost increases with every 
patient day of monitoring. 
Two separate monitoring 
systems to install and 
maintain. 
The ECG data provided 
by the RP2 is intermittent 
and not full waveform 
WristOx2 falling off 
frequently 
Yes – tape strap to ensure 
it cannot come undone 
Table 4.11: Key system flaws and potential mitigation strategies 
When considered as monitoring systems, rather than individual monitors, none of the sets of monitors in their tested 
form provide a robust solution to long-term inpatient monitoring. Although the RP2 was reliable and well-tolerated, the 
RP2/WristOx2 system was hampered by the unreliability of the WristOx2. It also had the undesirable features of being 
the most complex system, requiring two independent data transmission and logging systems and did not provide full 
ECG waveforms. The Dyna-Vision was unreliable and poorly tolerated. The Equivital was reliable when powered and 
was capable of recording the widest range of vital signs. However, without a redesign of the way in which it is worn, it is 
unlikely to be well tolerated over multiple days on account of the uncomfortable nature of the thoracic band. The 
Aingeal system was not adequately tested but even it had functioned flawlessly it would have suffered from the same 
undesirably system complexity as the RP2/WristOx2 combination. Additionally, as described, the data viewing 
interface was cumbersome. 
Some of the observed failures could be mitigated through changes in study procedures. However, no system had flaws 
which could be entirely mitigated without hardware redesign (Table 4.11). 
4.7 Conclusions 
In our evaluation of five novel wearable monitors assembled to form four monitoring systems, we could not identify a 
system which was sufficiently reliable to routinely record ECG and PPG for 24 hours. Of all the monitors tested, the 
most reliable and well tolerated was the RP2, an unobtrusive digital patch for recording ECG. Notable barriers to 
success were inadequate battery life, poor user tolerance of some devices and poor usability. 
Failure rates are increased when system status is hard to discern. The ability to easily view incoming data should be 
considered an important criteria for selection of wearable monitoring systems deployed in a hospital environment, 
irrespective of whether the planned application is real-time monitoring or simply physiological data capture. 
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When designing the implementation and evaluation of these systems, consideration should be given to the particular 
issues related to studying complex interventions and the added issues caused by the relative immaturity of wearable 
monitors compared to other more conventional medical devices used in hospital. 
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 The LISTEN Study: Feasibility of Continuously 
Monitoring Cardiac Surgery Patients With Wearable 
Monitors  
5.1 Introduction 
Based upon the findings of the study described in the previous chapter, we concluded that none of the monitoring 
systems evaluated were capable of reliably collecting both ECG and PPG in a clinical environment over a prolonged 
period. Key factors that influenced success were overall system complexity, reliability, usability, and wearer acceptance. 
Monitoring success was also affected by non-device factors, such as how frequently researchers could visit patients and 
whether the nurses on the ward were willing and able to support patients in wearing the monitors. 
The previous trial was designed to compare multiple wearable monitors in order to identify a candidate system for 
further evaluation. Monitoring periods were only 24 hours, which is far shorter than the mean inpatient length of stay, 
which is 5 days in English hospitals,173 and the number of patients recruited was small. In order to more thoroughly 
evaluate the feasibility of monitoring we undertook a second study, based around a single monitoring system, designed 
to address these issues. In this chapter we describe how the monitoring system was designed and report the results of its 
evaluation. 
5.2  Monitoring System Components 
 Essential Desirable 
Data Quality & Quantity 
Vital signs to be recorded HR and SpO2 Temperature, HR, BP, SpO2 and RR 
Waveform data Waveform data for ECG and SpO2 of sufficient 
fidelity to allow calculation of heart rate variability 
Waveform data for all signals recorded 
Recording frequency At least one segment of waveform/vital sign reading 
every 5 minutes 
Continuous recording 
Data Transmission   
Transmission frequency Capable of automated periodic data transmission 
during the recording period 
Continuous, real-time wireless data 
transmission 
Network protocols Wireless data transmission (using any protocol) Transmission of data via Wi-Fi 
Data Viewing   
Software features Real-time remote view of incoming data 
Able to export data for analysis 
 
Other   
Wearability Wearable Small and unobtrusive 
Regulatory compliance CE marked device  
System complexity  All components related to data transmission from the 
monitor to be provided by the same manufacturer 
Maturity  System components have previously tested and 
demonstrated to be reliable 
Table 5.1: The revised shortlisting criteria used for selecting a monitoring system. New or changed requirements are italicised. 
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Based upon our previous experiences we modified our shortlisting criteria (Table 5.1). The principal change was the 
removal of the restriction on the use of proprietary wireless protocols. This had been an exclusion criterion because it 
made scaling across multiple wards expensive and impractical. However, we now recognised that limiting the 
monitoring to a single ward was likely to facilitate data collection and therefore scalability was less of a concern in the 
short term. New requirements reflected the lessons learned from previous testing. 
Conventional cardiac telemetry monitors, which we had previously excluded from consideration based upon their use of 
proprietary network protocols met our modified criteria. These are expressly designed to provide a real-time overview of 
vital signs and system components have been tested over multiple years of clinical use. The infrastructure for using 
telemetry monitors manufactured by Philips was installed on the cardiac wards at one of our research sites, lowering the 
barrier to installation. Philips supplies a version of its telemetry monitors which is also capable of recording PPG, the 
Intellivue Telemetry M4841A Trx+SpO2. 
 
Figure 5.1: The wearable monitor used in the study. The picture on the left shows two monitors, one of which has a 5-lead ECG leadset and pulse 
oximeter probe attached. A 3-lead ECG leadset was used in the LISTEN study. The picture on the right shows the telemetry carried in a telemetry 
bag. (Images courtesy of Philips) 
Evidence that it might be feasible to use telemetry monitors for prolonged patient monitoring comes from a number of 
studies which have evaluated the clinical benefits from using telemetry monitors for arrhythmia monitoring in a non-
coronary care unit setting.37,174-176 None of the studies involved PPG recording and none reported on patient 
compliance with monitoring. As such, the feasibility of continuously monitoring ECG and PPG throughout a patient’s 
hospital ward stay remains unreported. 
The only essential criterion not met by the Philips telemetry system was the requirement to make the recorded data 
available for analysis. However, this functionality can be added using a third party product, BedMaster Ex (Excel 
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Medical Electronics, Florida, USA). This has been used successfully by other researchers to collect data from ICU 
monitors. 27,177,178 In addition to recording all waveforms and numeric data recorded by Philips monitors, the 
BedMaster Ex system provides the additional advantage of a better interface for remotely monitoring the functioning of 
multiple monitors at a glance on any computer than Philips own software. 
5.3 Methods 
5.3.1 Study Design 
We conducted a single-centre feasibility study. The study received ethical approval from the London Bloomsbury 
Research Ethics Committee. (REC reference: 11/LO/1667, National Clinical Trials Reference: 01549717).  
The primary aim of this study was to assess the feasibility of recording ECG and PPG waveform from patients using a 
wearable monitor. Secondary aims were to identify the factors which affected recording success. The study was 
conducted as a sub-study of the LISTEN study, which was designed to collect a database of physiological data covering 
the entire post-operative recovery trajectory suitable for the development of novel EWS algorithms. The LISTEN 
database includes multi-channel waveform data from ICU and HDU monitors, nurse charted vital signs, laboratory test 
results, drug chart data and the times and types of significant clinical events which occurred during the patient’s stay.179 
This chapter will only describe the methods and results relevant to the feasibility assessment of wearable monitoring. 
5.3.2 Patients and Setting 
Adult patients undergoing elective or semi-elective cardiac surgery at St Thomas’ Hospital were eligible for recruitment. 
Exclusion criteria were chronic confusion, an inability to understand or speak English or planned deviation from the 
standard cardiac post-operative pathway. Suitable patients were identified from cardiac surgery pre-assessment clinics 
and the cardiac surgery co-ordinator’s list of inpatients transferred from other institutions for semi-elective operations. 
Patients recruited in the outpatient setting had their consent reconfirmed when they were admitted for their operation. 
Patients undergoing cardiac surgery at St Thomas’ Hospital follow a standardised pathway after theatre consisting of 
ICU and HDU care for the first 72 hours before being stepped down to one of three cardiac surgery wards (Figure 5.2). 
The intervention was only implemented on the main cardiac surgery ward. Consented patients transferred to another 
ward were withdrawn from the study. Provided that patients agreed, data recorded prior to withdrawal were retained. 
Patients suffering severe deterioration were typically transferred to a dedicated cardiac HDU (cHDU) or post-operative 
ICU (poICU) for a period before returning to the cardiac surgery ward (CS Ward). In these cases we attempted to apply 
the monitoring both during their first stay on the CS Ward and upon their subsequent return. 





Figure 5.2: The post-operative surgical pathway. Wards on the standard pathway are outlined in bold. Escalation pathways for deteriorating patients 
are indicated by dashed lines. Data were recorded from patients on all wards shown in the diagram but wearable monitoring was only conducted on 
the CS Ward. If patients were transferred to other wards, coloured grey in the figure, they were withdrawn from the study.  
5.3.3 Study Intervention 
Patients were fitted with  the Intellivue Telemetry M4841A Trx+SpO2  shortly before or after transfer from cHDU to 
the CS Ward. Along with the monitor, patients were provided with a bag to hold the telemetry monitor and written 
advice on how best to wear the monitor and use it safely. Patients were asked to wear the monitors at all times until 
discharge, except when they needed to remove them for clinical purposes or washing.  
At the end of the monitoring period patients were asked to complete a questionnaire and participate in a semi-
structured interview regarding their experiences of wearing the monitor. By default the patients completed the 
questionnaires alone and unsupervised but researchers assisted patients by reading questions or providing explanation if 
patients asked for help. Interview feedback was contemporaneously summarised by researchers on a paper pro forma 
and later transcribed into the study’s electronic Case Report Form (eCRF). A sub-study, which involved asking patients 
to complete a more extensive questionnaire following the standard study questionnaire, was conducted towards the 
second half of the study. Results from the sub-study are discussed in the next chapter. 
The monitors were connected to a “central station” (Philips Intellivue Information Centre (PIIC)) via a proprietary 
radio frequency wireless network. The central station provided monitor configuration, real-time data display and 
onward data-transmission functions. It also had the facility to “admit” (enter demographics) and “discharge” patients 
(erase demographics). A real-time view of data from the telemetry monitors and the battery level of each monitor was 
visible at the CS ward nursing station and on two other dedicated screens outside patient bays on the CS ward. This 
supporting infrastructure had been installed and used clinically for many years prior to the study. However, additional 
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Signal waveforms, associated numeric parameters and monitor alarms from the web serving feeds of all central stations, 
were recorded using BedMaster Ex (version 4.1.12), which was installed on a dedicated virtual server in the hospital’s 
data centre. Numeric data was sampled at 1Hz. Waveform data were sampled at 125Hz, with a resolution of 8-bit for 
all waveforms, except for Impedance Pneumography which was sampled at 62.5Hz and then upsampled to 125Hz 
using linear interpolation. BedMaster was configured to automatically start recording whenever any patient was 
admitted on any central station and cease when they were discharged. Data were periodically manually transferred from 
the BedMaster server to a large capacity network drive in order to preserve sufficient space on the server for new 
recordings. 
We asked the ward nurses to fit patients with a monitor when the patient was transferred to the ward, “admit” the 
patients on the central stations, change batteries and support patients with wearing the monitoring equipment in 
accordance with their normal practice. Nursing staff were already familiar with the use of ECG-only telemetry 
monitors, including admitting patients to the central station, as routine clinical care on the CS Ward involves 
monitoring of arrhythmias using telemetry. However, continuous PPG monitoring had never previously been practised. 
The use of PPG monitoring reduced the monitor’s battery life from 56 hours for ECG-only monitoring to 18 hours. We 
instituted a policy of routine battery changes twice a day irrespective of battery charge. This was a change to normal 
ward practice. A battery change sheet was affixed to the patients’ drug charts to act as a prompt.  
Researchers visited all patients on the standard post-operative pathway wards at least once every day following their 
operation, including at weekends. The aims of the visits were to ensure the monitoring equipment was functioning 
correctly, address any patient concerns and encourage ward nurses to achieve continuous patient monitoring. Any 
problems identified were categorised using a pre-specified classification scheme, logged in the eCRF and fixed. 
Weekend visits were shorter than those during the week and focused mainly on troubleshooting and consenting of newly 
admitted patients.  
In addition to local visits, researchers had the facility to view data capture remotely. The BedMaster client software was 
installed on dedicated study laptops and computers in the research office. The BedMaster client provided both an 
overview of whether data were being collected across all wards as well as a detailed view of data collection from each 
individual monitor. As part of their web serving function, the central stations themselves also provided real-time remote 
view of waveform data from any connected monitor via a web browser. This was only used for system troubleshooting. 
Researchers were provided with remote access to the Trust network so that they could access these facilities from their 
home computers at the weekends. This allowed them to provide an additional level of support outside normal working 
hours. 
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The research team consisted of two experienced research nurses, a biomedical engineer and an acute 
medicine/intensive care registrar. One of the research nurses had previously worked in the cardiac surgery department 
and had previous experience with the monitoring equipment. The research nurses carried out study activities during the 
week but all members of the team participated in the weekend support activities. Data transfer from the BedMaster 
server was only carried out by the biomedical engineer. Data review meetings involving the whole research team were 
held once a fortnight to identify and implement improvements to data collection processes and system configuration. 
5.3.4 Data Processing 
The following processing steps were undertaken to prepare the monitoring data for analysis: 
1. Data were extracted from the proprietary BedMaster STP format to Matlab files via an intermediate XML 
representation. The STP files contained waveform data, numeric vital signs recorded by the monitor, monitor 
alarm type and alarm duration. 
2. Timestamps were adjusted from calendar time to time relative to theatre departure. 
3. Delays in network packet transmission occasionally caused waveform segments to overlap. The overlap was 
eliminated so that the waveform was correctly reconstructed.  
 
Figure 5.3: Timestamp correction. The algorithm used to correct these errors is described in more detail by Charlton.179 
4. Waveform data were analysed using non-overlapping windows 10 seconds in duration. Each window of each 
signal was assigned one of the following labels using a signal quality (SQI) algorithm described below: 
a. No data 
b. Flat-line recording 
c. Timestamp errors 
d. Artefact 
e. Good quality 
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Figure 3.1: Correction of continuous monitoring data timestamps: Errors in timestamps
resulted in simultaneous data at some times, and missing data at others, as shown in (a).
A bespoke algorithm was implemented to correct for erroneous timestamps, as shown in (b).
Figure and ca tio adapted from [34].
Table 3.2: Performance f the timestamp correction algorithm: the pr portion of data points,
and continuous data segments, available for analysis are shown before and after using the
timestamp correction algorithm. The key benefit of the algorithm is the increased percentage
of continuous data segments available for signal processing. Assessed using the first 24 hours of
heart rate data acquired from each subject after admission to critical care following surgery.
Proportion available [%], med (lower - upper quartiles)
Before algorithm After algorithm
Data points 94.2 (91.3 - 98.0) 95.3 (92.4 - 99.0)
10 s segments 90.5 (88.7 - 92.0) 94.6 (91.4 - 98.0)
30 s segments 85.9 (83.8 - 88.6) 93.2 (89.6 - 96.1)
60 s segments 82.0 (77.8 - 85.0) 91.2 (87.2 - 94.0)
on the Processed Dataset. This is an enhanced version of the Prepared Dataset in which data
deemed to be of low quality have been discarded. The processing steps performed to obtain the
Processed Dataset from the Prepared Dataset are now described.
3.3 Quality Assessment
The second stage of dataset curation consisted of eliminating unreliable continuous monitoring
data from the Prepared Dataset. Unlike intermittent physiological measurements, continuous
monitoring data are recorded without verification by a clinician. Therefore, they are susceptible
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5. The median of the vital sign values over each 10-second window was calculated so that each window had a 
single value for each vital sign. 
The SQI used to distinguish between good quality waveforms and artefact-corrupted data was based upon the template 
matching SQI described by Orphanidou et al.180 The waveform is firstly divided into 10-second windows. A peak 
detector is used to identify individual beats. The peak-to-peak intervals are compared with a heuristically defined set of 
thresholds intended to exclude physiologically implausible data. A template is formed from the average of all beats in 
the window. The correlation between each individual beat and the template is assessed with respect to an empirically 
derived threshold. If any test is failed, then the 10-second window of signal is assigned the label “artefact”. Study-specific 
extensions to the SQI were used to generate the labels for missing data, flat-line recording and time stamp error.  
Data from BedMaster were converted to XML format using the STP2XML script provided by the manufacturer. 
Matlab (Mathworks, Natick, USA) was used for all other data processing.  
 
 
Figure 5.4: Examples of the template matching stage of the SQI. a) Good quality ECG, b) Good quality PPG, c) Poor quality ECG, d) Poor quality 
PPG. 
 













Figur 3.3: Template-matching for signal qualit assessment: ECG and PPG signals were
segmented into windows, and the correlation between individual beats (thin grey lines) in a
window and the window’s average beat template (thick red line) was calculated. If the correla-
tion was below an empirically determined threshold then the segment was deemed to be of low
quality, as described in [122]. (a) and (b) show high quality windows, whereas (c) and (d) show
low quality windows. Figure and caption adapted from [9].
plausible. Secondly, a template beat is calculated as the average of each individual beat. The
correlation between each individual beat and this template is calculated, and compared to an
empirical threshold indicating the minimum acceptable correlation. If a window fails any of these
tests then it is deemed to be of low quality. The template-matching process is demonstrated
in Figure 3.3. These algorithms were chosen since they were designed for use with ambulatory
data.
Signal quality analysis of the ABP signal was performed using the algorithm proposed in [123].
This consisted of deriving a range of metrics for each beat, and assessing whether they are
physiologically plausible. The metrics included the systolic, diastolic and mean arterial blood
pressures, and the beat duration. If any metric was outside of a pre-specified range of physio-
logically plausible values then that beat was deemed to be of low quality. If a window contained
any low quality beats, then it was deemed to be of low quality. This algorithm is based on
the assumption that physiologically plausible ABP signals can be described by a fixed set of
metrics. Unlike the ECG and PPG SQIs, it does not adapt to an individual patient’s signal
morphology.
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5.3.5 Outcome Measures 
Analysis was restricted to patients who were not obliged to remove the monitoring equipment for clinical reasons. For 
the remainder analysis was conducted on an intention-to-treat basis. 
The primary outcome measure was the proportion of the patient’s stay on the CS Ward for which the wearable monitor 
simultaneously recorded good quality ECG and PPG waveforms, which we defined as the Data Capture Rate{ECG, PPG} 
(DCR{E,P}).  
More detailed measures of the feasibility of waveform capture were provided by calculating the DCRs for ECG alone 
(DCRE) and PPG alone (DCRP). These were calculated both for the whole ward stay and for each 24-hour period on 
the ward until discharge or the end of the seventh day, whichever came sooner.  
Researcher logs were analysed to derive counts of the number of times different failure types were observed. The data 
loss attributable to different causes was quantified using the SQI flags (Table 5.2). Results were calculated at a 
population level rather than on a per-patient basis.  
Measure Description Source of data for calculation 
Early Removal Data loss caused by patient requesting early 
removal of monitoring. (Either the whole 
monitor or one of the sensors (ECG/PPG).) 
Study case report form 
PPG Probe Removal/ ECG Removal PPG probe removal or one of the three ECG 
leads being removed, causing data to be 
recorded as a flat line 
PPG: SQI label “Flat-line” 
ECG: SQI label “Flat-line” and SQI label “No 
data” if PPG recorded concurrently. 
General system failure  Potential causes include: battery failure, leaving 
the ward, transmission failure and failure of the 
data logging software. Leads to a gap in the 
recording. 
SQI label: “No data” from both ECG and PPG 
simultaneously. 
Timestamp Corruption Data loss caused by corruption of timestamps 
due to network transmission delays 
SQI label “Timestamp corruption” 
Artefact Data loss caused by signal artefact SQI label “Artefact” 
Table 5.2: Measures of data loss 
Questionnaire responses were summarised as medians. Differences in responses between patients who wore the monitor 
until discharge and those who removed the monitor early were compared with a Wilcoxon rank-sum test. 
Interview notes were analysed by a single researcher to draw out common themes. A list of themes was iteratively 
developed based upon the results (a grounded theory approach) rather than pre-specified. A single researcher assigned a 
rating for patient experience (positive, neutral or negative) based upon the interview responses. A neutral rating was 
assigned where the number of positive and negative comments was evenly balanced or the patient feedback was neither 
strongly positive nor strongly negative. 





Figure 5.5: CONSORT recruitment flow diagram. 
228 patients were recruited between November 2012 and January 2014. 1 patient had their operation postponed. 227 
patients underwent cardiac surgery. 206 patient were transferred to the CS Ward but 4 were not fitted with telemetry: 2 
patients declined to wear it, 1 patient had become confused and 1 patient was not fitted with telemetry in error. 1 
patient subsequently withdrew permission for their data to be used and 6 patients had the telemetry removed early for 
clinical reasons leaving 195 patients included in the analysis (Figure 1). Patients were predominantly male, white and 
admitted for heart valve repair or replacement (Table 5.3). The median length of stay on the CS Ward was 4.8 days 
(IQR: 3.1-8.0 days). 
Demographic Value 
Median Age (IQR) 69 (59-76) 
Male gender (number (%)) 143 (73%) 
Ethnicity (number (%)) 
    White 
    Asian 
    Black 






Operation Type (number (%)) 
    Coronary artery bypass (CABG) 
    Valve repair/replacement 
    CABG + valve repair/replacement 














195 patients included 
in feasibility analysis
1 not admitted within study time-frame
19 patients were moved to non-study wards
2 patients were transferred to ICU and died
2 patients declined to wear telemetry
1 patient became confused
1 patient not assigned telemetry in error
1 patient withdrew permission for any of their data 
to be used
6 patients had telemetry withdrawn early for clinical 
reasons
325 screened
97 declined to participate
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In total, the study population stayed on the CS Ward for 32700 hours (1362 days). During this time wearable monitors 
were worn for 22018 hours (67% of the population CS Ward length of stay (LOS)). 4424 hours of recordings contained 
simultaneous ECG and PPG, giving a DCR{E,P} of 14%. More ECG was recorded than PPG (13186 hours (DCRE 40%) 
vs 4906 hours (DCRP 15%). 
Analysed on a per-patient basis, the median length of stay on the CS Ward was 4.8 days (IQR: 3.1-7.1 days). 118 (62%) 
patients wore telemetry until discharge. The median period for which patients wore telemetry was 3.3 days (IQR: 2.3 – 
5.1 days). The median DCR{E,P} was 13% (3-30%), the median DCRE was 52% (26-72%) and the median DCRP was 
14% (4-33%).  The distributions of DCRs are shown in Figure 5.6. The DCRE distribution was weakly positively 
skewed with peaks at 5% and 75%. The DCRP distribution was strongly negatively skewed. 
 
Figure 5.6: The distributions of DCRs calculated on a per patient basis. The left hand plot shows DCRs for ECG. The right hand plot shows DCRs 
for PPG. 
The amount of data recorded decreased in a linear fashion with each day of a patient’s stay on the CS ward until the 
fifth day (Figure 5.7). The peak DCRE over 24 hours was 62%. The peak DCRP over 24 hours was 26%. 




Figure 5.7: Population DCR vs time. 
In descending order, the causes of greatest data loss were; removal of the monitoring due to discomfort, temporary 
removal of the PPG probe and general system failure. The most commonly logged causes of general system failure were 
patients temporarily leaving the ward and batteries being fully depleted but not changed immediately. Other causes of 
general system failure were user error and software or hardware failure.  
 ECG (hours) PPG (hours) 
All loss 18961 (100%) 27241 (100%) 
Early removal 13267 (70%) 14591 (54%) 
Whole monitor 10681 (56%) 10681 (39%) 
Lead/probe 2586 (14%) 3910 (14%) 
Temporary lead/probe detachment 225 (1%) 7331 (27%) 
General system failure (battery/off ward) 3457 (18%) 3457 (13%) 
Artefact 689 (4%) 1728 (6%) 
Timestamp corruption 1422 (7%) 687 (3%) 
Table 5.4: Causes of Data Loss. For each signal, the percentages are the percentage of all data lost for that signal. The figure for ECG accidental lead 
detachment is an estimate of the minimum loss attributable to this failure. The true value is likely to be higher. 
Hardware failure was rare. No systematic problems were identified. Two notable software flaws were identified. The 
first caused intermittent failure of data transmission from the poICU, which had an unusual configuration of its central 
station. In the early phases of the study this caused data loss across all wards when researchers trialled restarting the 
BedMaster server in order to troubleshoot the problem. Once the problem had been isolated the configuration was 
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adjusted to permanently mitigate this flaw. A flaw which we were unable to mitigate was intermittent corruption of 
timestamps. This occurred when there were delays in network transmission. Investigation of changing network traffic 
prioritisation policies was beyond the scope of this study. 
The only consistently identified user error was delay in entering patient demographics into the monitoring central 
station, the trigger for the system to start recording. This reflects the fact that there was no immediate clinical utility to 
admitting patients to the central station and ward nurses appropriately prioritised other clinical duties.  
Failure type 
Number of times logged 
during study 
Nurse/Researcher error 70 
    Patient details not entered into monitoring 
    central station 
33 
    Miscellaneous researcher error 24 
    Miscellaneous nurse error 13 
Software failure 15 
Hardware failure 12 
    Monitor/lead malfunction 4 
    Infrastructure failure (servers/network) 8 
   Table 5.5: Causes of general system failure related to usability and system reliability identified from researcher logs 
For both ECG and PPG, 99% of all gaps in good quality signal, including those caused by artefact, were less than 15 
minutes long. These gaps accounted for 26% of all ECG lost and 19% of all PPG lost. The distributions of gap duration 
by signal and cause of data loss are shown in Figure 5.8. 
All patients who wore telemetry completed the basic questionnaire. The median rating for comfort and interference was 
50/100, suggesting that respondents neither found the monitor comfortable nor uncomfortable and that it only 
interfered with their activities a moderate amount. The median response to whether the monitor made wearers feel safe 
was 61/100, indicating that monitoring patients with telemetry was moderately successful in making them feel safe.  
76 of those who answered the questionnaire (39%) had removed the monitoring early. Those who removed the monitor 
early had a longer stay on the CS ward than those who wore the monitor to the end (median 6.1 vs 4.0 days, p < 
0.0001, z = -4.489) but they wore the monitor for a shorter duration (median 2.9 vs 3.8 days, p 0.01, z = 2.565). They 
also had a longer post-operative stay prior to transfer to the CS Ward (median 2.9 vs 2.0 days, p = 0.004, z = -3.542). 
There was a statistically significant difference in responses to all three questions given by those who removed the 
monitor early and those who did not (Table 5.6), with patients who removed the monitor early giving more negative 
responses to all three questions. The largest absolute difference was seen in the ratings for how much the monitor 
interfered with activity. 




Figure 5.8: Distribution of gap duration by signal and gap type. Counts on the y axis are on the log scale. For dark grey plots the x axis runs from 0 to 
12 hours (1440 minutes). For the lighter grey plots the x axis runs from 0 to 90 minutes. Gaps caused by artefact and timestamp corruption were 
typically short. Gaps caused by removal of probes or battery failure were more prolonged. 
System characteristics All Group 1: 









Number of patients 195 120 (61%) 75 (39%) n/a n/a 
Monitoring statistics 
Median length of stay 
on CS Ward (days) 
4.8 
(3.1 – 8.0) 
4.0 
(3.1 – 5.2) 
6.1 
(3.9 – 12.0) 
n/a p < 0.0001 
z = -4.489 
Median length of stay 
prior to transfer to 
CS Ward (days) 
2.2 
(1.9 – 3.9) 
2.0 
(1.8 – 3.0) 
2.9 
(2.0 – 4.8) 
n/a p = 0.004 
z = -3.542 
Median duration 
monitor worn (days) 
3.5 
(2.5 – 5.1) 
3.8 
(2.9 – 5.1) 
2.9 
(1.4 – 6.1) 
n/a p = 0.01 
z = 2.565 
Proportion of 
expected monitoring 
duration for which 
monitor worn 
91% 
(56 – 98%) 
97% 
(92 – 100%) 
46% 
(23 – 74%) 
n/a p = 0.004 
z = 10.137 
Questionnaire responses 
Provided a feeling of 
safety 
61 (42 – 75) 70 (52 – 79) 49 (25 – 63) 21 p < 0.0001 
z = 5.594 
Comfort 50 (28 – 64) 55 (46 – 71) 30 (25 – 50) 20 p < 0.0001 
z = 5.282 
Interfered with 
activities or mobility 
50 (29 – 71) 41 (27 – 54) 70 (46 – 78) 29 p < 0.0001 
z = -5.164 
Table 5.6: Responses to basic questionnaire. Median ratings for the different system characteristics are out of 100. IQR in brackets. For the safety and 
comfort characteristics a higher rating is better. For interference with activities a lower rating is better. 
 
150 patients gave interview feedback (77% of all patients who wore telemetry). 107 (71%) of interviews contained 
predominantly negative feedback about the experience of wearing the monitor, 33 (22%) neutral and 18 (12%) positive. 
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11 common themes were drawn from the comments (Table 5.7). The most common complaints were that the monitor 
was too heavy (44%) and that the leads caused distress or irritation (31% ECG leads, 31% PPG lead).  Positive 
statements related to the benefits of wearing the monitor. 25 patients said it made them feel safe and 14 described an 
altruistic motivation, to aid research. 
Themes Number of interviews where theme stated 
(n = 150) 
Negative themes 
Monitor  too heavy 69 (44%) 
ECG leads bothersome 49 (31%) 
PPG leads bothersome 49 (31%) 
Overall wearability poor 48 (30%) 
PPG probe bothersome 47 (30%) 
ECG electrodes bothersome 23 (15%) 
Sleep disturbed 18 (11%) 
Wearing monitor caused surgical wound pain 14 (9%) 
PPG probe unhygienic 9 6(%) 
Positive themes 
Felt safe because of the monitor 25 (17%) 
Felt good to be aiding research 14 (9%) 
Table 5.7: Themes drawn from interview feedback. Where patients did not specify which type of leads were bothersome it was assumed that both 
ECG and PPG leads caused distress. Wearability, was defined as the ability to mobilise or carry out routine activities without discomfort or conscious 
consideration of how to transport the monitor. 
5.5 Discussion 
5.5.1 Overview 
Our study, which was conducted in 2012 and involved post-operative patients on a cardiac surgery ward, demonstrates 
the challenges of continuously recording ECG and PPG from patients using wearable monitors over multiple days in a 
clinical setting. Patients’ median length of stay on the CS Ward was 4.8 days. Despite provision of a high level of 
support from research staff and choice of an environment conducive to cardiac monitoring, we were only able to record 
good quality ECG and PPG simultaneously for between 3 and 30% of this period. 
Nevertheless the level of data capture represents an improvement over the study reported in Chapter 4. Recordings in 
this study consistently spanned multiple days and the DCRE for the first 24 hours was higher than those from all 
previously tested, with the exception of the RP2 ECG patch, which did not provide continuous waveform data. A 
further point to note in the comparison is that the DCRs calculated in this study were based upon a good quality 
waveform, whereas no signal quality assessment was undertaken in calculating the DCRs in the previous study. 
The reliability and usability of the monitoring infrastructure and software used in this study was high, which avoided the 
extended learning curve seen in the previous study and made it feasible to involve ward staff in helping maintain 
monitoring.  
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5.5.2 Technology-Related Factors Affecting Monitoring Success 
Battery depletion was less commonly observed in our study than previously. Three aspects of the system design served to 
mitigate the effects of short battery life. Firstly, battery charge levels were displayed as a segmented battery icon rather 
than simply flagging when charge was critically low. This allowed anticipation of battery failure and early replacement. 
Secondly, battery status was visible at the nursing station as well as at the bedside. Thirdly, the batteries were easily and 
quickly replaced by ward nurses. 
Despite the fact that the majority of patients wore the monitor until discharge, patient request for early removal of 
monitoring was the largest single cause of data loss in this study, supporting the assertion by previous researchers42,181,182 
that excellent ergonomic properties should be a key goal when designing a wearable monitor.e Early removal of the 
monitor was associated with a longer stay on the  post-operative ICU and HDU prior to transfer to the CS Ward. Given 
the standardisation of the cardiac surgery pathway at St Thomas’ hospital, this suggests that patients who withdrew 
earlier were more unwell. This interpretation is supported by the fact that their stay on the CS Ward was also longer. 
The most consistent complaints related to the weight of the monitor, the leads and the PPG probe. Being sited on the 
finger, the PPG probe and cable interfered with patients’ daily activities, more often than ECG leads. Some patients 
refused to wear the PPG probe but were happy to continue with ECG-only monitoring. The reverse did not occur. 
By increasing wearer discomfort, the use of a PPG probe almost certainly increased the probability of patients 
requesting that all monitoring be removed early. In addition to negatively affecting the patient experience, the use of a 
PPG sensor decreased overall system reliability. The manufacturer-quoted battery life decreased from 56 hours for 
ECG-only recording to 18 hours for ECG and PPG recording, increasing the probability of battery depletion during 
prolonged recording threefold.  
It may be possible to mitigate these problems using alternative sensor locations and intermittent PPG waveform 
sampling. It is possible to record PPG at the base of the thumb84, wrist88, on the ear153 or behind the ear.78 Orphanidou 
et al180 have also demonstrated potential improvements in battery life using an SQI-based recording strategy. An 
alternative approach would be to adaptively alter the sampling period dependent on the value of the SpO2 such that 
more frequent recordings are made when the SpO2 is low. However, until such time as pulse oximetry can be 
incorporated into a wearable monitor without significantly affecting battery life and patient comfort future researchers 
                                                        
e A more detailed consideration of the ergonomic properties of the monitor is given in the next chapter, which reports the results of 
the questionnaire sub-study. 
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should be circumspect about including pulse oximetry as an essential requirement for a multi-parameter wearable 
monitor. 
The data transmission infrastructure was considerably more reliable than that of the Visensia-based systems tested in the 
previous chapter. However, we were only able to monitor patients while they were on the word. Reliance on 
proprietary access points poses a barrier to scaling the system hospital-wide. Novel wearable monitors which use mobile 
phones as network bridges promise to address this issue. However, in practice these theoretic benefits may not be 
realised. Our previous testing has demonstrated how these can introduce a further element of unreliability into a 
monitoring system, especially on account of battery depletion. Our solution in the previous study was to plug the phones 
into the mains power, effectively turning them into fixed network access points. Monitors which are able to transmit 
direct to Wi-Fi should be theoretically easier and cheaper to deploy at scale within a hospital environment. The benefits 
of scalability may offset the disadvantages of the larger monitor size required to house a battery of sufficient capacity to 
make Wi-Fi transmission over prolonged periods feasible. 
5.5.3 Intervention-Related Factors Affecting Monitoring Success 
We have already alluded to the properties of the system that facilitated recording success. However, the intervention 
design, patient population and environment are also likely to have had an impact on system performance.183,184  These 
external factors were considered when designing our study. We selected a cohort of patients who might derive 
reassurance from being monitored and an environment where staff were already trained in the use of telemetry. 
Researchers visited the CS Ward at least once a day, 7 days a week to maintain monitoring equipment and support staff 
and patients. We maximised the time researchers could spend on the wards by providing them with laptops and remote 
access to the central monitoring server and all research materials. Through regular data review meetings, which 
included detailed review of the recorded data, we were able to rapidly identify  and mitigate systematic problems. 
One aspect we had not anticipated was the benefit of real-time display of data in a location accessible to both staff and 
patients. 17% of patients reported feeling reassured by being monitored and some who removed the monitoring early 
reported that they would have worn the monitor for longer had they realised that the data were visible to staff. 
Anecdotally, we are aware of a few patients who used data from the monitors as an objective marker of their daily 
progress. 
In the absence of a formal assessment of these different aspects of the intervention, it is difficult to quantify their impact 
on study outcomes. Nonetheless our experience and the wealth of literature on technology acceptance models185,186 and 
information system implementation187,188 would support the assertion that designers of future wearable monitoring 
interventions should draw up their list of requirements based not only on the data to be recorded but also on the 
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monitoring environment and wearer characteristics. Selection of a monitor based purely on its physical and technical 
properties is an overly simplistic approach. 
5.5.4 Limitations 
The differences between a clinical trial and routine clinical practice necessitate care in extrapolating our results. In a 
trial there is no consequence to removal of monitoring whereas, if monitoring is part of routine care, patients may be 
more likely to perceive a risk to being unmonitored and therefore persist with a monitor they find uncomfortable. We 
would expect patients to wear monitors for longer periods outside of a trial setting. Whether this would translate into a 
substantially better DCR depends on the reliability of the monitor, how frequently ward staff are able to identify and 
correct problems that arise and whether they perceive a benefit to maintaining high quality monitoring. 
5.6 Conclusions 
Despite a reliable, usable recording infrastructure, an environment and patient population conducive to monitoring 
success and high levels of researcher support, it was not possible to record high-quality waveform data for a large 
proportion of patients’ ward stays. Key failings of the system were the discomfort and obtrusiveness of the device, most 
notably with respect to the pulse oximeter probe. More work is needed to develop hardware and software systems 
capable of prolonged data capture within a hospital environment. Most particularly there is a need for improved 
methods of unobtrusively recording PPG in a power-efficient manner.  
We have highlighted the contribution that intervention design might make to the success of an intervention based 
around patient monitoring. Research in this field would be enhanced by a standardised reporting framework and tools 
to measure the quality of patient monitoring interventions. The next chapter describes our attempt to design a 
questionnaire to address the latter issue. In addition, the development of a planning framework to help clinicians and 
researchers identify their requirements, select the optimal monitor and design an intervention which takes account of 
both the monitor’s properties and the aims of the intervention would be valuable. Such a framework is proposed in 
Chapter 7. 
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 The Clinical Acceptability of Wearables Tool: A 
Wearable Monitor Acceptance Questionnaire 
6.1 Introduction 
Our studies of wearable monitors have identified low patient acceptance as a significant barrier to effective monitoring 
using such technology. Other researchers have come to similar conclusions.41,182,189,190 A measure of acceptance would 
be useful to both wearable monitor designers and evaluators. We were only able to identify four questionnaires in the 
published literature. 
Knight and Baber developed the Comfort Rating Scale using a modified Delphi process.191 92 terms relating to comfort 
were clustered into six dimensions, Emotion, Attachment, Harm, Perceived Change, Movement and Anxiety. For each 
dimension a statement was generated. 10 students were asked to wear four different wearable devices and score their 
agreement with the six statements. All four devices were worn within a single 30-minute period. There was no statistical 
analysis to validate the questionnaire, other than assessing the intra-class correlation coefficient. 
This work was subsequently extended to form part of a multi-modal assessment which analysed wearability along 3 
dimensions, exertion, effects on posture and motion, and comfort.192 Exertion was assessed using the Borg Relative 
Perceived Exertion Scale,193 postural changes were assessed with a structured observational tool, Rapid Entire Body 
Assessment,194 and comfort was measured using the Comfort Rating Scale and a visual comfort score, the Visual Effects 
Scale. The assessment was trialled using 58 Greek and Swedish teenagers who were asked to wear a computing device 
during visits to museum exhibits. No validation of the method was attempted. 
Fensli et al195 devised the Sensor Acceptance Model, a questionnaire comprised of 58 questions, 39 to be asked at the 
onset of wearing a sensor and 19 questions to be asked at the end. It was piloted on 36 patients, 25 patients assigned a 
reference Holter monitor and 11 patients assigned a novel wearable sensor. Factor analysis was conducted using the 
responses but, as the authors themselves concluded, there was no evidence that the Sensor Acceptance Index actually 
measured acceptance. 
Spagnolli et al193 developed a questionnaire consisting of 45 items related to the factors which the authors hypothesised 
were important, based upon previous research. 110 participants, 50 domain experts and 60 students were asked to assess 
3 devices by listening to one of six scenarios and then rating the acceptability of the device based upon a video 
describing the devices and a wearing period which lasted a few minutes. 
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In the previous chapter we hypothesised that device acceptance was a product of both the properties of the wearable 
monitor and the properties of the intervention - the manner in which monitor use was supported. All of the 
questionnaires described focus solely on device ergonomics and user attitudes. Furthermore, none of them have been 
well validated. 
The primary aim of this sub-study was to develop and pilot a questionnaire which had the following properties: 
1. Provides an overall measure of acceptance (summative evaluation)f 
2. Measures both device ergonomics and properties of the monitoring intervention 
3. Allows an understanding of which particular aspects of the monitor and the intervention wearers liked and 
disliked (formative evaluation) 
The secondary aims of the sub-study were to provide recommendations on how the design of the wearable monitor used 
in the LISTEN study might be improved and to evaluate the potential for a questionnaire with a fixed core set of 
questions supplemented by variable device and context-specific questions. The reasons for this are discussed below. 
6.2 Questionnaire Development 
6.2.1 Theory 
Best practice guidelines for questionnaire development suggest that a questionnaire should be based upon an underlying 
framework.196 In common with Fensli and Spagnolli, we chose to base our questionnaire on the most widely cited 
technology acceptance model, the Unified Theory of Acceptance and Use of Technology (UTAUT).185 
The UTAUT model defines four primary factors, Performance Expectancy (perceived benefits), Effort Expectancy 
(perceived ease of use), Social Influence and Facilitating Conditions. The influence of these factors is modified by the 
user’s gender, age, previous experiences related to the technology and the degree to which use of the technology is 
voluntary (Figure 6.1). We hypothesised that the ergonomic properties of the device would relate to the Effort 
Expectancy and the properties of the intervention would predominantly relate to the other three primary factors. 
                                                        
f Summative assessment provides an overall measure of success (or, in this case acceptance). It allows comparison between different 
individuals so that they can be ranked. In the context of wearable monitors this might be used by a clinician to identify which 
wearable monitor was best accepted by patients. Formative assessment provides insight into which particular factors need 
improvement. The feedback is then used to make improvements. In the context of wearable monitors, this would be used by 
engineers designing the monitor to identify which aspects of a prototype needed to change in order to create a better design. 




Figure 6.1: The UTAUT Model 
To fulfil our aim of devising a questionnaire which allowed both formative and summative evaluation of wearable 
monitor acceptance we proposed that a future iteration of the questionnaire should comprise two parts: a core set of 
questions, valid for all wearable monitors, and a variable set of questions specific to each class of monitor design 
described in Chapter 1. In effect the questionnaire would become a suite of closely-related questionnaires. This 
complexity would be required to manage the competing aims of providing data for both formative and summative 
evaluation. In this initial development phase, we opted to design a questionnaire with supplementary questions suitable 
for the ‘box and leads’ style of monitor used in the LISTEN study. 
6.2.2 Development 
Published recommendations were used to develop questionnaire items.196 Items were derived inductively from the 
UTAUT framework and deductively from peer-reviewed studies and from the interview responses recorded in our 
previous studies of wearable monitors. 
The first draft of the questionnaire was evaluated by three research nurses with experience of using wearable monitors 
in clinical trials of over 200 patients. Revisions to the items were made based upon their feedback. The final 
questionnaire comprised questions which measured a dimension of the UTAUT framework and questions which 
assessed potentially important covariates. 
Best practice guidelines informed item phrasing, sequencing and presentation.197 We chose to incorporate a mixture of 
positively and negatively worded statements. Clarity of phrasing was prioritised over maintaining a strict balance of 








Gender Age ExperienceVoluntariness of Use
Behavioural 
Intention Use Behaviour
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and readability were iteratively improved, based upon feedback from two human factors researchers with basic domain 
expertise and previous experience in questionnaire design. 
The final questionnaire, the Clinical Acceptability of Wearables Tool (CAWT),  comprised a mixture of 3 informational 
questions and 35 feedback questions (Table 6.1). Information questions asked about how the patient preferred to wear the 
monitor and how much they wanted the nurses to help them. The purpose of these questions was to provide context. 
Feedback questions, answered using a Likert-scale, asked about the patients’ opinions and experience. Banded shading 
of columns was used to help respondents match column headings to the response check box. The questionnaire was 
made available in two sizes, a large print size and a more compact format. 
A brief guide to evaluation of questionnaire quality 
Early models of questionnaire quality described three types of validity, content, criterion and construct 
validity.198  Over time these terms have changed their meaning and relationship to each other, causing 
confusion as to their definition. In this chapter we use the terminology from the 4th revision of the American 
Psychological Association (APA) standards (1999).199 The 1999 APA model groups all types of validity under 
the term construct validity. More importantly the notion of validity is changed from being a property of the 
questionnaire to being a property of the interpretation and instead of describing sub-types of validity, 
describes sources of evidence to support validity. There are five categories of evidence: content, response 
process, internal structure, relations to other variables, and consequences. 
Content evidence supports the notion that the questionnaire items measure what they are intended to 
measure. It incorporates the traditional concept of ‘content validity’. Key content evidence is the opinion of 
experts that the question content, wording and presentation are all appropriate. 
Response process evidence supports the notion that the method by which respondents answer questions does 
not adversely bias the answers. 
Internal structure consistency refers to whether the questionnaire is reliable and is underpinned by a 
theoretical model. Reliability is a measure of how consistently a questionnaire is answered. There are four 
principal dimensions of reliability: 
Internal consistency is a measure of whether similar questions give rise to similar answers. It can be 
quantified using Cronbach’s alpha, split-half reliability or the Kuder-Richardson statistic. 
Test-test reliability is a measure of whether the same respondent gives the same answers on multiple 
occasions. 
Parallel forms reliability evaluates whether the same questions given to the same respondent in two different 
formats on two different occasions elicit the same responses. 
Agreement, or inter-rater reliability, ensures that the administrators of the questionnaire all provide the same 
ratings (for types of questionnaire where this is relevant) 
Support for internal structure consistency is also provided by factor analysis. Factor analysis is used to 
investigate relationships between questions and the constructs they are intended to measure. In the CAWT 
questionnaire these intended constructs are the factors in the UTAUT model. 
Relations to other variables refers to correlation with associated external variables. For instance if high scores 
on a questionnaire about predisposition to ischaemic heart disease were associated with increased incidence 
of myocardial infarction, this would support the notion that the questionnaire was valid. Traditionally this 
form of evidence has been divided into ‘concurrent validity’, correlation with variables measured at the same 
time as the questionnaire and ‘predictive validity’, the ability to predict future outcomes. 
Consequences of taking a questionnaire may bias the results. For instance, if scoring high on a questionnaire 
leads to social stigma, it may alter respondents’ answers. Evaluation of consequences is controversial and is 
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Table 6.1: Questionnaire items, the UTAUT dimension they were intended to assess and whether they could be used generally in any sort of study or 
whether they were specific to the monitor and context 
6.3 Methods 
6.3.1 Administration 
The CAWT study was conducted as a sub-study of the LISTEN study. It started once researchers judged the LISTEN 
standard operating procedures had stabilised and finished when the LISTEN study ended. 
A questionnaire pack was presented to patients when they stopped wearing the monitor. The pack consisted of the 4-
item basic questionnaire used in our previous studies followed by the CAWT questionnaire.  By default the patients 
completed the questionnaires alone and unsupervised but researchers could assist patients by reading questions or 
Question UTAUT dimension Specific/General 
Informational Questions 
During the day I mostly wore the monitor… [options]  
During the night I mostly wore the monitor… [options] 
I preferred the nurses to reattach the monitor leads rather than trying to do it myself. 
Feedback questions 
It was easy to move about while wearing the monitor. Effort Expectancy General 
Wearing the monitor disturbed my sleep. Effort Expectancy General 
The monitor didn’t interfere with my daily activities (washing, dressing, eating, going to the toilet 
etc). 
Effort Expectancy General 
The monitor was unhygienic. Effort Expectancy General 
The monitor was easy to remove. Effort Expectancy General 
The monitor was easy to put back on. Effort Expectancy General 
The grey leads that went to the sticky dots on my chest were too restrictive. Effort Expectancy Specific 
The blue lead going to the probe on my finger was too restrictive. Effort Expectancy Specific 
The grey leads that went to the sticky dots on my chest were too long. Effort Expectancy Specific 
The blue lead going to the probe on my finger was too long. Effort Expectancy Specific 
The weight of the monitor was not a problem. Effort Expectancy General 
The monitor made me feel sweaty. Effort Expectancy General 
The sticky dots on my chest didn’t bother me. Effort Expectancy Specific 
The monitor was too tight. Effort Expectancy Specific 
The monitor was uncomfortable. Effort Expectancy General 
The leads came off accidentally Effort Expectancy Specific 
The nurses helped me reattach the monitor leads. Facilitating Conditions Specific 
I was aware of the monitor when I was wearing it. Effort Expectancy General 
Wearing the monitor made me stand out from other patients on the ward. Social Influence General 
I didn’t like friends or relatives to see me wearing the monitor when they came to visit. Social Influence General 
I felt that people looked at me differently because I was wearing the monitor. Social Influence General 
People told me things about the monitor that made me want to take it off. Social Influence General 
My friends or relatives encouraged me to keep wearing the monitor. Social Influence General 
Other patients encouraged me to keep wearing the monitor. Social Influence General 
The nurses encouraged me to keep wearing the monitor. Social Influence General 
I noticed other people wearing the same monitor as me. Social Influence General 
I have not had any complications following my surgery. Facilitating Conditions Specific 
I have a lot to cope with since my operation. Facilitating Conditions Specific 
I am used to being monitored in hospital. Experience Specific 
Wearing the monitor was stressful. Effort Expectancy General 
I didn’t see any benefit to me from wearing this monitor. Performance Expectancy General 
Wearing the monitor made me feel safer. Performance Expectancy General 
Wearing the monitor made me feel like my recovery was being held back. Effort Expectancy General 
I think the monitor helped the ward staff look after me better. Performance Expectancy Specific 
If I hadn’t been participating in this research project I would have wanted to remove the monitor 
earlier in my stay. 
Performance Expectancy Specific 
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ticking boxes if patients asked for help. Immediately after patients had completed the CAWT questionnaire, the 
administering researcher conducted a semi-structured interview to discuss the responses further. Results from the basic 
interview and the interview feedback are presented in the previous chapter. 
6.3.2 Analysis 
6.3.2.1 Questionnaire Validation 
Results from informational questions were summarised but not analysed further. Responses to the CAWT feedback 
questions were reverse coded where necessary so that 1 indicated a highly negative sentiment and 5 a highly positive 
sentiment for all questions. Poorly performing items were identified using the following published criteria201 
• ≥10% of responses to the item are “don’t know” 
• ≥ 80% of responses to the item are the same 
• Cronbach’s alphag for the item is <0.7 
• Corrected item-total correlation for the question is <0.3 
Poorly performing questions were excluded from further analysis unless they were deemed to be theoretically important. 
Following exclusion two versions of the questionnaire were analysed, one which contained all retained questions and 
one which contained only the questions which were generalisable to all monitor designs and contexts (see Table 6.1). 
Assessment of validity was carried out on both variants of the questionnaire. Internal consistency was assessed using 
Cronbach’s alpha.   
Evidence of concurrent validity was assessed by determining whether there was a statistically significant association 
between questionnaire score and early removal of monitoring. The questionnaire scores were calculated by summing 
the coded values. The mean of a participant’s responses, rounded to the nearest integer, was imputed for missing and 
“don’t know” responses. The statistical difference between median scores for the two groups was assessed using the 
Wilcoxon rank-sum test. 
                                                        
g Cronbach’s alpha is a measure of internal consistency. The formula for calculation is: 𝛼 =	 𝑁 ∙ 𝑐̅?̅? + (𝑁 − 1) ∙ 𝑐̅ 
where N is the number of items, 𝑐 ̅is the average inter-item covariance among the items and	𝑣.  is the average variance. A value of 
alpha between 0.8 and 0.9 is considered to indicate good internal consistency. The value of alpha increases with the number of items. 
Extremely high values of alpha indicate redundancy in items. Maximum values of 0.9 to 0.95 have been recommended.202 
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6.3.2.2 Assessment of the LISTEN monitor design 
Narrative synthesis based upon the distributions of individual questionnaire responses was used to identify elements of 
the monitor design which might be improved. Additionally, questions were grouped into the four UTAUT factors to 
provide additional insight. 
Groups were compared with the Wilcoxon rank sum test for continuous data and Chi-squared test for categorical data. 
Stata (version 13, StataCorp, College Station, Texas, USA) was used to perform all statistical tests. 
6.4 Results 
6.4.1 Recruitment 
Patients were recruited to the LISTEN study between December 2012 and December 2013. The CAWT questionnaire 
was introduced 5 months into the study, after 106 patients had been recruited. 103 (87%) of the 119 patients recruited 
after CAWT was introduced completed the questionnaire. Those who did not complete the questionnaire either did not 
wear the monitor (n = 15) or were discharged before we had collected feedback (n = 4).  
The median age of participants was 70 years old (IQR: 59-77).  65% were male. 44 (43%) of those who completed the 
questionnaire asked for the monitor to be removed early. Those who requested early removal tended to be younger 
(median age 68 vs 72, p = 0.03) but there was no significant difference in the gender ratio. 
6.4.2 Item Analysis 
10 questions were rated as poor according to the quality criteria. 3 questions had “don’t know” or were unanswered for 
over 10% of responses: 
- Question 24: I felt that people looked at me differently because I was wearing the monitor. - Question 25: People told me things about the monitor that made me want to take it off. - Question 27: Other patients encouraged me to keep wearing the monitor. 
The item-total correlation for the question was <0.3 for 7 questions: 
- Question 20: The nurses helped me reattach the monitor leads. - Question 22: Wearing the monitor made me stand out from other patients on the ward. - Question 26: My friends or relatives encouraged me to keep wearing the monitor. - Question 28: The nurses encouraged me to keep wearing the monitor. - Question 29: I noticed other people wearing the same monitor as me. 
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- Question 30: I have not had any complications following my surgery. - Question 32: I am used to being monitored in hospital. 
All were excluded except for question 28 which was deemed to be theoretically important.  
The majority of the questions removed corresponded to the “Social Influence” UTAUT dimension. Both before and 
after item removal, the majority of questions assessed the Effort Expectancy Dimension (Table 6.2). 
The questionnaire had high internal consistency both before and after item exclusion. Prior to exclusion Cronbach’s 
alpha was 0.89. Following exclusion Cronbach’s alpha was 0.92 for the version retaining all questions and 0.89 for the 
version containing only generalisable questions. The total score for both versions of questionnaire was significantly 
associated with early removal of monitoring (z = 2.694, p <0.01 for all questions, z= 2.802, p<0.01 for only 
generalisable questions). 
The median total score for the all questions version was 70 (IQR: 62-78) for patients who removed the monitoring early 
and  81 (IQR: 68-92) for those who wore the monitoring until the end of the study. The absolute difference between 
total scores for the two groups was smaller for the version containing only generalisable questions. (Median scores were 
43 (IQR: 36.5-49.5) for the early removal group and 49 (IQR: 42-57) for those who wore the monitoring until 
discharge.) 
UTAUT Dimension Prior to question removal Following question removal 
Primary factors 
Effort Expectancy 19 19 
Performance Expectancy 4 4 
Social Influence 7 2 
Facilitating Conditions 4 3 
Modifying Factors 
Experience 1 0 
Voluntariness of Use 0 0 
Table 6.2: UTAUT Dimensions 
6.4.3 Use as Formative Evaluation 
Responses to individual questionnaire items are shown in Figure 6.2. Extremely negative sentiments (n=309, 9%) were 
more common than extremely positive sentiments (n = 217, 6%).  The most frequently reported complaints were that 
patients were often aware of the monitor (n = 79, 77%), that it frequently interfered with activity (n = 67, 65%) and the 
PPG lead was too long (n = 74, 72%). Factors which supported patients in wearing the monitor were help from nursing 
staff (n = 52, 50%) and a feeling that wearing the monitor increased safety (n = 51, 50%). Patients did not feel that 
wearing a monitor changed people’s perception of them. The majority of the respondents (n = 80, 93%) wore the 
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monitor on-body (around the neck, across the chest or in a pocket) during the day. At night, most respondents put the 
monitor in the bed or an adjacent chair (n = 52, 60%). 
On other issues there was a divergence of opinion, demonstrated by the bimodal distribution of responses (Figure 6.2). 
Participants disagreed regarding whether the monitor interfered with sleep, was too restrictive, was difficult to remove 
and refit, frequently interfered with mobility, whether the electrodes were bothersome and whether the ECG leads were 
too long. 
Comparison between the group who removed monitoring early and the group who wore the monitor until discharge 
did not reveal a clear pattern with regards to responses to individual questions. Grouping the questions into their 
UTAUT categories revealed that, although patients who kept the monitor on to the end were typically less negative 
regarding the Effort Expectancy (the difficulty caused by wearing the monitor), the most marked disparity in ratings was 
found for Performance Expectancy (Figure 6.3). Patients who wore the monitoring until the end of the study were more 
likely to identify the benefits of being monitored. 




Figure 6.2: A diverging stacked bar chart showing questionnaire responses. The number of responses indicating a positive sentiment are charted  to 
the left of the midline. The number of responses indicating negative sentiments are charted to the right. The depth of shading is proportional to the 
strength of agreement. Neutral responses are shown in the lightest shade of grey. Questionnaire responses sorted in order of most negative to most 
positive (i.e. hardly any patients felt that the monitor made them stand out). 
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Figure 6.3: A diverging stacked bar chart showing questionnaire responses grouped according to UTAUT categories and whether patients removed 
the monitoring early or not. Solid shaded bars indicate the responses from patients who removed the monitoring early. Patterned bars indicate the 
responses from patients who did not remove the monitors early.  
6.5 Discussion 
We have developed and piloted a questionnaire for measuring the acceptability of wearable monitors in a hospital 
environment. Results from the pilot demonstrate excellent internal consistency and a statistically significant correlation 
with early removal of monitoring. The questionnaire is based on the most widely cited technology acceptance model, 
UTAUT, and assesses both the ergonomic aspects of the monitor itself and the quality of the monitoring intervention. 
The evidence related to the validity of CAWT as a tool to measure wearable monitor acceptance is summarised in 
Table 6.3. 
We have demonstrated the potential validity of an approach whereby a core set of questions can be supplemented by 
questions specific to the device design, thereby allowing extra formative feedback to be gained. Reducing the number of 
questions reduced Cronbach’s alpha below 0.9. This adds further support to the notion that the device-specific 
questions can be considered optional extras and only used when formative evaluation is required. 
CAWT improves upon previous work in that it has been piloted on a larger number of participants than previous 
studies, evaluated in a clinical setting and feedback is based upon prolonged monitoring periods rather than brief 
exposure. The study is unique amongst wearable monitor questionnaires in assessing the correlation of the questionnaire 
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Content Response Process Internal Structure Relation to other 
variables 
Consequences 
Questions derived from 
previous experience and 
literature search 
Question content 
assessed by research 
nurses experienced in the 
use of wearable monitors 
Best practice guidelines 




wording assessed by two 
human factors experts 
Not assessed. Possible 
bias when research 
nurses helped fill in 
questionnaire 
Internal consistency: 
Cronbach’s alpha high 
Other forms of reliability 
not tested 
Based on the most widely 
cited technology 
acceptance model  
Statistically significant 
association between 
questionnaire score and 
early removal of 
monitoring 
Questionnaire responses 
similar to interview 
feedback 
Not assessed 
Table 6.3: Summary of evidence, grouped into the American Psychology Association categories, related to whether CAWT can be considered a valid 
measure of wearable monitor acceptance. 
While some properties of the monitor such as weight, interference with activity and obtrusiveness were universally 
problematic, there was a marked diversity in patients’ opinions regarding other aspects of the monitor. One plausible 
explanation is that patients’ opinions were related to their ability to wear the monitor comfortably. Anecdotally, we 
noticed that some patients quickly learnt to neatly coil sensor cables and route them through clothing in an ergonomic 
manner whereas others repeatedly failed to do this, making it harder to ambulate. Formal data collection will be 
required to identify whether this is a relevant factor. 
A second possible explanation is that patients’ preferences for certain features are dependent on the patients’ physical 
dimensions. Until a monitor design reaches a certain threshold of comfort and unobtrusiveness a flexible design which 
allows the wearer to individualise elements such as cable length or pulse oximeter probe type might be better accepted 
by a wider population, even if implementing flexibility increases the volume or weight of the monitor. 
Although clinicians have little or no ability to change the monitor design they can ensure that demonstration of benefit 
is built into the design of their intervention or choose monitors that support demonstration of benefit. A simple example 
of benefit demonstration is displaying the output of the monitor on a screen accessible to the patient. As described in the 
previous chapter, many patients who removed the monitors early stated that they might have behaved differently had 
they realised that they could view their own vital signs on the ward telemetry screens. 
6.5.1 Limitations and Further Work 
While the questionnaire contains numerous questions related to device ergonomics and Effort Expectancy, there are far 
fewer related to the properties of the intervention and the other UTAUT dimensions. Many of our questions intended 
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to measure these aspects were excluded as poorly performing, suggesting that we have not fully understood which 
properties of the intervention are most influential on acceptance. 
Our study involved a single model of monitor. The utility of the questionnaire as a summative tool would be better 
assessed in a study where two models of monitor were compared within the same environment. Similarly, the 
generalisability of the questionnaire to the outpatient setting is yet to be tested. This will require modification of some 
questions related to facilitating conditions and social support. When devising supplementary questions specific to each 
monitor design, these will need to be evaluated to ensure that they do not adversely interact with the core questions. 
One approach to avoid this interaction might be to administer the core and device-specific questionnaires sequentially. 
Though larger than previous studies, the sample size was inadequate for rigorous validation. Ferketich advocates a 
sample size of 5 patients per item or 200 patients, whichever is greater.203 For our 38-item questionnaire this would 
necessitate a sample of 200 patients. For this reason, and the fact that the number of items per UTAUT dimension were 
low, we have not undertaken confirmatory factor analysis, to ensure that questions load onto the dimensions as we 
intended. A future validation study with a revised set of questions and a larger sample size should incorporate this 
analysis to demonstrate that the questions fit the underlying UTAUT model. 
We have not assessed whether the questionnaire might have predictive validity. The questionnaire would be most useful 
if it could predict wearer acceptance for a prolonged monitoring period when administered following a short trial of 
wearing a monitor. This should be evaluated in a future study. 
In terms of the conclusions that can be drawn regarding patient preferences, all comments above should be regarded as 
hypothesis-generating rather than definitive statements of fact. Furthermore, the fact that researchers helped patients in 
some cases may have biased results. We did not record whether researchers provided assistance so cannot quantify the 
potential risk of bias. Mitigation for these limitations is provided by the design of the LISTEN study, which gathered 
both questionnaire and interview feedback. The conclusions drawn from the questionnaire parallel the interview 
findings, giving greater credence to our findings. 
6.6 Conclusions 
We have developed a questionnaire which aims to measure factors related to the acceptability of a wearable monitor to 
end-users. Development and evaluation of the questionnaire has been more rigorous than those previously reported in 
this field. Initial results from the pilot study are promising. Further work will be needed to refine the existing questions 
and validate with a larger sample size, different monitors and in different contexts. 
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 A Framework for the Implementation and 
Evaluation of Wearable Monitoring Systems 
7.1 Introduction 
An intervention based on a wearable monitoring system is a combination of hardware, software and psychosocial 
processes. Making such a complex system function effectively is a challenging undertaking. Currently the problem is 
compounded by the relative immaturity of the technology. Wearable monitors have yet to make much of an impact in 
routine healthcare, beyond their traditional niches of cardiac telemetry and diagnostics, leading some to describe the 
field of novel patient monitoring systems has been described as being cursed by a “plague of pilots”.204 
In many cases monitors are evaluated in the context of a clinical trial. This results in both temporal and financial 
constraints on the amount of effort that can be spent troubleshooting and optimising a system before data collection 
according to a rigid trial protocol must commence. The complex interactions between the technology, users and 
hospital environment make efficient testing and performance optimisation challenging. Consequently, researchers may 
be forced into the situation of starting data collection early and losing data needlessly. This is both wasteful of funding 
and of participants’ time and effort. 
Use of a systematic approach to identifying failure points in a system prior to deployment would help address this issue. 
Numerous frameworks and guidelines for evaluating complex systems have been published in the social sciences,183 
engineering205 and human factors206 literature. However, the nature of the existing literature on the design and 
evaluation of complex systems poses a number of barriers to a non-expert seeking to implement an intervention based 
on a wearable monitoring system. 
Firstly, the fact that existing publications are located in different areas of the literature poses challenges to a newcomer 
to the field, who many not be aware of the different domains of relevance. Secondly, even if the publications are located, 
there can be a considerable barrier to integration as each field has its own jargon and underpinning assumptions, which 
may not be immediately apparent to the reader. Thirdly, none of the existing frameworks covers all topics of relevance 
for the design and evaluation of a wearable monitoring system. 
We aim to address this issue by proposing a framework to guide the implementation of wearable monitors. The 
framework is designed with a clinical audience in mind and based upon the assumption that device evaluation is a 
stepping stone towards implementation rather than a goal in and of itself. Therefore there is a strong focus on cost-
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effective methods rather than those which seek to be exhaustive. However, the framework could also be used as the basis 
of a system evaluation. 
7.2 Methods 
Recommendations for assessment methods were based upon a series of reviews of specific sub-domains of the literature 
and our own experiences of evaluating and implementing wearable monitoring systems in a hospital environment. Full 
details of the review process are contained within Appendix A. 
7.3 Framework 
7.3.1 Failure Model 
Reliability is defined by the Institute of Electrical Engineers as the ability of a system or component to perform its 
required functions under stated conditions for a specified period of time.205 In a clinical context the “required function” 
of a wearable monitor is to provide physiological measurement of sufficient accuracy to be used for clinical decision-
making. This is achieved by recording biological signals (e.g. voltage), processing them to extract a physiological signal 
(e.g. ECG) and deriving clinically useful measurements (e.g. heart rate). 
The inverse of reliability is failure. For a physiological monitor failure is either the absence of an expected reading or 
provision of an inaccurate reading. The causes of failure may be divided into two categories, those caused by poor 
validity and those caused by malfunction (Figure 7.1). 
Poor validity is the failure to provide an accurate reading even when the system is functioning as intended. It is caused 
by limitations of the measurement technique or failure of the recording equipment to record a signal of sufficient fidelity 
to allow derivation of an accurate measurement. 
Malfunction is defined as failure caused by an element of the system not functioning as intended. It is caused by 
component failure (either hardware or software) or adverse user behaviour. Adverse user behaviour may be deliberate 
or accidental. Deliberate interference, usually refusal to wear the monitor, is caused by poor acceptability. Accidental 
interference may either be the result of sporadic errors which are unlikely to recur or systematic usage errors caused by 
poor usability. 




Figure 7.1: Proposed classification of failures 
We propose an model of failure, based on this taxonomy, where the types of failure are poor validity, poor component 
reliability, poor acceptability and poor usability. In the model the probability of all types of failure, with the exception of 
validity, are influenced by the monitoring environment and the users (Figure 7.2). 
 
 
Figure 7.2: Types of failure sorted according to the ease with which they can be mitigated. The characteristics of the environment and users influence 
failure rate for the component reliability(shown with a grey background). 
7.3.2 Framework Overview 
Studies involving wearable monitoring systems can be motivated by one of two aims. Either the monitoring system is 
pre-defined and the objective of the study is to characterise its performance or the intervention is pre-defined and the 
Failure to provide 
an accurate 
reading

















































Chapter 7: A Framework for the Implementation and Evaluation of Wearable Monitoring Systems 
 
 108 
optimal monitor is sought to achieve the intervention objectives. Where monitoring is pre-defined, the technology is the 
focus and the aim of implementation design is to choose a supportive environment in which to test the monitor. This 
style of study is appropriate for proof-of-concept studies. Where the intervention is pre-defined, the effectiveness of the 
intervention is the focus and the aim of implementation design is to maximise all aspects of the intervention to achieve a 
clinical effect. 
Our framework is suitable for both types of study and consists of the following steps: 
1. Requirements Analysis 
a. Define the aims of the intervention. 
b. Define the constraints affecting the intervention, if these are fixed 
i. Environment 
ii. Users 
c. Document monitor technical characteristics if the monitor is fixed or derive them from the aims and 
constraints if the intervention is fixed. 
2. Estimate the baseline likelihood of monitoring system failure. 
3. Failure Analysis 
For each class of failure in our model 
a. Conduct a theoretical analysis to predict likely causes of failure 
b. Structured laboratory testing to estimate failure incidence and identify unanticipated failures 
c. Design mitigations to address the identified causes of failure 
These steps are shown as a flowchart in Figure 7.3. The remainder of this chapter describes the rationale for each of 
these steps and recommended methods for carrying them out. 




Figure 7.3: A flowchart summarising our recommended approach 
Are you selecting a monitor for 
a fixed intervention or are you 
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7.4 Baseline Likelihood of System Failure 
The amount of time which should be invested in failure analysis is determined by the cost of failure and the likelihood of 
failure.207,208 If there is no significant consequence to a failed recording session or changing study methodology then 
there is little merit to undertaking the process we propose. In the context of a clinical trial, however, the cost to failed 
recording is usually high, because recruitment is often difficult, the timespan of a trial is usually finite and making major 
changes to a clinical trial protocol involves review by an ethics committee. Therefore there is a strong incentive not to 
learn how to mitigate system flaws by trial and error. 
Models which predict the likelihood of system failure vary in complexity from those which predict failure simply based 
on the number of components to complex simulations. We recommend basing predictions upon the bathtub curve, an 
idealised depiction of the relationship between failure rate and time (Figure 7.4).209 
The bathtub curve is divided into the three phases. During the initial, “infant mortality phase” the failure rate is high 
but decreases with time until it reaches a steady state, the “useful life phase”. In the third phase, the “end of life phase” 
the failure rate increases with time. The bathtub curve may be used to model component failures at the level of an 
individual device, failures of a product line over its lifecycle and failures caused human-machine interactions. 
 
Figure 7.4: The bathtub curve 
When analysing a wearable monitoring system, factors to consider are, the maturity of the system components, how 
familiar users are with the use of the system and researcher experience with the field of wearable monitoring in general. 
The influence of these factors on the success of a wearable monitoring intervention can be illustrated by comparing the 
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more reliable than the majority of the novel wearable monitors tested in Chapter 4. The LISTEN system comprised of 
Philips monitors and BedMaster software, both of which are mature products and have been successfully used in 
multiple medical institutions.177,178,210 The researchers were experienced in the use of wearable monitors and the nurses 
on the ward were familiar with the monitoring equipment. None of these factors applied to the study described in 
Chapter 4, which was remarkable for the number of recordings where no data was captured at all. 
Published reports of system performance may also provide useful information to guide prediction of the failure rate. 
However, as discussed in Chapter 3, many studies are limited by small sample sizes, biased reporting of results and may 
be carried out in an non-clinical environment. 
7.5 Requirements Analysis 
7.5.1 Overview and Rationale 
Requirements analysis is widely accepted to be the foundational step of effective systems design.211 It involves structured 
documentation of project objectives, constraints and the required characteristics of the system. The output of the 
analysis is a document called a System Requirements Specification (SRS). 
At a high level a wearable monitoring system can be modelled as comprising of three functional components, one or 
more wearable monitors, data transmission and storage infrastructure and data analysis and display infrastructure. We 
recommend that the SRS for a wearable monitoring system should define the characteristics of these components in an 
objective, measurable manner. 
Undertaking requirements analysis serves multiple purposes. Firstly it allows failure to be objectively defined. Secondly, 
it provides a structured description of the users and the monitoring environment, which will be used for later analyses. 
Thirdly, if a monitoring system has not been selected for the planned intervention, the output of the SRS can be used to 
define shortlisting criteria.  Fourthly, once a monitoring system has been selected, the SRS can be used determine 
whether the components of the selected system have the requisite characteristics to reliably achieve the project aims. 
Having identified  gaps between actual and required performance either the system can be modified, mitigating 
processes instituted or project aims changed. 
7.5.2 Practical Conduct 
We recommend using the IEEE 1233-1998 standard as the best guide for conducting this requirements analysis. 212 It is 
concise, easy to read, and provides explicit guidance suitable for a novice to the field. Appendix A provides further detail 
regarding how this recommendation was derived.  
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The intended audience of IEEE 1233-1998 is software developers seeking to create a new system in a commercial 
environment. Hence some suggested sections of the guideline are irrelevant to the purposes of evaluating a wearable 
monitoring system. We propose that the following subset of the IEEE suggested headings are used: 
1. Project aims 
2. Constraints 
a. environment in which the system will be used 
b. the users of the system 
c. others (e.g. finances, time, available resources) 
3. Required system capabilities 
4. Performance requirements 
These are similar to the headings mandated by IEC 62366:2007,171 a guideline for usability testing of medical devices. 
In the sections below we make some additional recommendations specific to wearable monitoring systems. 
7.5.2.1 Derivation of Technical Requirements 
 Monitor properties 
(notably sensor 





Data analytics and 
display 
infrastructure 
Data recording    
What physiological parameters must be recorded in order to achieve the trial 
objectives 
X X  
Are signal waveforms required (e.g. ECG) or numeric parameters (e.g. HR) or 
both? X X  
For numeric parameters…    
What accuracy is required? X   
How frequently are new values for numeric parameters required? X X  
For waveform data…    
What is the minimum acceptable sampling frequency and resolution? X X  
Is waveform data going to be divided into windows for analysis? If so, what is 
the minimum usable window length for waveform data? 
 X  
How frequently are new windows of waveform data required?   X  
For both…    
Assuming gaps are sporadic events, what is the maximum acceptable gap in 
recording? 
 X  
What is minimum envisaged duration of each monitoring period? X   
What is maximum envisaged duration of each monitoring period? X X  
Data Usage    
Do the study aims require wearers to act on the data during the recording?  X X 
Do the study aims require other users to act on the data during the recording?  X X 
Does the data need to be analysed while the recording is ongoing (e.g. to 
generate alerts or physiological measurements) 
 X X 
Table 7.1: Questions to aid specification of the key technical requirements of the system 
We have devised a list of questions from which the key technical requirements of a wearable monitoring system may be 
derived. This are listed in Table 7.1, which also indicates which system components will be affected by the answer to 
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each question. As described in Chapter 1, in general the more data required, the higher the system power consumption, 
the shorter the battery life.  
7.5.2.2 Description of the Monitoring Environment 
As indicated by IEEE 1233-1998, the environment is a broad term which encompasses not only the physical 
environment but also the technical, regulatory and political environments in which the system must operate. With 
respect to a wearable monitoring intervention, important considerations are the pre-existing wireless data transmission 
infrastructure, institutional policies such as infection control or network security policies, medical device regulations and 
research ethics. For instance, there are ethical considerations surrounding clinical decision-making based on a consumer 
monitor which has not been certified as a medical device. 
7.5.2.3 Description of User Characteristics 
We recommend the use of the Perception Cognitive Action (PCA) model categories (Figure 7.5) for describing user 
characteristics. The PCA model provides a more systematic, objective and comprehensive approach to describing users 
than techniques such as personas213 or the checklists of characteristics found in other guidelines.171 
 
Figure 7.5: The Perception Cognitive Action (PCA) model for describing user characteristics. (Image courtesy of Dan Jenkins, DCA Design) 
User characteristics should be defined for each class of users that will regularly interact with the system. In a wearable 
monitoring intervention there will be at least two classes of users, wearers and researchers. Other possible user classes 
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7.6 Measurement Validation 
7.6.1 Failure prediction 
The most reliable source of data regarding measurement accuracy is likely to be a well-conducted validation study 
published in a peer reviewed journal. When assessing validation studies the generalisability of the results should be 
carefully considered. A device which provides perfect measurements in healthy young volunteers at rest may not do so 
when applied to elderly patients mobilising around a hospital ward. In the absence of such data, certification of a 
monitor as a medical device implies that some level of validation has been carried out and measurement accuracy will 
be listed in the manufacturer’s technical specifications. 
If no formal validation data is available a monitor then it is advisable to conduct a validation study to ensure that the 
measurements are sufficiently accurate for the purposes of the planned intervention. 
7.6.2 Laboratory Testing 
In order to formally assess measurement accuracy of a wearable monitor recordings should be taken from the test device 
and a ‘gold standard’ reference device simultaneously. Detailed description of how to conduct a formal validation study 
is beyond the scope of this chapter. Our own work on the validation of respiratory rate algorithms214 provides an 
example of how to conduct such a study and the statistical considerations when comparing recordings from continuous 
monitors. 
In lieu of a formal validation study, the probability of measurement error can be estimated by measuring the statistical 
dispersion of measurements. This approach involves dividing recordings into windows and calculating the standard 
deviation measurements within each window. The window length should be set such that it is reasonable to assume that 
the measured parameter will be stationary throughout the window. Thus a window containing good quality data will 
have a low standard deviation. The pooled standard deviation (the standard deviation of all the calculated standard 
deviations) can be calculated to give an overall quality metric for the entire recording. 
The advantages of this method are that it is simple to conduct and can be carried out using data recorded during other 
stages of failure analysis, thereby lowering the overall time taken for failure analysis. The principle disadvantages of this 
method is that it cannot be used to accurately estimate the magnitude of measurement error and it will be falsely 
reassuring if measurements are consistent but systematically biased. 
7.6.3 Mitigation Strategies 
The following mitigation strategies may be used to compensate for poor measurement accuracy: 
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• If waveform data are available: 
o Suppression of measurements derived from noisy segments of waveform using signal quality indicator 
algorithms 
o Filtering to improve signal quality followed by derivation of measurements from the filtered signal 
• If only numeric data are available: 
o Temporal data fusion – combining of consecutive measurements (e.g. using a median filter) to provide 
more accurate measurements less frequently 
o The use of heuristic rules to filter out implausible data 
• If multiple sources of data are available for the same measure (e.g. HR from both ECG and PPG or HR from 
multiple different ECG leads) 
o Fusion of multiple simultaneous estimates, (e.g. by calculating the mean or median) 
• In some cases measurement inaccuracy may be caused by a flaw in the monitor firmware and correctable by a 
software patch. 
Multiple approaches may be combined. Researchers in the VIE-VENT study215 employed a combination of 10 
methods, both statistical and heuristic, to validate mechanical ventilation data obtained on a neonatal ICU. 
A notable characteristic of all the mitigation strategies described is that they are comparatively complex to institute 
unless specialist biomedical engineering expertise is available. Even if such expertise is available practical 
implementation may be impossible if the study aims require data to be displayed in real-time. 
7.7 Component Reliability 
7.7.1 Failure Prediction 
Based on a formal assessment of methods described in the reliability engineering literature, we recommend Failure 
Modes Effects and Criticality Analysis (FMECA) as the most suitable method for novice assessors to use to predict 
failures. Appendix A gives further details of how this recommendation was arrived at.  
A concise, readable guide to conducting an FMECA is provided by the American Army Technical Manual 5-698-4, 216 
which is freely available online. In summary the technique consists of the following stages: 
1. Describe the system architecture. 
2. For each component list all possible modes of failure (how the component might fail) 
3. For each mode detail the possible causes of the failure mode (why the component might fail) 
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4. For each possible cause detail the effects of the failure mode occurring 
5. Conduct a criticality analysis to rate failures according their impact on the overall system 
7.7.1.1 Describing System Architecture 
There are two variants of the FMECA technique, one where a system is decomposed into its individual components 
(e.g. washer, piston) and one where it is decomposed into functional components (e.g. pump). We recommend that the 
latter approach (termed a functional FMECA) is used and that the system architecture is described using a reliability block 
diagram (RBD). 
The framework for describing wearable monitoring systems proposed by Pawar et al43 which we reference in Chapter 1 
is useful as a starting point for constructing an RBD (Figure 7.6). Specific functional blocks, can be decomposed into a 
more detailed representation if this is helpful. There is no requirement to describe all system components to the same 
level of detail and there are no rules which dictate how much detail is “correct”. Judgement is needed. We provide an 
example of what we consider to be a useful level of detail in Figure 7.7. This shows the Equivital monitor described as 
an RBD in preparation for an FMECA. Notable differences between our RBD and Pawar’s diagram is the emphasis on 
connectors, as these are commonly points of failure. 
 
Figure 7.6: The scheme recommended by Pawar et al for describing wearable monitoring system architecture. 
M-Health can be defined as the emerging mobile communications
and network technologies for healthcare systems.
However, this definition focuses more on mobile computing as
compared to mobility of persons involved in the healthcare system.
We propose a definition of m-Health as:
M-health is the application of mobile computing, wireless commu-
nications and network technologies to deliver or enhance diverse
healthcare services and functions in which the patient has a free-
dom to be mobile, perhaps within a limited area.
In this definition, we stress the mobility of the patient within
the healthcare system. The patient is a person who is receiving
medical care. Of course mobility of health professionals may also
be facilitated by m-Health systems, but we see patient mobility
as essential to the concept of m-Health.
The Medical Dictionary Online defines patient monitoring as the
continuous or frequent periodic measurement of physiological pro-
cesses such as blood pressure, heart rate or respiration rate of a pa-
tient. There exist a variety of terms for the use of ICT in patient
monitoring, e.g. telemonitoring, remote patient monitoring, wireless
patient monitoring and mobile patient monitoring.
The American Telemedicine Association defines telemonitoring
as the process of using audio, video and other telecommunications
and electronic information processing technologies to monitor the
health status of a patient from a distance. In the context of health-
care, the terms telemonitoring and remote patient monitoring are
synonymous [10]. In the current state of telemonitoring [10] it is
pointed out that apart from monitoring people who are ill (pa-
tients), telemonitoring may also refer to health monitoring of
healthy individuals such as athletes or astronauts.
We consider mobile patient monitoring to be a subclass of re-
mote patient monitoring, since with the latter all the associated
healthcare tasks could be conducted solely using wired communi-
cation links (thereby possibly restricting movements of the pa-
tient). For instance the digital electrocardiogram (ECG) system
described in [11] transmits a patient’s ECG to a remote cardiologist
using a fixed phone line modem, hence this is classed as remote
patient monitoring but not as mobile patient monitoring. In this
case the system enables home-based monitoring for example but
not monitoring of the mobile patient at any arbitrary time and
place. During mobile patient monitoring however, the patient is
able to move freely anywhere inside or outside the home. Hence
we define mobile patient monitoring as follows:
Mobile patient monitoring is the continuous or periodic measure-
ment and analysis of a mobile patient’s biosignals from a distance
by employing mobile computing, wireless communications and
networking technologies.
Wireless networking technologies, essential for monitoring the
mobile patient, can be broadly categorized as: (1) Wireless wide
area network (WWAN) technologies which provide low-band-
width and high-latency service over a wide geographic area; and
Table 1
Parameters for comparison of mobile patient monitoring systems.
Parameter Description
Architecture Architecture of a mobile patient monitoring
system according to the generic architecture
shown in Fig. 3
Sensor/actuator set Types of sensors/actuators/other BAN
devices used
Sensor front end Details of the sensor front end in terms of its
make/model, included features and
supported biosignal processing functions
MBU Features of the MBU, in terms of supported
applications, network interfaces and
biosignal processing functions
Intra-BAN communication ! Communication type (wired/wireless) for
communication between BAN devices and
MBU
! Biosignal processing along the
communication path and on the MBU
! QoS requirements for biosignal transfer
! Communication protocol used for
biosignal transfer
Extra-BAN communication ! Communication techniques for
communication between MBU and BESys
! Biosignal processing along the
communication path and on the BESys
! QoS requirements for biosignal transfer
! Communication protocol used for
biosignal transfer
BAN Back-End server and
supplementary
applications
! BAN Back-End server information such as
technology choices for its implementation
and deployment
! Supplementary applications which use
biosignal and other health related data
available at the BAN Back-End server
Clinical Back-End server and
supplementary
applications
! Clinical Back-End server information such
as technology choices for its
implementation and deployment
! Supplementary applications which use
biosignal and other health related data
available at the clinical Back-End server
Back-End System
communication
! Mechanisms for making data generated at
the Back-End servers available to the
supplementary applications
! Communication protocols and technology
choices for data transfer
Trial patient group Target patient groups which are intended to
be monitored by a mobile patient
monitoring system
Trial information Information about trials conducted to
validate a mobile patient monitoring system
with a focus on the number of patients and
duration of the trial
Reported findings/problems Information about significant technical
findings and problems reported during the
trial
Fig. 3. A gene ic ar hitecture of mobile patient monitoring sys ms.
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Figure 7.7: The architecture of the Equivital wearable monitoring system described as a Reliability Block Diagram 
7.7.1.2 Failure Modes and Their Causes 
The accuracy and comprehensiveness of the list of failure modes and causes is dependent on analyst judgement and 
experience. The results of Failure Modes and Effects Analysis (FMEA)h generated by novices in a healthcare domain 
have been criticised for being inaccurate.217 Inexperienced analysts may either miss important failures or hide important 
failures within a long list of possible but unlikely failures, making the process time consuming and the results difficult to 
read. 
The dependence of FME(C)A on the skills of the analyst can be partially mitigated through the use of supportive 
documentation such as checklist and handbooks. The handbook approach has previously been adopted by the US 
military.205 Each handbook contains a comprehensive list of components, their failure modes and empirically 
determined failure rates which can be used to populate an FMEA. The disadvantage of this approach is the 
considerable expense of maintaining accurate, comprehensive and up to date data. 
Checklists can be considered a simplified form of a handbook. These provide a list of failure modes for generic 
components as oppose to failure modes and failure rates for specific makes and models of component. An example is 
provided in the ANSI HE74 standard171 which provides a list of failure modes for connectors. The advantage of this 
high-level approach is that a checklist is generalisable to wider range devices than a handbook and is less expensive to 
maintain. Unfortunately we are not aware of any checklists directly relevant to wearable monitoring systems. 
                                                        
h FMEA is the same process as FMECA except that it does not involve the criticality analysis 
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Ad hoc testing is also useful. It allows estimation of the relative incidence of common failures and is likely to reveal 
failures that the analyst might have missed. For instance, three of the six systems we have previously tested had flaws 
which intermittently caused errors in the timestamps and two systems recorded waveform with a much lower resolution 
than the stated technical specifications, rendering the data unsuitable for analysis. 
7.7.2 Laboratory Testing 
No matter how rigorous the FMECA some degree of laboratory testing will be necessary. In particular, software 
components of the system are especially hard to model without detailed knowledge and therefore these are best 
evaluated empirically.  Providing it is well-designed, a single study can encompass reliability testing, usability testing and 
acceptability testing. An aim of such testing should be to estimate the incidence of different types of component failure 
in order to understand which are the most important to mitigate against. 
7.7.3 Mitigation Strategies 
The most definitive mitigation strategies would involve replacing components which fail recurrently with better 
performing versions. This is likely to be difficult if commercial hardware is used. However, it may well be possible if the 
failing component is software and the vendor is sufficiently responsive to feedback. Our testing identified software flaws 
in every system evaluated in this thesis. 
If the components cannot be changed and the failure is exacerbated by environmental factors, changing these may be 
effective. With software this may be especially effective if the computing environment (hardware and software) within 
which the software is deployed differs from the manufacturer’s certified setup. 
Component failure may be mitigated by redundancy. For instance if data is stored both on device and transmitted to a 
remote monitoring station then the risk of data loss caused by failure of the transmission or data storage infrastructure is 
reduced. Another example of redundancy would be measuring the same physiological parameter with two different 
sensors.  
For failures which cannot be effectively mitigated by the means discussed above human intervention will be needed. 
Standard operating procedures can provide effective mitigation for failures can be anticipated, such as battery depletion. 
For sporadic failures, routine checking of system function is required. 
The extent to which sporadic failures can be effectively mitigated depends on their incidence, their visibility and the 
resources available to correct them. Failure visibility and the resources available to fix them are partly dependent on 
system usability. If the signs of failure are sufficiently obvious and the solution simple to implement then the wearers 
themselves, if sufficiently motivated, can correct failures. In the LISTEN study, ward nurses were able to correct the 
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most common problems with the monitoring equipment. By contrast, in the testing described in Chapter 4, failures 
were not readily visible to ward staff therefore it fell to the researchers to correct all failures. Furthermore the incidence 
of sporadic failure was high. As a result data loss was substantial. 
Possible approaches to address an imbalance between resources for fixing problems and the incidence of sporadic failure 
are, cohorting wearers in a single area to reduce the time travelling between each patient, adapting the system to 
increase visibility of error, training and motivating wearers or other non-researchers (e.g. patient relatives, ward staff) to 
help fix problems or recruiting more researchers. If the failures are predominantly caused by software, the installation of 
remote administration tools may provide an effective strategy for improving the effectiveness of a limited problem-fixing 
resource. 
7.8 Acceptability Testing 
7.8.1 Failure Prediction 
The previous chapter of this thesis has provided a brief discussion of technology acceptance models. It has also 
described how these might apply to wearable monitoring in the form of a questionnaire. Therefore we will not revisit 
these topics here. Suffice it to say that we recommend the use of a technology acceptance model.  
We could only find one comprehensive review of acceptance models. The review, conducted by Venkatesh et al185, 
compared the validity of 8 different models of technology acceptance and combined features from the different models 
to create a new model, the Unified Theory of Acceptance and Use of Technology (UTAUT). Their paper reported that 
UTAUT has a higher validity than other models. 
We could not identify any other papers which performed a similar comparison to confirm the superiority of UTAUT 
over other models. However, a meta-analysis of empirical studies using UTAUT217 concluded that the constructs were 
valid. It also noted that the UTAUT constructs were generally well correlated with measures of acceptance external to 
the model. Another review comparing UTAUT to the Technology Acceptance Model (TAM) and Diffusion of 
Innovation model (DOI) suggested that UTAUT was the best model to use in healthcare applications based upon the 
fact that UTAUT constructs seemed to qualitatively match findings from empirical healthcare studies.218  
7.8.2 Laboratory Testing 
Practical wearer acceptability testing can be conducted by having the researchers wear the monitors themselves or 
recruiting volunteers for the same purpose. We recommend that a combination of questionnaires and interviews are 
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used to gather feedback. In the OPTIMI project Totter et al181 used this approach to improve the design of their 
wearable monitor and maximise wearer acceptance. 
Care should be taken with interpretation of the results from laboratory testing if the wearers in the laboratory testing are 
not from the population who will participate the planned intervention. The population easiest to recruit for a laboratory 
study, research and clinical colleagues, may be biased or have significantly different perspectives on technology 
acceptability.182 This can lead to erroneous conclusions about the acceptability of the devices. The structured user 
description conducted as part of the requirements analysis can be useful in comparing the target wearers with those 
participating in laboratory testing and make it easier to predict where there might be differences. 
Another low-cost approach is to conduct a public engagement exercise or formal focus group to ascertain the views of 
the target user group.219 These approaches have the benefits of engaging with an appropriate user population. However, 
they have the disadvantage that people’s actual behaviours and motivations may be different from their stated 
behaviours and motivations. 
7.8.3 Mitigation Strategies 
Approaches to intervention design lie of a spectrum. At one end interventions can be designed based on behavioural 
theories. Morrison has compiled a list of behaviour change theories relevant to digital health implementations.220 At the 
other end of the spectrum are iterative approaches based upon engagement with end users. Yardley et al have described 
a ‘person-centred’ approach for developing successful digital health interventions.219 Both types of approach have their 
advantages and disadvantages and one size does not fit all.221 Expert consensus is that intervention design based on 
behavioural theory, refined by early user engagement is the most effective approach.222 
A theoretical approach based on the UTAUT model would aim to minimise the negative aspects of the monitoring, 
discomfort, interference with daily activities, negative social influences, and increasing the positive aspects, perception of 
benefit, facilitating conditions, positive social influences.  
The comfort and obtrusiveness of a monitor is intrinsically related to its physical form which is strongly affected by the 
sensors incorporated into the monitor. In Chapter 2 we have discussed how different sensors attach to patients in 
different ways and that some methods of attachment are more comfortable and less obtrusive than others. Sensor choice 
also affects power consumption which in turn affects required battery capacity and thus the volume and weight of the 
device. Thus there is a relationship between the required data and the comfort of the device.  
Where the same data (e.g. HR) can be acquired by different sensors, careful consideration should be given to which 
sensor is likely to be the most comfortable. Similarly, by lowering the requirement for data fidelity, overall data capture 
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rates may be increased. This was our experience with the monitors tested in Chapter 4. The best data capture rate was 
achieved by the Proteus RP2 patch, which only recorded periodically and did not capture full ECG waveform. 
Lowering the requirements for data fidelity allowed for a smaller, less obtrusive monitor design. 
In the LISTEN study we were not able to identify a strong social influence on user acceptance (Chapter 6). However, 
fear of stigmatisation has been recurrently observed as an important factor in the outpatient setting.181,190,223 Therefore, 
for outpatient monitoring. We recommend a higher importance should be placed on ensuring the monitor is not readily 
visible. 
In terms of increasing the perceived benefit, our own research (Chapter 6) and that of others159,223 highlights a feeling of 
safety as a motivator for many patients. Ensuring that the intervention reinforces this feeling may help engagement not 
only directly but also by improving perceived comfort.224 
The research team and ward staff can also have an important influence on patients’ desire to continue with monitoring. 
Mohr et al have developed a model which describes how best to use human support to increase adherence with eHealth 
interventions.225 
7.9 Usability Testing 
7.9.1 Failure Prediction 
Following a review of 42 different usability assessment methods we recommend Tabular Task Analysis (also called Task 
Decomposition) as the best usability assessment tool for our purposes as it provides a good balance between simplicity 
and rigour. Full details of the process leading to this recommendation are given in Appendix A. 
Tabular Task Analysis (TTA) consists of the following steps: 
1. Select the task to be analysed. 
2. Describe the task as a series of goals, operations and plans. (See Figure 7.8 for an example.) 
3. Specify the users involved in the task. 
4. For each user group consider the answers to a series of pre-defined prompts for each operation. (See 7.9.1.2 for 
the recommended prompts.)  
5. List the likely errors 
6. Consider mitigation strategies 
We now discuss the practicalities of this process in more detail 




Figure 7.8: Task analysis for making a cup of tea. Goals are contained within boxes which are not underlined. Operations are contained within 
underlined boxes. Plans detail the timing and sequence of operations. The level of detail is at the analyst’s discretion. For instance, if desired, 1.1 – Fill 
kettle could be further decomposed into the individual actions required to fill a kettle. 
7.9.1.1 Task Selection 
The most important tasks to analyse are those that affect the likelihood of data loss. Table 7.3 lists tasks which are 
common to the usage of all wearable monitors and the potential consequences of making an error whilst completing the 
task. We recommend that each of these tasks form the basis of a usability analysis. 
Task Potential consequence of task failure 
System Installation All study data potentially affected 
Configuration of monitor settings/ pre-fitting 
procedures 
(e.g. assigning a monitor to a patient within 
the monitoring software or Bluetooth pairing 
with a mobile device) 
Depends on the monitor design. If settings are input at the beginning of the study and the device is 
reused then all monitoring sessions conducted with the device will be affected 
If settings are specific to a monitoring session then all data from a single monitoring session will be 
affected 
Initial fitting All data from a single monitoring session affected 
Re-fitting All data from the time of re-fitting affected 
Removal Depends on the error made. If a re-usable monitor is damaged during removal has the potential to 
affect future recording sessions 
Charging/replacing battery All data from the time device is fitted may be affected 
Data download Depends on the frequency and method of data download. If multiple recordings downloaded 
simultaneously then potential for data loss is high. 
System maintenance All data potentially affected 
Table 7.2: Usage tasks common to all wearable monitors and the consequences of error. 
7.9.1.2 User Groups and Task Prompts 




Clinical Staff Researcher 
Support 
Engineer 
System Installation     • 
Configuration of monitor 
settings 
  • (occasionally) •  
Initial fitting    •  
Re-fitting • • (Very rarely) • •  
Removal • • (Very rarely) • •  
Charging/replacing battery  • (Very rarely) • •  
Data download    •  
System maintenance    •  
Table 7.3: An exemplar task-user matrix for a wearable monitoring intervention conducted in a hospital ward setting. 
0. Make a 
cup of tea
1. Boil water 2. Empty pot 3. Put tea leaves in pot
4. Pour in 
boiling water
5. Allow to 
brew 6. Pour tea
1.1 Fill kettle 1.2 Put kettle on stove
1.3 Wait for 
kettle to boil




• Do 2 at the same time, if put is full
• Then 3 and 4
• Wait 5 minutes then do 5
Plan 1
• Do 1.1 > 1.2 > 1.3
• When kettle boils, 1.4




Where a task is conducted by multiple users a separate analysis should be conducted for each user type. We propose the 
considering the following set of prompts for each operation: 
1. How could a user fail to complete this operation? (List all causes of failure before moving on to the next 
prompt.) 
2. Will the user have all the equipment and consumables they need to complete this task? 
3. Does the user have a sensory impairment which might cause an error when carrying out this operation? 
4. Does the user have the correct knowledge/skills to complete the operation? 
5. Does the user have the correct physical capabilities to complete the operation? 
6. What feedback is provided to the user regarding whether the operation has been completed successfully? 
7. Will the user notice and understand the feedback? 
8. Will the user know what to do next? 
The prompts above are based on existing prompts from human error analytic techniques and have been selected to 
balance simplicity, comprehensiveness and speed. The first prompt is taken from the Murphy Diagram technique.226 
Prompts 3-5 are based on the Perception Cognition Action (PCA) model227 of human behaviour.i Prompts 6-8 are based 
on Norman’s theory of action.228 
7.9.2 Laboratory Testing 
Although there are multiple formal usability testing methods we do not recommend these over careful logging of errors 
observed in practice as, in our experience, the cost-benefit ratio is unfavourable. Practical testing in a laboratory context 
may facilitate closer inspection of user behaviours than ward testing. This also has the secondary benefit of familiarising 
researchers with the systems to be tested. 
7.9.3 Mitigation Strategies 
Errors highlighted by our prompts can be grouped into three main categories, errors caused by lack of equipment, 
errors caused user impairment and errors caused by lack of knowledge. Errors caused by lack of equipment can be 
mitigated by ensuring the right equipment is always available. Errors caused by user impairment can be mitigated by 
either modifying the system design in some way or ensuring that the user has support to complete the task. Errors 
                                                        
i The PCA model states that every action has three steps, perception, cognition and action. If the user’s ability to carry out any of 
these steps is impaired then the chance of error is increased. Depending on the degree of impairment it may be impossible for the 
user  
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caused by lack of knowledge can be mitigated by written guides and standard operation procedures, user training or 
delegating the task to a more knowledgeable user. 
7.10 Conclusions 
We have proposed a model of system failure for wearable monitoring systems and structured framework for predicting 
the likely causes of failure in order. The framework is useful for either comparing monitors or for designing mitigations 
to maximise the probability of successful data collection from a given monitor. Analytic techniques suitable for novice 
analysts have been made based on a series of literature reviews. 
Whilst our proposals have a foundation in both the literature and personal experience, the framework remains untested. 
Further work is required to evaluate how effective it is in the hands of novice analysts, how long it takes to conduct and 
whether it leads to significant improvements in data capture rates over unstructured observation and standard practice 
in running clinical trials. 
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 Estimation of Respiratory Rate from ECG and 
PPG: Underlying Theory 
8.1 Introduction 
In the preceding chapters we have evaluated the feasibility of using wearable monitors in a general ward setting and 
highlighted user acceptance as a key determinant of monitoring success. The desire to monitor as many vital signs as 
possible to improve clinical utility must be balanced against patient comfort. Respiratory rate is widely held to be the 
most sensitive marker of clinical deterioration, making it an important input into any physiological model of 
deterioration.13 However, the respiratory sensors commonly incorporated into wearable monitors all have disadvantages 
which are likely to either impair patient comfort or make readings less accurate in an ambulatory patient population. 
The most commonly used measurement techniques are impedance or inductance plethysmography, impedance 
pneumography and accelerometry. Impedance and inductance plethysmography sensors both require a tight band to be 
placed around the base of the thorax. As we have already described, many patients find uncomfortable to wear for 
prolonged periods, making them unsuitable for prolonged monitoring. Electrical impedance pneumography sensors 
work best when electrodes are placed on opposite sides of the chest,229 making it ergonomically less attractive than more 
compact “patch” or “watch” style sensors.j Accelerometry is sensitive to motion artefact and body position, making it 
less reliable in ambulatory patients. 
An alternative approach to the use of a dedicated sensor is to use an algorithm to derive the respiratory rate from the 
ECG or PPG waveform. This has the advantage of increasing the pool of potential monitors which might be used, does 
not require uncomfortable thoracic bands to be applied and, by eliminating the need for a dedicated respiratory rate 
sensor, allows monitor size and power consumption to be minimised. Furthermore, the technique can be applied 
retrospectively to waveform datasets, thereby increasing the quantity of the physiological information which can be 
extracted from them. 
This is particularly useful in the ward context where respiratory rate is often measured inaccurately.230 Figure 8.1 shows 
the distribution of RRs measured from the LISTEN study population as measured by an automated monitor and by 
nurses on the ward when the patients were transferred from HDU. Even allowing for the fact that patients on the ward 
are in better health, the range of respiratory rates measured by the nurses is compressed with a disproportionately tall 
                                                        
j The Sensium patch includes impedance pneumography sensors to measure respiratory rate in a compact digital patch form factor. 
This information is supplemented by ECG-derived data. When patients are not in sinus rhythm a respiratory rate is not reliably 
reported.50 
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peak at 18 breaths per minute. An EWS derived from data like this is likely to have un-physiological thresholds due to 
the errors in measurement. A sufficiently accurate RR estimation algorithm could provide a much more accurate 
picture of the trajectory of patients’ RRs prior to deterioration. 
 
Figure 8.1: The distribution of respiratory rates from the LISTEN study population measured by an automated HDU monitor (left) and by manual 
charting on the ward (right) 
Over 190 algorithms have been described in peer-reviewed literature. 231 However, when we came to select an RR 
algorithm from amongst the numerous options we found that it is not clear from the literature which is the most 
accurate. Therefore we designed a structured validation to identify which algorithms  might be used to provide reliable 
respiratory rates in a real-world patient population with multiple comorbidities. In this chapter we provide an overview 
of the underlying theory which needs to be taken into account in designing a study to evaluate RR algorithms. We 
describe the physiological mechanisms underlying respiratory modulation of the ECG and PPG, the algorithms 
developed to estimate RR and the factors which affect algorithm performance. In the following chapter we report the 
results of an evaluation of RR algorithms (the VORTAL study). 
8.2 Physiological Basis for Respiratory Modulation of ECG and PPG 
 
Figure 8.2: Illustration of the modulations of the ECG and the PPG by respiration. From top to bottom: No modulation (provided for reference), 
Baseline Wander(BW), Amplitude Modulation (AM), Frequency Modulation (FM). In vivo all three modulations are present simultaneously. 
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Algorithms which estimate respiratory rate from the ECG or PPG do so by measuring the respiration-induced 
modulation of these signals. As shown in Figure 8.2, respiration modulates the ECG and PPG in three ways:232 
1. Frequency Modulation (FM): modulation of the beat-to-beat heart rate 
2. Amplitude Modulation (AM): modulation of the amplitude of the ECG/PPG signal for each heartbeat 
3. Baseline Wander (BW): modulation of the signal baseline 
The physiological mechanisms by which respiration induces these modulations differ according to the signal and the 
type of modulation. 
8.2.1.1 Frequency Modulation 
The interval between each heart beat varies continuously, a phenomenon termed heart rate variability (HRV) or, in 
signal processing terms, Frequency Modulation (FM). The time difference between each heartbeat is termed the ‘heart 
period’ or the ‘instantaneous heart rate’. In the spontaneously breathing subject the heart period decreases with 
exhalation and increases with inspiration. The component of HRV associated with respiration is termed Respiratory 
Sinus Arrhythmia (RSA).233 (RSA is often misused as a synonym for HRV234 but it is not the only determinant of 
HRV.235) 
HRV is primarily modulated by the Autonomic Nervous System (ANS).236 The heart receives both sympathetic 
stimulation via neurones arising from the middle and inferior paravertebral ganglia 237 and parasympathetic stimulation 
via the vagus nerve. 
Heart rate is determined by the balance between parasympathetic and sympathetic activity. Beat-to-beat variation in 
the balance gives rise to HRV.238 The differing levels of activation of the two branches of the autonomic nervous system 
can be observed in the HRV frequency spectrum. Low-frequency variation (0.04-0.15Hz) is caused by sympathetic 
activation, while high-frequency variation (0.15-0.40Hz) is caused by parasympathetic activity.238 
The cardiac sensitivity to stimulation from the two branches of the ANS differs. The cardiac response to sympathetic 
stimulation is relatively slow. Parasympathetic influences on the heart are almost instantaneous239  and are primarily 
responsible for HRV. 
Increased parasympathetic activity increases vagal tone, the frequency with which the vagus nerve fires. The heart rate 
response has a quadratic relationship with vagal tone – initially the heart rate decreases as the vagal tone increases but 
beyond a certain level of stimulation the heart rate begins to increase again.240 
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Neurological control of vagal tone is primarily mediated by the central cardiovascular centre neurones located in the 
ventrolateral nucleus ambiguous and the dorsal motor nucleus within the medulla oblongata. These nuclei receive 
inputs from arterial baroreceptors (blood pressure), carotid and aortic chemoreceptors (sensing plasma carbon dioxide 
concentration and pH), atrial stretch receptors and higher mental centres. 
Respiration is thought to influence HRV through modulation of vagal tone via these inputs.241 Changes in intra-
thoracic pressure cause alterations in blood pressure and venous return, affecting baroreceptor and atrial stretch 
receptor activity. Changes in minute volume alter plasma carbon dioxide concentration, affecting chemoreceptor 
activity. Furthermore respiration modulates heart rate via direct effects on cardiac neurones and activation of 
pulmonary stretch receptors.242  
The physiological mechanisms described above are the most widely accepted explanations for how respiration affects 
heart rate variability. However, alternative theories exist. Some have postulated that that the association between HRV 
and respiratory rate is simply correlation due to common control by a cardiopulmonary oscillator243 or that a feedback 
loop exists between heart rate and respiration whereby inspiration is intermittent triggered by heart beats.244  
8.2.1.2 Amplitude Modulation and Baseline Wander 
AM and BW in the ECG is caused by respiration-induced cardiac rotation,245 changes in transthoracic impedance 
related to the volume of air in the lungs and variation in distance between the thoracic wall and heart.246 AM and BW 
in the PPG are caused by; thermoregulation, vasomotor activity, Traube-Hering-Mayer waves (rhythmical oscillations 
in vasomotor tone caused by baroreceptor and chemoreceptor reflexes) and respiration.247 The strength of the 
modulation observed is partially determined by body position, which affects baroreceptor reflexes by central 
mechanisms.248 
The physiology of respiration-induced component of AM and BW in the PPG is poorly understood. The most 
commonly accepted hypothesis is that respiration-related changes in stroke volume and intrathoracic pressure alter the 
arterial and venous filling pressures, thereby modulating the PPG.247 The magnitude of the modulation is related to tidal 
volume.249 
8.3 Respiratory Rate Algorithms 
Algorithms for deriving the respiratory rate from the ECG or PPG raw signals consist of two essential stages and three 
optional ones (Figure 8.3). 
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1. Extraction of respiratory signal(s) from the raw signal. One or more respiratory modulations may be extracted 
from one or more signals. 
2. Estimation(s) of respiratory rate based upon the extracted respiratory signal(s). 
These may be supplemented by techniques designed to reduce errors – data fusion or detection and suppression of 
artefact using signal quality indices (SQIs). Data fusion may occur at the level of the raw sensor data, extracted features 
or respiratory rate estimates.250 Signal quality estimates may also theoretically be applied at any stage. Most commonly 
signal quality assessment is usually carried out on the raw signal. Algorithms to assess the quality of the respiratory 
information within a signal, Respiratory Quality Indices, have also been developed.231 
 
Figure 8.3: Stages of a RR algorithm 
8.3.1.1 Extraction of Respiratory Signals 
Extraction of respiratory signals can be carried out using either feature or filter based techniques. Feature-based 
techniques involve measurement of salient points on the signal waveform. Following segmentation of the signal into 
beats, peaks and troughs within a beat are detected. RSA can be derived from the peak-to-peak time interval, BW from 
the amplitude of peaks and AM from the amplitude difference between a trough and its corresponding peak. 18 
techniques to detect these features have been proposed, some of which require multiple simultaneous channels of 
ECG.231 Figure 8.4 provides illustrations of feature-based extraction and examples of extraction techniques are listed in 
Table 8.1. 
 
Figure 8.4: Feature-based extraction of RR modulations from ECG (left) and PPG (right). From top to bottom, extraction of Baseline Wander, 
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Toolbox Code Modulations 
extracted 
Features used 
XB1 BW Mean amplitude of troughs and preceding peaks. 
XB2 AM Difference between the amplitudes of troughs and preceding peaks 
XB3 FM Time interval between consecutive peaks 
XB4 BW Mean signal value between consecutive troughs 
XB5 BW, AM Peak amplitude 
XB6 BW, AM Trough amplitude 
XB7 FM QRS duration. Q and S waves were identified as the minima immediately before and after the R 
wave 
XB8 AM, FM QRS area, defined as the integral of the ECG waveform between Q and S waves after 
subtraction of a baseline linearly interpolated between Q and S waves. 
XB9 BW Kernel principal component analysis using a radial basis function, with the variance of the 
Gaussian kernel determined by maximising the difference between the first eigenvalue and sum 
of the remainder 
XB10 FM PPG pulse width estimated using a wave boundary detection algorithm  
Table 8.1: Exampless of feature-based extraction components. 
Instead of detecting respiratory modulations in the time domain, using feature-based extraction, they can be isolated in 
the frequency domain using filter-based extraction. Conventionally ECG and PPG are represented in the time domain, 
which shows how the signals change with time. However, as with any signal, they can be represented as a set of 
frequencies in the frequency domain. The conversion of a simple signal into a frequency spectrogram is illustrated in 
Figure 8.5.  
 
 
Figure 8.5: The relationship between the time domain and the frequency domain. The red wave can be decomposed into a series of sine waves, each 
of a different frequency. In the frequency domain exactly the same information can be represented as a plot of the amplitude and frequencies of each 
of the component waves. 




Figure 8.6: Extraction of respiratory information from the PPG. The top plot shows a segment of PPG in the time domain. The middle plot shows the 
same signal represented in the frequency domain. The large peak on the right corresponds to the heart rate frequency. The respiratory information in 
the signal is contained within the grey box. Filters can be used to eliminate all frequencies outside the grey box. The bottom plot shows the PPG in the 
time domain after filtering with a band-pass filter whose upper cut-off frequency is 1 Hz. Each peak on the waveform corresponds to a breath. 
Filters can be used to isolate the respiratory frequencies in order to make them easier to detect as shown in Figure 
8.6.Filter-based techniques attenuate frequencies outside the plausible range of the respiratory rate. They may be 
applied to the raw ECG or PPG waveform or used to refine a modulation signal extracted using one of the feature-
based techniques. 16 different filter-based techniques for respiratory modulation extraction have been developed,231 four 






XA1 BW Band-pass filter between 4 and 60 breaths/min (1/15 and 1 Hz) 
XA2 AM The maximum amplitude of the Continuous Wavelet Transform (CWT) within plausible cardiac frequencies 
(30–220 beats per minute)  
XA3 FM The frequency corresponding to the maximum amplitude of the CWT within plausible cardiac frequencies  
XA4 BW, AM, FM Filter using the centred-correntropy function (CCF) 
Table 8.2: Filter-based extraction components implemented in the VORTAL toolbox 
Filter-based (frequency domain) techniques are less susceptible to noise in recordings than feature-based (time domain) 
methods. However, they are dependent on an assumption of stationarity (an assumption that the respiratory rate does 
not change during the recording period). Over long periods this assumption will not be true. Therefore they are usually 
applied to short windows of signal, typically less than a minute long.251 Even within this period the assumption of a 
Chapter 8: Estimation of Respiratory Rate from ECG and PPG: Underlying Theory 
 
 132 
regular breathing pattern may not be met.  From a theoretical standpoint, whether a time domain or frequency domain 
technique is more accurate depends on the signal-to-noise ratio and the regularity of the patient’s breathing pattern. 
These are likely to be context and patient-dependent. 
8.3.1.2 Estimation of Respiratory Rate 
Estimation of respiratory rate may be done in either the time domain or the frequency domain. Time-domain 
techniques work by identifying breaths using peaks, troughs or zero crossings in the respiratory modulation signals. 
Accuracy may be improved by applying certain thresholds or heuristics to only identify peaks matching certain 
characteristics.252,253 The respiratory rate is calculated based upon the mean (or median) time interval between breaths. 
Frequency domain techniques work by identifying the frequency within the modulation signal that is most likely to 
represent the respiratory rate. 5 time domain and 7 frequency domain techniques have been implemented in the 
VORTAL toolbox (Table 8.3 and Table 8.4).   
Toolbox 
Code 
Details of Technique 
ET1 Breath detection by peak detection 
ET2 Breath detection by positive gradient zero-crossing detection 
ET3 Breath detection by combined peak and trough detection  – elimination of peaks less than the mean, and troughs greater than the mean; 
elimination of peaks (and troughs) within 0.5s of the previous peak (or trough); elimination of peaks (and troughs) which are immediately 
followed by a peak (or trough). 
ET4 Breath detection using ‘Count-orig’ – detrend; detect peaks and troughs; define a threshold as 0.2 times the 75th percentile of peak 
values; ignore peaks with an amplitude below this threshold; identify valid breaths as consecutive peaks separated by only one trough 
with an amplitude less than zero. 
ET5 Breath detection using ‘Count-adv’ – detrend; detect peaks and troughs; define a threshold as 0.3 times the 75th percentile of amplitude 
differences between consecutive extrema; eliminate the pair of extrema with the smallest amplitude difference if this is below the 
threshold; repeat until no more pairs can be eliminated; remaining peaks represent breaths. 
Table 8.3: Time domain extraction components implemented in the VORTAL toolbox 
 
Toolbox Code Details of Technique 
EF1 Fast Fourier transform spectral analysis 
EF2 Auto-regressive spectral analysis  using model order 8 
EF3 Auto-regressive spectral analysis using the median spectrum for model orders 2–20 
EF4 Auto-regressive all-pole modelling (order 8), with the highest magnitude pole selected as the respiratory pole 
EF5 Auto-regressive all-pole modelling (order 8), with the lowest frequency pole selected as the respiratory pole 
EF6 Find periodicity using the autocorrelation function 
EF7 Spectral analysis using the Welch periodogram 
Table 8.4: Frequency domain extraction components implemented in the VORTAL toolbox 
8.3.1.3 Data Fusion 
Data fusion techniques seek to improve the accuracy of algorithm output by combining multiple sources of information. 
Fusion may be used after modulation extraction to combine respiratory signals or after RR estimation to combine 
multiple estimates. 8 modulation fusion techniques have been described in the literature, ranging from simple point-by-
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point multiplication of signals in the time domain to the use of an artificial neural network.231 None of these techniques 
have been implemented in the VORTAL toolbox 
There are two subtypes of RR estimate fusion. Temporal fusion combines the current estimate with previous estimates, 
thereby preventing large changes in RR from successive estimates. Modulation fusion is used with algorithms which 
extract multiple respiratory modulations and generate an estimate of RR from each modulation. 5 RR estimate fusion 
methods have been implemented in the VORTAL toolbox (Table 8.5).  
Toolbox 
Code 
Fusion Method Details 
Modulation fusion 
FM1 Smart fusion  RRs estimated from BW, AM and FM respiratory signals (XB1,2,3) are quality assessed. If their standard deviation 




 Frequency spectra calculated from BW, AM and FM respiratory signals (XB1,2,3) using the Welch periodogram 
(FT7) are fused to give a mean spectrum. Only those spectra for which a certain proportion of spectral power is 
contained within a frequency range centred on the frequency corresponding to the maximum spectral power are 
included (a modification of the reported method). RR is estimated as the frequency corresponding to the maximum 
power in the mean spectrum. 
FM3 Pole magnitude 
criterion 
The respiratory pole is chosen as the highest magnitude pole obtained from auto-regressive spectral analysis of BW, 
AM and FM respiratory signals (XB1,2,3). 
FM4 Pole ranking 
criterion 
The pair of highest magnitude poles obtained from auto-regressive spectral analysis of BW, AM and FM respiratory 




 The current RR is calculated using a weighted average of the current estimate of RR and preceding estimate. 20% 
weight is given to the current estimate and 80% to the previous estimate. 
Table 8.5: Data fusion techniques implemented in the VORTAL toolbox 
8.3.1.4 Algorithm Implementation 
Although almost any combination of components can be combined together to make an RR algorithm only a subset of 
the permutations have been explored in the literature. In creating the VORTAL toolbox Charlton assembled 370 
algorithms from the different feasible permutations of components. 214 In order to verify correct implementation the 
algorithms were tested on synthetic ECG and PPG modulated by simulated FM, AM and BW at known frequencies. 
Following testing 56 algorithms, all of which contained either the XB10 (Table 8.1) or EF5 components (Table 8.4), were 
deemed to have performed poorly and were excluded. Of the remaining 314 algorithms, 270 could operate on either 
the ECG or PPG waveform. 44 algorithms could only be used with ECG as they utilised extraction components which 
were reliant on features of the QRS complex.  
8.3.2 Factors Affecting the Accuracy of Respiratory Rate Estimation 
The accuracy of ECG or PPG-derived RR estimates is dependent on a series of factors. Firstly, the respiratory signal 
must be present in the ECG/PPG. The strength of the signal is influenced by multiple physiological factors. Secondly, 
the ECG/PPG should be sufficiently free from noise, the most common source of which is motion artefact. Thirdly, the 
ECG/PPG must be accurately detected by the sensor and the respiratory information must not be suppressed by any 
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signal processing carried out by the monitor to “clean” the signal. Finally, the RR estimation algorithm must perform 
adequately. 
 
Figure 8.7: Factors influencing the accuracy of respiratory rate estimation. 
8.3.2.1 Factors Affecting Physiology 
Alterations in the overall magnitude of HRV or the balance between sympathetic and parasympathetic cardiac 
stimulation may confound detection of RSA. The influence of the ANS on cardiac function is affected by factors 
including; age254-256, gender254,256, athleticism257, diseases such as diabetes which alter autonomic function and 
conditions such as ischaemic heart disease which alter the cardiac response to autonomic stimulation.236 Other 
determinants of HRV include heart’s intrinsic pacemaker,258 thermoregulation, endocrine stimulation,238 drugs, body 
position, physiological stress and psychological stress.  
In addition to respiratory rate, both tidal volume242 and inspiration:expiration (I:E) ratio259 affect RSA amplitude. 
Therefore any pulmonary disease which alters these variables might affect the algorithms which estimate RR by 
measuring RSA. Factors known to influence tidal volume are age and body mass index.260 
The mechanism of ventilation affects RSA. Mechanical ventilation inverts the normal pattern such that inspiration 
increases heart period and expiration decreases it, and decreases the overall RSA magnitude.261 Mechanical ventilation 
affects the I:E ratio, intrathoracic pressures and tidal volumes in a manner which may not accurately match a subject’s 
spontaneous breathing pattern. Therefore respiratory rate algorithms validated on data from ventilated subjects may 
perform differently when applied to spontaneously breathing patients. 
Spontaneous breathing may be either consciously or unconsciously controlled. Controversy exists over whether 
consciously controlling of respiratory rate, ‘paced breathing’, has any effect on RSA as results vary between studies 
investigating this phenomenon. Many experimenters failed to control for tidal volume or I:E ratio. It is plausible that 
these are responsible for the differences observed rather than any conscious cognitive influences.233 
Many of the factors which influence RSA may also influence AM of the PPG via influences on autonomic nervous 
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Factor Physiological mechanism Modulation affected 
Age Tidal volume 
Autonomic nervous system function 
AM (ECG and PPG), RSA 
Gender Autonomic nervous system function RSA 
BMI Tidal volume AM (ECG and PPG), RSA 
Body position Baroreceptor reflex AM (PPG), RSA 
Environmental temperature Skin thermoregulation AM (PPG), RSA 
Psychological state Sympathetic nervous system activation AM (PPG), RSA 
Drugs Autonomic nervous system function 
Cardiovascular system function 
AM (PPG), RSA 
Pathological processes affecting the 
autonomic nervous system 
Autonomic nervous system function AM (PPG), RSA 
Pathological processes affecting the 
cardiovascular system 
Cardiovascular system function AM (PPG), RSA 
Pathological processes affecting the 
respiratory system 
Tidal volume 
Carbon dioxide clearance 
I:E ratio 
AM (ECG and PPG), RSA 
Spontaneous breathing vs paced breathing 




AM (ECG and PPG), RSA 
Mechanical ventilation Tidal volume 
Carbon dioxide clearance 
I:E ratio 
Other unknown factors 
AM (ECG and PPG), RSA 
Table 8.6:  Summary of physiological factors which affect how strongly the respiratory signals are expressed in the ECG and PPG waveforms. AM = 
amplitude modulation and is followed by whether AM in both signals is affected or only in the PPG. RSA = Respiratory Sinus Arrhythmia 
8.3.3 Recording Factors 
The precision with which the signal modulations can be measured is dependent on sampling frequency and signal 
resolution. According to the Nyquist-Shannon sampling theorem, the sampling frequency of a signal should be at least 
twice the maximum frequency of the signal component which needs to be detected.262 Pulsatile waveforms, such as the 
PPG, do not contain high frequency components and therefore can be sampled at lower frequencies without impairing 
the fidelity of recording. Conversely, the ECG contains high frequency components such as the QRS complex which 
require higher sampling rates to accurately digitise. 
Pizzuti evaluated the effects of sampling rate on the amplitudes and timings of all clinically important peaks in the ECG 
signal and concluded that there was no statistical difference between sampling rates of 500Hz and 250Hz.263  When the 
sampling frequency was decreased from 250Hz to 125Hz he observed errors in measurement of the amplitudes of the 
peaks and troughs of the signal. The timing of R-R intervals was well preserved, however. Whether these errors 
significantly affect the performance of a respiratory rate algorithm depends partially on the algorithm and partially on 
how strongly the respiratory signal is expressed within the ECG and PPG waveforms. 
Recording of RSA from the ECG may be affected by signal filtering. Clinical ECG monitors apply filters to eliminate 
baseline drift and artefact such as mains power noise and muscle activity which may affect the magnitude of the 
respiratory signals contained within the waveform. The American Heart Association recommends that routine ECG 
filters should have a low pass frequency cut-off of 0.05Hz but that the threshold could be raised to 0.67Hz for linear 
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digital filters with zero phase distortion.264 Filtering at 0.67Hz eliminates components below 40 cycles per minute and 
would thus eliminate some, though not all, respiratory modulation. The default filter settings on the Philips Intellivue 
MP30, a commercial monitor commonly used for bedside monitoring, applies a low pass cut-off of 0.5Hz (30 cycles per 
minute). A “diagnostic” filter is available which decreases the low pass cut-off to 0.05Hz.265  
Lesser inaccuracies may be induced by the downsampling algorithm used by the monitor. ECG monitors with a 
pacemaker-detecting function are required to oversample to detect the pacing spike. After pacemaker detection the 
signal is usually downsampled. Philips monitors utilise a peak-picking algorithm which improves the visual appearance 
of the signal but risks introducing minor temporal distortions. 
Similar issues affect the PPG recorded using clinical pulse oximeters. Many modern monitors incorporate complex 
motion artefact rejection filters which have the potential to distort the signal266 as well as auto-gain functions which can 
impair assessment of amplitude changes.267 
Another important technical consideration is the recording site. Shelley examined the how strongly respiration 
modulated PPG amplitude using recordings from the ear, forehead and finger and concluded that the respiratory signal 
was 10 times more prominent in the ear/forehead PPG readings than in the finger.40 These findings were confirmed by 
Nilsson who extended the study and determined the forearm to be an even better site for derivation of respiratory rate 
from the PPG.268 Variations in AM magnitude according to body site are thought to reflect the differing vascular 
sympathetic innervation of the sites. 
8.4 Summary 
Respiration modulates the ECG and PPG waveforms, changing the amplitude, the beat-to-beat interval and causing 
baseline wander. These phenomena are caused by a combination of the autonomic nervous system, the movement of 
the chest wall and changing intrathoracic pressure. 
A variety of signal processing techniques can be used to extract the modulations and from these modulations RR can be 
estimated. RR algorithms can be built by combining extraction and estimation components. Optionally signal quality 
and data fusion components can be added to improve estimation accuracy. A number of the techniques described in the 
literature have been implemented and combined to form algorithms which have been made publicly available in the 
form of a toolbox. 
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The accuracy of the RR estimates output by an algorithm is dependent not only on the algorithm itself but also on 
technical and physiological factors. Technical factors include sampling frequency and resolution, and in-monitor 
filtering. Physiological factors potentially include age, gender, co-morbidities, medications and the mode of breathing. 
Estimation of RR from ECG or PPG would allow comfortable continuous RR monitoring from a wide range of 
wearable sensors and allow RR measurements to be added to waveform databases which only contain ECG and PPG, 
such as the data collected from the wearable monitor in the LISTEN study.  
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 The VORTAL Study: Estimation of 
Respiratory Rate from ECG and PPG – A Systematic 
Evaluation of Algorithms 
9.1 Introduction 
Although there are nearly 200 papers describing RR algorithms it is not clear which performs best. Existing RR 
algorithm validation studies have a number of limitations. Firstly, they are not sufficiently detailed to described how the 
accuracy of RR estimates are affected by patient physiology, disease processes, recording method and input signal (ECG 
or PPG). No existing databases of ECG, PPG and respiratory rate waveform (Table 9.1) include all the correct data to 
allow the contributions of these differing factors to be separated.  This limits prediction of whether results from 
validation based on a healthy young population at rest in a laboratory can be generalised to ambulatory hospitalised 
patients, who are typically elderly with multiple co-morbidities. Better validation datasets are needed. 
The fact that algorithm accuracy is dataset dependent is compounded by the fact that the implementations of the same 
algorithm vary between papers. Therefore even if a study demonstrates superiority of a novel algorithm over a 
previously published one, it is not clear whether any performance differences in a given algorithm are caused by 
implementation differences or dataset differences. Researchers in the field would benefit from a set of reference RR 
algorithm implementations which can be used as benchmarks against which novel algorithms can be compared. The 
creation of the VORTAL toolbox, described in the preceding chapter, addresses this issue. 
A third issue is that a variety of statistical techniques are used to report the accuracy and precision of the results. Many 
papers use inappropriate statistical measures,231 notably measures of correlation which may be highly misleading,k are 
highly sensitive to the degree of variation in the study population and automatically increase with the range of 
measurements taken.270-274 Few compensate for repeated measurements taken from the same subject. The variety in 
type and quality of statistical evaluation inhibits direct comparison of results. 
In order to address the issues identified we devised a study, Validation of Respiratory Rate Algorithms (VORTAL), with 
the aims of: (i) creating a database of recordings suitable for investigating the effects of physiological and technical 
factors on algorithm performance (ii) creating a toolbox of RR algorithms and (iii) conducting a series of analyses to fully 
characterise algorithm performance. We envisaged three benefits from this work. Firstly we could identify which 
                                                        
k Even a correlation coefficient of 0.94 may indicate significant measurement error.269 
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algorithms, if any, would be sufficiently accurate for clinical use. Secondly, by determining precisely why algorithms fail 
to provide accurate estimates we could identify potential avenues for developing novel algorithms. Thirdly, by making 
the dataset, algorithms and evaluation framework publicly available we could provide a resource for other researchers in 
the field to conduct their own investigations. 





Subject demographics Previously 
used for 
validation 
Apnea-ECG Yes For 8 out of 70 
recordings 
Yes 70 32 subjects, mix of healthy 
volunteers and patients with 
sleep apnoea 
Yes 
CAP sleep database Yes 6 out of 16 Yes 108 16 healthy subjects + 92 
patients with various sleep 
disorders 
No 




96 59 children + 
35 adults (25-76 years old) 
Yes 
Fantasia Yes No Yes 40 40 healthy volunteers 
(20 young (21-34 years old) + 
20 elderly (68-85 years old)) 
Yes 
MGH/MF Yes No 76/250 
spontaneous 
250 250 Patients on ICU Yes 
MIMIC-II Yes Yes Mixture of 
ventilated and 
spontaneous 
>13,500 >13,500 Patients on ICU Yes 
MIT-BIH 
Polysomnography 
Yes No Some having 
CPAP 
16 16 young obese males referred 
for evaluation of sleep apnoea 
Yes 
PhysioNet - SHHS 
Polysomnography 
Database 
Yes No Yes 9736 6441 subjects at least 40 years 
old contributing  from a cohort 
study designed to investigate 
the relationship between sleep 
disordered breathing and 
cardiovascular disease. 
Exclusions: sleep apnoea, 









University Hospital / 
University College 
Dublin Sleep Apnea 
Database 
Yes No Yes 25 25 subjects, 28-68 years old, 
with no known cardiac disease, 
autonomic dysfunction, and not 
on medication known to 
interfere with heart rate 
Yes 
Stress Recognition in 
Automobile Drivers 








Yes No Yes 20 20 “presumed healthy” 
volunteers aged between 19 
and 30 years old 
Yes 
Table 9.1: Databases containing a reference respiratory rate signal as well as ECG and/or PPG. 
In order to select a clinically useable algorithm we conceived a sequence of six analyses which are listed in Table 9.2. 
This chapter describes the creation of the VORTAL database and the results of the first analysis, which uses a subset of 
the VORTAL dataset to describe how the RR algorithms implemented in the VORTAL toolbox perform under ideal 
conditions. 




Analysis Rationale Dataset 
Baseline study Determination of algorithm performance in 
ideal conditions 
VORTAL 
Young vs Elderly subjects Determination of the effects of age on 
algorithm performance 
VORTAL 
Reference signals vs signals from a clinical 
monitor 
Determine whether use of clinical monitors 
for data collection affects algorithm 
performance 
VORTAL 
Hospitalised patients (with data recorded 
from clinical monitors) 
Determine whether performance changes 
when applied to acutely unwell patients with 
comorbidities 
LISTEN (HDU and ICU data) 
Arrhythmia Determine how performance is affected by 
arrhythmia 
LISTEN  (HDU and ICU data) 
Multi-dataset validation Verification of our results by evaluation on 
other datasets 
Other datasets such as those listed in Table 
9.1 
Table 9.2: The sequence of analyses planned to identify algorithms which perform sufficiently well to be usable for clinical purposes 
9.2 Data Collection Methods 
9.2.1 Participants and Setting 
We recruited two cohorts of patients, young volunteers (YVs) and elderly volunteers (EVs). YVs were aged between 18 
and 40 years old, EVs were 70 years old or above. Exclusion criteria were designed to avoid recruiting participants with 
pathological conditions or medications which were likely to influence respiratory modulation of the ECG or PPG. In 
summary these were diseases and medications affecting the cardiovascular, respiratory and autonomic nervous systems. 
Exclusion criteria were slightly less strict for the EV cohort to increase the feasibility of recruitment. Full details of the 
exclusion criteria are provided in Table 9.3. 
YVs were recruited from amongst research and clinical colleagues. EVs were recruited from community centres in 
South East London and the ophthalmology clinic at St Thomas’ Hospital. The study was carried out in the Clinical 












Exclusion Criteria YVs EVs 
Cardiovascular disease   
Arrhythmia • • 
Any abnormalities on resting ECG •  
Any arrhythmias on resting ECG  • 
History of cardiac arrest • • 
Ischaemic heart disease • • 
Structural heart disease of any type •  
Structural heart disease, with the exception of asymptomatic, uncomplicated valvular incompetence or stenosis  • 
Known orthostatic hypotension • • 
Hypertension •  
Hypertension with systolic BP > 200mmHg • • 
Respiratory disease   
Any respiratory disease other than mild asthma not requiring regular inhaled medications • • 
Any disease or chest wall deformity causing abnormal chest wall movement • • 
Conditions affecting the autonomic nervous system   
Hepatic disease • • 
Renal disease • • 
Neurological disease • • 
Diabetes mellitus • • 
Thyroid disease • • 
Surgery or antibiotic usage within 3 months of participation • • 
Drugs   
Any medication other than simple analgesia and the oral contraceptive pill •  
Systemic anti-cholinergic drugs or drugs, other than analgesics, whose primary site of action is the central nervous system • • 
Other   
Pregnancy • • 
Prisoners • • 
Skin conditions which might preclude placement of adhesive electrodes on the torso • • 
Table 9.3: Exclusion criteria 
9.2.2 Recording Equipment 
Three classes of monitor were used to record signals: 
1. A laboratory-grade analogue-to-digital converter capable of digitising signals at high sampling rates and 
resolutions. (Hereafter termed the reference monitor.) 
2. A clinical monitor, the Intellivue MX30 (Philips, Eindhoven, Netherlands) 
3. A wearable pulse oximeter, WristOx2 3150 (Nonin Medical, Plymouth, Minnesota, USA) 
Recording software for the reference equipment and clinical monitor, Spike (Cambridge Electronic Design, Cambridge, 
UK) and ixTrend (ixellence, Wildau, Germany) respectively were installed on a single laptop. Signals from the 
WristOx2 3150 were collected using custom software running on a separate laptop. The clocks on the two laptops were 
synchronised using a network time server at the start of every recording session. The equipment configuration is 
summarised in Figure 9.1.  
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Multiple channels of ECG, PPG and respiratory sensor data were recorded from all participants. Examples of the 
signals recorded are shown in Figure 9.2. Further details regarding the sensors and signal processing are provided 
below. 
 
Figure 9.1: Recording equipment configuration 
 
Figure 9.2: All recorded signals except the wearable monitor data. Press = Differential pressure transducer signal, ImP = Impedance Pneumography, 
Lab) = signal from the reference (laboratory) equipment, (Clinical) = signal from the clinical monitor, PPGfin = PPG from the finger, PPGear = PPG 
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9.2.2.1 Reference Respiratory Rate 
The gold standard for measuring respiration rate is a pneumotachometer.275 However, this requires either the 
participant to hold a mouthpiece to their lips while they breathe or that they wear a tight-fitting mask, with the risk of 
causing participants to alter their natural breathing pattern.276 
Based upon the review of respiratory sensors conducted by the American Academy of Sleep Medicine Task Force 275 a 
differential pressure transducer, the Ultima Airflow 0850D (Braebon, Ontario, Canada) connected to an oronasal 
cannula was chosen as the reference sensor from which RR was calculated. A second measure of RR was provided by 
the electrical Impedance pneumography signal measured by the Intellivue MX30. For each 32s window of signal the 
RR estimated from impedance pneumography was calculated as the mean of all the RR values provided by the 
Intellivue MX30 during that window.  
The reference RR was calculated using a bespoke algorithm which detected breaths using the zero crossings in the 
differential pressure transducer signal. In order to validate the algorithm we implemented a custom annotation tool 
using Matlab (Mathworks, Natick, MA, USA). Corresponding windows of airflow signal and transthoracic impedance 
waveform were displayed together. Two clinical researchers, independently annotated the peaks and troughs of the 
airflow signal of 20 recordings from the YV cohort. Half the annotations were used during algorithm development. The 
remaining half were used to validate the automated algorithm. Further details regarding algorithm development are 
provided by Charlton et al. 214 
 
Figure 9.3: A screenshot of the annotation interface showing the annotated pressure transducer signal (top) and impedance pneumography waveform 
(bottom). 




Three sets of ECG recording were collected using two 3-lead leadsets. One leadset was connected to the reference 
recording equipment and the other to the clinical monitor. ECG recorded using the reference equipment was digitised 
at 2KHz with 16-bit resolution. Two ECG signals were obtained from the clinical monitor, the signal from the digital 
output (125Hz/8-bit) and the analogue signal from the defibrillator output. The latter was digitised using the reference 
recording equipment at a higher sampling rate (500Hz) but the 8-bit resolution was maintained. 
Each ECG leadset were connected to separate ECG electrodes, which were placed in the standard Mason-Likar 
configuration. Prior to applying the ECG electrodes the participants’ skin was prepared with an alcohol wipe followed 
by 10 to 20 light strokes with an abrasive pad. 
9.2.2.3 PPG 
PPG was recorded from the finger and ear using infra-red photoplethysmography transducers (MLT1020FC, 
ADInstruments, Dunedin, New Zealand) and digitised by the reference equipment. PPG recorded using the MX30 and 
WristOx2 3150 was captured using soft silicone finger probes. The plethysmography finger probes were applied to digits 
on the right hand. The ear probe was applied to the right ear. 
9.2.2.4 Signal Processing and Quality Assessment 
PPG and ECG signals from the reference equipment were high-pass filtered above a -3 dB cut-off of 6 bpm for RR 
estimation.  ECG and PPG were divided into non-overlapping windows, 32s in duration. The signal quality in each 
window was assessed with the previously described template-matching algorithm180 which provides a binary assessment 
of signal quality.  
The quality of the oronasal pressure transducer signal was assessed by calculating the signal to noise ratio (SNR). The 
SNR threshold was chosen to eliminate windows where breaths could not be clearly identified, based upon the 
previously described annotations. 
9.2.3 Recording Procedures 
There were five stages to the recordings taken from the YVs: 
1. autonomic function testing 
2. recording at rest 
3. recording while walking 
4. recording during exercise 
5. recording during the post-exercise recovery period 
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For the EVs we only took recordings during the first two stages on the grounds that recordings during exercise might 
prove distressing for this group. 
9.2.3.1 Autonomic Function Testing and Recording at Rest 
Participants’ height and weight were measured and a resting 12 lead ECG was performed. Chest circumference during 
maximal inspiration and maximal expiration was measured at the level of the fourth intercostal space using a tape 
measure.  
Respiratory rate, ECG and PPG were recorded continuously during the study. Data to be used for analysis was 
indicated using the timestamp annotation feature of the Spike recording software. Autonomic function tests were based 
upon those described by Ewing277 and consisted of: 
• Measurement of lying and standing blood pressures 
• Measurement of heart rate response to standing (30:15 ratio)l 
• Measurement of the heart rate variability induced by breathing at a rate of 6 breaths per minute 
• Measurement of the heart rate response to a Valsalva manoeuvre 
Blood pressure was measured in the supine position and at 1, 2 and 3 minutes after standing. Data for calculation of the 
30:15 ratio were taken from the same period. 
All subsequent cardiac autonomic function tests were carried out with the participant in a seated position. To enable 
subjects to pace their breathing at 6 breaths per minute a visual and auditory aid was provided using the 
WebMetronome software (http://www.webmetronome.com/) set to 60 cycles per minute and 10 beats per cycle. 
Valsalva manoeuvres were conducted by asking participants to blow into a manometer with sufficient force to generate 
a pressure of 40mmHg for 15 seconds. 3 manoeuvres were recorded with a 30 second rest period between each one. 
Participants were asked to conduct extra manoeuvres if researchers deemed they had carried out the manoeuvres 
incorrectly. Immediately prior to recording of signals during paced breathing and Valsalva manoeuvres, participants 
were given the opportunity to practise. There was a gap of at least 30 seconds between the end of the practice period 
and start of data collection. 
Following autonomic function testing all participants were asked to return to a supine position and lie still for 10 
minutes with their hands flat on the bed beside them. Their blood pressures were recorded every 2.5 minutes during this 
period. Data collection from EVs ended at this point. 
                                                        
l The ratio between the heart period at the 15th and the 30th heart beats after standing. 
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9.2.3.2 Recording during Walking, Exercise and Post-Exercise Recovery Periods 
YVs participated in three further stages of recording, recording during walking, recording during exercise and recording 
post-exercise. Walking recordings were carried out with participants walking on a treadmill set to a flat gradient and a 
speed of 1.3km/hr, a slow walking pace for 2 minutes, the aim being to simulate motion artefact that might be 
encountered as patients moved around a hospital ward or inside their home. The aim of the exercise period was to 
increase the participants’ heart rates and respiratory rates in order to increase the range of values in the dataset. 
During the exercise stage participants ran on a treadmill until they achieved 85% of their age-predicted maximum heart 
rate (calculated as 220-age for males, 210-age for females). Treadmill speed and gradient were gradually increased at the 
researchers’ discretion to achieve this. The time to target heart rate varied between participants. Having achieved the 
target heart rate participants were asked to continue running on the treadmill for a minimum of 30 seconds before 
returning to a supine position on a couch.  
Post-exercise recordings were carried out in the same fashion as the pre-exercise recordings and lasted 10 minutes. 
9.3 Analysis Methods 
9.3.1 Aims 
The data analysis was designed to describe algorithm performance under ideal circumstances with the intention of using 
the results as a benchmark for future comparisons. The primary aim of the analysis was to determine which algorithm 
had the closest agreement with the gold standard measure. Secondary aims were to: fully characterise the performance 
of algorithms, compare the performance of algorithms on ECG and PPG and to contextualise algorithm performance 
by comparison to impedance pneumography, the non-invasive technique most commonly used to continuously monitor 
patients’ respiratory rates in hospital. 
9.3.2 Dataset Used for Analysis 
We selected data as free from technical or physiological confounders as possible for the analysis. ECG and finger probe 
PPG recorded from the YV cohort during the rest and recovery periods using the reference monitor were filtered and 
assessed for signal quality as described above. Windows labelled as poor quality were excluded. Good-quality windows 
were included in the analysis and their data used as inputs to the RR algorithms.  
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9.3.3 Statistical Analysis 
9.3.3.1 Rationale for selection of metrics 
In selecting statistical analyses to describe algorithm performance we defined two basic criteria. Firstly, the analysis 
should be appropriate for the structure of the data and account for the repeated measurements within subjects. 
Secondly, the results should have an intuitive interpretation such that the potential clinical impact of the difference 
between monitor performance can be readily understood. 
Furthermore, we wished the analysis to provide answers to the following questions : 
1. What is the likely typical error of a single measurement chosen at random? 
This question is important for describing the performanceof the algorithm if used in a continuous monitor 
where new measurements are made frequently. 
2. What is the likely maximum error of a single measurement chosen at random? 
This question is important for scenarios where a single value is documented at periodic intervals and used as 
the basis for decision making, or as the input into a risk prediction algorithm such as an EWS. 
3. How well does a monitor track trends? 
A monitor which can accurately track trends may still be useful, even if the absolute measurements are 
incorrect. Accuracy of trending ability can be considered to be a special measure of precision. Accurate 
measurement of a change requires that both the initial and the subsequent measurements are precise and that 
bias is not proportionate to the magnitude of the parameter being measured. 
4. What proportion of measurement error is attributable to systematic error?  
Measurement error has two components, systematic error and random error. Systematic error, often termed 
bias, is a constant error and can be corrected by calibration. Random error is caused by unexpected (and 
usually unobserved) changes in the environment or measuring instrument, such as electrical noise in a sensor’s 
circuits, which causes measurement error to vary unpredictably between successive observations. Random 
error causes measurement imprecision. 
9.3.3.2 Choice of Descriptive Metrics 
Based upon our criteria we selected two complementary metrics to describe algorithm performance, the Limits of 
Agreement (LOA) technique described by Bland and Altman278 and the Coverage Probability (CP∂). 
The LOA technique has the advantage of providing an intuitive description of the agreement between measurements 
and being widely understood. Three outputs are produced, the mean bias, estimates of boundaries within which 95% of 
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the errors lie (the 95% LOA) and a graphical plot of the biases versus the measured values. The bias is a measure of 
systematic error, given in the units of measure. The 95% LOA is a measure of precision. The graphical plot allows rapid 
assessment of whether the error and error variance are proportional to the value being measured. 
In order to compensate for repeated measurements we used the modification of the basic LOA technique proposed by 
Carstensen et al279 which uses a random effects model to calculate the LOA:  
𝑦012 = 	𝛼0 +	𝜇1 +	𝑎12 +	𝑐01 + 	𝑒012 
𝑎12	~𝒩(𝑂,𝜔;)	     𝑐01	~𝒩(𝑂, 𝜏;)	   	𝑒012	~𝒩(𝑂, 𝜎0; ) 
where y is the measurement value, m is method of measurement, i is the subject from whom measurements were taken, r 
is the replicate, α is a fixed effect related to the method, μ a fixed effect related to the subject, air and cmi are random 
effects related to the within-subject replication and the subject-method interaction respectively, and emir is an error term. 
The bias was calculated for each algorithm as αreference − αalgorithm, and the 95% LOAs as mean bias ±2 standard 
deviations (2SD) where  
2𝑆𝐷 = 2A2?̂?; + 𝜎Cref; +	𝜎Calg; 	 
The LOA provides an answer to the question regarding the likely worst case scenario but can only describe typical 
measurement error if the distribution of errors is normal. In many case the assumption of normality may be violated. In 
order to compensate for this we report the CPδ. 
CPδ is conceptually the inverse of the LOA. Whereas the LOA provides the bounds within which a predefined 
proportion (95%) of measurements fall, the CPδ describes the proportion of measurements falling within predefined 
bounds, δ. For our analysis we set δ at ±2 bpm. The non-parametric form of CP, expressed as a percentage, was 
calculated using the empirical cumulative distribution of the absolute error.280  
9.3.3.3 Group Comparisons and Ranking 
The primary ranking statistic was precision, as given by 2SD, with absolute bias being used as the secondary ranking 
statistic. We prioritised precision over bias for two reasons. Firstly, from a clinical perspective, there is a difference in the 
utility of a precise but miscalibrated monitor (which can be used to accurately track trends and response to treatment) 
and one where the error varies randomly between successive measurements (which may only be useful for giving a 
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general impression of physiological status).m Secondly, from an engineering point of view, the amount of work required 
to correct random errors is usually significantly greater than that required to correct systematic errors.280   
The Wilcoxon signed-rank test was used to compare bias and 2SD for the subset of algorithms which could operate on 
both ECG and PPG.  
9.4 Results 
9.4.1 Recruitment 
We recruited 45 participants to the YV cohort and 16 participants to the EV cohort. Recordings from 6 participants in 
the YV cohort were partial. 5 had incomplete recordings on account of technical problems and 1 developed a 
supraventricular tachycardia following exercise. Demographics of all participants are provided in Table 9.4. 
 Young volunteers (n = 45) Elderly volunteers (n = 16) 
Median Age (IQR) – years 29 (26-31) 75 (72-78) 




Body Mass Index (IQR) – kg/m2 23 (21-26) 25 (24-26) 
Table 9.4: Demographics of all subjects from whom data was recorded 
Following the exclusion of the 6 imperfect recordings, data from 39 participants from the YV cohort were included in 
the analysis. The reference signal was of high quality in a median of 40 windows (IQR: (37-40). Of these, ECG and 
PPG were of high quality in 37 (IQR: 34-40) and 36 (IQR: 34-39) windows respectively. The ranges of RR and HR in 
the dataset were 5–32 breaths per minute and 41–111 bpm respectively. 
9.4.2 Algorithm performance 
Where possible algorithms were tested using ECG and PPG as input signals. Of the 314 algorithms in the VORTAL 
toolbox, 270 could operate on both ECG and PPG and 44 were specific to the ECG. Therefore 314 algorithms were 
tested using ECG as an input signal and 270 using PPG as an input signal – 584 algorithm-signal combinations overall. 
The random effects model did not converge for 34 of these, all of which used EF4 component (estimation of RR using 
autocorrelation, selecting the highest magnitude pole as the RR). Inspection revealed minimal correlation between the 
reference and estimated RRs in these instances. These combinations were excluded from further analysis.  
The algorithm which was ranked first overall was XB1,2,3ET4FM1 using ECG.  It was also the most accurate algorithm of 
all those using PPG. The algorithm uses time domain methods to extract all three types of respiratory modulation, 
                                                        
m Many clinicians will have practical experience of these types of monitors on ICU, cardiac output monitors and CVP transducers 
being prime examples. 
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estimated respiratory rate using a time domain method and fused estimates using the ‘smart fusion’ technique281 which 
suppresses RR estimates if there is a wide disparity between estimates of RR from the three modulations. 














Clinical Monitor 5 5.4 -0.2 -5.6 – 5.2 76 100 
ECG 
XB1,2,3ET4FM1 1 4.7 0.0 -4.7 – 4.7 81 74 
XB1,2,3ET2FM1 2 5.2 1.4 -3.8 – 6.4 73 72 
XB1,2,3ET5FM1 3 5.2 2.0 -3.3 – 7.2 69 75 
XB1,2,3ET3FM1 4 5.3 1.4 -3.8 – 6.7 73 73 
XB2ET2 6 5.6 -0.2 -5.8 – 5.4 75 100 
XB2ET3 7 5.7 -0.2 -5.9 – 5.4 74 100 
XB2ET2FT1 8 5.7 -0.2 -6 – 5.5 69 100 
XB2ET5 9 5.7 0.5 -5.2 – 6.3 75 100 
XB2ET3FT1 10 5.8 -0.2 -6.0 – 5.6 70 100 
XB1,2,3ET4FM1FT1 11 5.9 0.0 -5.9 – 6.0 67 100 
PPG 
XB1,2,3ET4FM1 15 6.2 1.0 -5.1 – 7.2 72 54 
XB1,2,3ET1FM1 17 6.5 -1.0 -7.5 – 5.5 62 62 
XB1,2,3ET1FM1FT1 35 7.0 -1.3 -8.3 – 5.7 54 100 
XB2ET5FT1 46 7.5 3.0 -4.5 – 10.5 44 100 
XB5ET1FT1 48 7.6 0.7 -6.9 – 8.3 57 100 
XB2ET2FT1 53 7.6 2.7 -4.9 – 10.3 47 100 
XB1,2,3ET4FM1FT1 54 7.8 1.1 -6.8 – 8.9 57 97 
XB1,2,3ET5FM1 55 7.8 3.8 -4.0 - 11.5 50 71 
XB2ET4FT1 56 7.9 0.3 -7.7 – 8.2 61 100 
XB1,2,3ET2FM1FT1 58 7.9 3.7 -4.2 – 11.5 60.5 100.0 
Table 9.5: The performance of the clinical monitor (impedance pneumography) and the top ranked algorithms when using ECG and PPG. 
When using ECG, the algorithm had a measurement bias of 0.0 bpm, 95% LOA of −4.7 to 4.7 bpm and CP2 of 
80.5%. When using PPG it was ranked 15th overall and had a measurement bias of 1.0 bpm, 95% LOA of −5.1 to 7.2 
bpm and CP2 of 71.5%. As a result of the fusion algorithm, the algorithm provided estimates for only 74% of windows 
when using ECG and 54% of windows when using PPG. 
For both ECG and PPG-derived estimates, measurement errors were related to the RR. At low RRs the algorithm 
tended to underestimate the RR and at high RRs the algorithm tended to overestimate the RR. The variance of the 
errors also increased with RR (heteroscedascity), most markedly when using PPG. Bland Altman plots of the 
distribution of measurement errors are shown in Figure 9.4 (ECG) and Figure 9.5 (PPG). 
Visual inspection of the Bland Altman plots showed that for some algorithms less than 95% of the measurements lay 
between the LOA lines. This reflects the skewed distribution of errors for these algorithms, a violation of the assumption 
of normality that underlies the LOA technique. Transforming the data to correct the skew would have been 
inappropriate in this case as the same transformation would not have worked for all algorithms tested. The CP2 provides 
another metric of typical measurement error which, being based on the empirical cumulative distribution function, is 
not dependent on any assumptions about the shape of the distribution. 





Figure 9.4: Bland Altman plot showing the agreement between XB1,2,3ET4FM1 using ECG and the reference RR. 
 
 
Figure 9.5: Bland Altman plot showing the bias and limits of agreement between XB1,2,3ET4FM1 PPG ECG and the reference RR. 




The performance of the remaining top-ranked algorithms is shown in Table 9.5. All used time-domain techniques for 
modulation extraction and RR estimation. Four algorithm-signal combinations were more precise than IP. These 
combinations all used a modulation fusion technique, and operated on the ECG. They provided RR estimates for 
between 72.3 and 75.4% of windows. In contrast, IP and the next best-performing combinations provided estimates for 
all windows.  
The values of 2SD of the remaining algorithm-signal combinations ranged from 4.7 bpm to 50.1 bpm (Figure 9.6). 
There was a sharp increase in the error for the worst performing 20%, all of which use either XA1 (BW extraction by 
band-pass filtering), XA4 (extraction of all three modulations using the centred correntropy function) or EF4 components, 
suggesting that these components were responsible for the errors observed. 
 
Figure 9.6: 2SD (line plot on the left y axis) and Bias (scatter plot on the right y axis) vs Algorithm rank. Each point represents an individual algorithm 
Of the algorithms included in the analysis, 253 algorithms could operate on both ECG and PPG. 161 (63.6%) were 
more precise when using ECG and 92 (36.4%) were more precise when using PPG. There was a statistically significant 
median decrease in the 2SD of 0.8 bpm when algorithms operated on ECG (11.6 bpm) compared to when they 
operated on PPG (12.4 bpm), z = −4.024, p = 0.001. The majority of algorithms whose performance improved using 
PPG had clinically unacceptable precision even with the improved performance.  




Our study represents the most comprehensive investigation of RR algorithm performance to date. Not only have we 
characterised the performance of previously described algorithms but we have also evaluated algorithms formed from 
novel combinations of components. Both the data and the algorithm toolbox have been made freely availablen to assist 
future researchers conduct reproducible, comparable evaluations.  
Operating in ideal circumstances, the best performing algorithm, XB1,2,3ET4FM1 using ECG, had no bias and 95% LOA 
of -4.7 to +4.7. 81% of RR estimates were within ±2 bpm of the reference. The same algorithm operating on PPG had 
a bias of +1bpm and 95% LOA of -5.1 to +7.2 bpm. 72% of RR estimates were within ±2 bpm of the reference.  
This compares favourably to routine clinical practice. Edmonds et al282  conducted a study in an emergency department 
triage, comparing the agreement of different clinician researchers. They found a bias of 0.04 and 95% LOA of ±6.2 
breaths per minute. Lovett et al230compared respiratory rates given by triage nurses unblinded to observation, 
impedance pneumography and the respiratory rate measured by an expert observer who both counted chest wall 
movements and auscultated the chest. They found the 95% LOA of to be -8.6 to 9.5 for nurses and -9.9 to 7.5 for the 
impedance pneumography monitor. 
4 RR algorithms operating on ECG exceeded the precision of impedance pneumography, the current non-invasive 
clinical standard for RR monitoring of acutely unwell patients. This was achieved at the expense of providing estimates 
for all windows. However, even if RRs were produced for only 50% of windows, this would represent a significant 
advance in the frequency of RR measurement over standard ward practice. 
Algorithms typically performed better on ECG than on PPG. The reasons for this are not entirely clear. It may be that 
respiratory modulation of the PPG is less pronounced than that of the ECG. Alternatively it may be that there are other 
confounding sources of PPG modulation at respiratory frequencies. Further investigation will be needed. In the interim 
we would recommend that RR be estimated from the ECG rather than the PPG if possible. 
The best performing algorithms all used smart fusion. Intuitively it makes sense that algorithms which extract all the 
respiratory information from the signal should perform better than those which only extract some of the information 
available. However, the more accurate results of the smart fusion method are achieved at the expense of occasionally 
failing to provide an estimate.  
                                                        
n They can be downloaded from http://peterhcharlton.github.io/RRest/ 




As described in the results, at least some of the algorithms provided measurement where errors were linearly related to 
the RR and also exhibited heteroscedascity. Both of these violate the assumption of normality that underpins the LOA 
technique. Classical advice is to use regression to correct for the changing bias and attempt to correct for 
heteroscedascity using a log transformation and then calculating the anti-log of the resulting LOA.270 
We deliberately omitted to implement these corrections for two reasons. Firstly, both of them impair the comprehension 
of the results. If regression is used the result is that the LOA are expressed as a formula, which the reader then has to 
calculate. If a log transformation is used then LOA are expressed as a percentage or a ratio. Neither of these are 
conducive to easy comprehension. The second reason is that different correction procedures would need to be used for 
different algorithms. Not all exhibit the same phenomena. This would impede comparison.  
The effect of failing to implement regression-based correction is that the calculated LOA will be wider than strictly 
correct for the subset of algorithms whose errors are related to the RR. The effect of failing to compensate for 
heteroscedascity is that the LOAs will be wider than necessary for low RR and narrower than necessary for high RR.270 
The significance of this with respect to our overall conclusions is debatable. 
Some compensation for the violation of the assumptions of normality is provided by the reporting of the non-parametric 
form of the Coverage Probability. This provides a measure of typical error. Arguably for our planned context – 
continuous monitoring of patients on the general ward - this might be a more important statistic than the LOA. On the 
ward RR measurements are not required every 32s. If the value of CP2 is high then the median of successive 
measurements taken over a 5 or 15 minute period should be highly accurate, far more so than manual counting. 
Nevertheless, one should be cautious about extrapolating the results of this study to patients with high respiratory rates. 
The maximum RR observed in the dataset was 32bpm, well below what might be observed in a population of acutely 
unwell patients on the ward. Similarly, the promising results found in this analysis do not necessarily imply that 
performance will be maintained in cohorts of elderly subjects or those with co-morbidities.  
From an engineering perspective, limitations of this study are that not every single technique proposed in the literature 
has been implemented and there is no guarantee that implementations of the components in the toolbox are exactly the 
same as the original authors’ versions. However, as the toolbox is open source, other researchers are at liberty to 
improve the implementations for future versions of the toolbox. 




Based upon our findings, it is feasible that an RR estimating algorithm, especially one based on ECG might form a 
useful clinical or research tool. In the introduction we outlined the sequence of studies which are required to 
conclusively prove or disprove this hypothesis. Preliminary results from some of these have been reported by Charlton 
in his thesis. 179 
From an engineering and physiological perspective it would be interesting to further investigate why measurement error 
changes with respiratory rate and signal type. In the first instance this could be done by measuring the strength of the 
individual respiratory modulations in the ECG and PPG. Not only would this provide useful physiological information 
but it might also form the basis of a useful error suppression technique whereby estimates from low amplitude 
modulations are either ignored or weighted accordingly in a fusion component. 
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 Assessing The Advantages of Continuous 
Monitoring 
10.1 Introduction 
Cardiac arrests and admissions to ICU are commonly preceded by abnormalities in vital signs.6,283,284 Early intervention 
is thought to improve outcomes.285 Failure to monitor patients sufficiently frequently has been implicated in delayed 
recognition of deterioration.3 Expert consensus suggests that continuous monitoring could be an effective tool in 
addressing this issue.22 Possible mechanisms by which continuous monitoring could deliver benefit are: earlier 
identification of abnormal vital signs in the deteriorating patient, identification of transient abnormalities associated with 
worse outcomes286,287 and measurement of dynamical properties of the vital sign time series which herald 
deterioration.288-290 Alerts generated from these data may be of three types, conventional single-parameter alerts, 
human-mediated alerts or algorithmic. 
Cardona-Morell et al conducted a systematic review of studies of the clinical effectiveness of continuous monitoring 
using conventional alerts.291 9 studies were identified, 5 of which were sufficiently homogenous to be included in a meta-
analysis. The review concluded that the majority of studies do not demonstrate the effectiveness of continuous 
monitoring in reducing cardiac arrests, ICU admission or length of stay. For studies that did report statistically 
significant improvements in outcome292 the magnitude of change was so small that there was unlikely to be any clinical 
benefit. Studies of the widespread application of cardiac telemetry have arrived at similar conclusions.37,176,293 
The use of human-mediated alerts is standard practice in many American hospitals.294 These institutions employ 
telemetry technicians, staff dedicated to watching the output from continuous monitors and calling ward nurses if they 
notice an arrhythmia or equipment failure. This approach has the advantage of reducing distraction of ward staff by 
false alerts and ensuring that important events do not get missed. 159 
Cantillon et al295 evaluated the effectiveness of telemetry technicians at the four hospitals of the Cleveland Clinic. By 
default technicians only monitored the ECG waveform but could also monitor BP, RR and SpO2 upon special request. 
On identifying a problem they called ward staff unless there was a critical emergency, in which case they could activate 
the Rapid Response Team directly. Ward staff also had access to the output of the monitors. Maintenance and review 
of monitoring was considered a shared responsibility. 
99,048 patients were selected by their care teams to be continuously monitored over the course of one year. Of these 
15,375 patients (16%) were monitored for non-cardiac conditions, including gastrointestinal bleeding, sepsis, 
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pancreatitis and persistent hypotension. The watchers provided 410,534 notifications (mean: 4.1 notifications per 
patient). 52% of notifications were related to technical problems such as lead failure or battery depletion. 48% of alerts 
were related to physiological derangement. Over half of these were for arrhythmias reflecting the predominantly cardiac 
patient population. The hospital’s Rapid Response Team attended 3243 events in the monitored population, 30% of 
which were related to an arrhythmia. 979 patients had an arrhythmia, 772 of whom had the event identified by the 
technicians prior to ward nurse activation of the hospital’s rapid response team. Figures for the timeliness of non-
arrhythmia alerts were not reported. The technicians directly activated the Rapid Response Team in 105 cases. 27 cases 
of these were for cardiac arrests and in 25 cases patients were successfully resuscitated. However, there was no 
significant reduction in the cardiac arrest rate (126 arrests pre-intervention, 122 arrests post-intervention). 
In addition to being of limited effectiveness, human-mediated alerting is dependent on the expertise of the technician, 
which may be highly variable. 296  Furthermore, implementation is expensive. Cantillon estimated the revenue costs of 
technician salaries alone to be $1.5-2.5m for surveillance of 300 beds. 
An alternative approach is the use of algorithms to generate alerts based upon a physiological model. The BioSign 
algorithm,297 commercialised as Visensia, is an example of such a system. It has been trialled on an American surgical 
trauma Step Down Unit30 in a before-and-after study involving 622 patients. HR, RR, BP and SpO2 data from a 
continuous monitor were combined to generate alerts. Using an alerting threshold optimised based on a locally-
acquired training dataset, the Visensia alerts preceded the detection of abnormal vital signs by single-parameter 
thresholds in 80% of cases. The mean advanced warning was 9.4 minutes. There were 6 unexpected deaths in the pre-
intervention phase and none in the post-intervention phase. We are not aware of any other clinical trials of automated 
multi-parameter alerts using continuous monitoring data in a ward setting. However, others have conducted 
retrospective analyses to demonstrate the potential of the approach.204,298,299 
In summary, multiple studies of continuous monitoring have failed to demonstrate that continuous monitoring leads to 
improved outcomes when applied to patients on general wards. The conclusions are consistent irrespective of the 
number of parameters monitored and whether alerting is conventional, human-mediated or algorithmic. 
In the face of such a consensus of evidence that continuous monitoring provides little or no clinical benefit, one might 
conclude that continuous monitoring in ward patients should be abandoned. However, multiple factors make it unlikely 
that the studies described above would have demonstrated any benefit. 
Firstly, the effectiveness of alerting is affected by the proportion of time patients wear the monitoring equipment. Our 
work has shown that patient acceptance of monitoring is an important barrier. This is supported by the study by 
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Watkinson et al31 in which only 16% of patients tolerated conventional continuous monitoring for 3 days. Few studies 
report compliance with monitoring but patient removal of monitoring may have affected their outcomes. 
Secondly, clinician response to alerts is reduced if the incidence of false alerts is high, a phenomenon termed alarm 
fatigue.300 The false alert rate from continuous monitoring has been found to be as high as 86%.301 Alarm fatigue has 
been linked with patient death302 and was ranked as the most serious Health Technology Hazard by the ECRI Institute 
in 2012.303 The effectiveness of the monitoring is likely to have been reduced in the studies where no alarm 
management strategy was instituted. 
Thirdly, the adverse event rate in the general population is low. In Cantillon et al’s study, only 1085 patients (1%) out of 
the 99,048 patients selected by clinicians as high risk had an event.295 Another study estimated the prevalence of severe 
deterioration in the general ward population was 3%.304 The studies described above were underpowered to detect 
changes in such low event rates. The restriction of continuous monitoring to those with conditions whose outcome 
would be altered by early warning would make its benefit easier to discern. This has long been recognised in cardiac 
telemetry literature and practice, leading to the American Heart Association to issue guidance on which patients should 
receive telemetry.305  
Fourthly, the potential for early alerting to alter hospital mortality or ICU admission rates is dependent on the 
population case mix. If a disease is self-limiting or progresses slowly, such as a minor urinary tract infection, outcomes 
will be unchanged, even if continuous monitoring leads to earlier treatment. Similarly, some diseases will progresses 
inexorably despite timely initiation of appropriate treatment.306 In such cases the best outcome of an alert might be an 
early decision to palliate. In a population where deteriorations are predominantly caused by slowly progressing diseases 
or irreversible conditions the mortality rate and ICU admission rate will be relatively unaffected by the introduction of 
continuous monitoring. Studies using these metrics as their endpoints will fail to measure any benefits in the quality of 
care brought about by earlier relief of symptoms. 
Finally, continuous monitoring has no ability to directly affect outcomes. Whether the patient outcome is improved is 
dependent on timely perception of the alert, swift escalation to a skilled decision-maker, formulation of an appropriate 
management plan, and efficient execution of the plan (Figure 10.1). 307,308 At each stage there is the potential for error or 
delay. 3 A UK review of the care of patients who underwent cardiopulmonary resuscitation identified delays in 
escalation in 18% of cases and inappropriate management in 17% of cases.20 In the face of such confounding factors, an 
intervention would need to have a large effect size to cause a detectable change in patient outcomes.  




Figure 10.1: The sequence of events required for successful response to patient deterioration in standard hospital practice. A monitor helps with the 
first step, observation of the patient. Alerts generated by the monitor help with the second step, recognition of deterioration. 
*Escalation is shown here as a single step. In actual practice escalation may involve a chain of escalations. For instance, nurse to junior doctor, junior 
doctor to middle-grade, middle-grade to senior doctor, senior doctor to ICU registrar, ICU registrar to ICU consultant. Each of these escalations has 
the potential for miscommunication or delay. 
Although continuous monitors have been used routinely in hospitals for decades as measuring devices, their use as a 
screening test to “diagnose” deterioration in a general ward population, with or without the addition of smart alerting 
algorithms, is relatively novel. Ferrante di Ruffano et al309 have published a framework for evaluating diagnostic tests 
consisting of five stages: 
Stage 1. Assessment of the feasibility of testing 
a. Technical failure rates 
b. Acceptability to patients 
c. Contraindications and procedural harms 
Stage 2. Assessment of the test result 
a. Accuracy 
b. Time to produce a result 
c. Ease of interpretation 
Stage 3. Assessment of the diagnostic decision made as a result of the test 
a. Speed of decision making 
b. Weighting in the decision-making process compared to other information 
c. Clinicians’ confidence in the diagnosis 
d. Patients’ confidence in the diagnosis 
Stage 4. Assessment of treatment decisions made as a result of the test 
a. Influence of the test in the formulation of a management plan 
b. Clinicians’ confidence in the management plan 
c. Patients’ confidence in the management plan 
Stage 5. Patient outcomes 
a. Are patient outcomes improved? 
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With the exception of the study of Visensia conducted by Hravnak et al,30 the continuous monitoring studies discussed 
above assessed the effect of continuous monitoring on patient outcomes, a Stage 5 study in Ferrante di Ruffano’s 
framework. Studies addressing Stages 1 to 4 are required to determine whether the failure to demonstrate any benefit 
from continuous monitoring is predominantly caused by poor feasibility, inaccurate detection of deterioration, poor 
patient selection or failure to positively influence diagnostic and management decision making.  
Previous chapters in this thesis have demonstrated that technological and human factors issues pose barriers to 
prolonged continuous monitoring using currently available wearable monitors (a Stage 1 study). In this chapter we 
assess the utility of continuous monitoring as a method of providing information about a patient’s physiological state 
that might be useful for clinical decision making (a Stage 2 study). 
10.2 Theoretical Model 
Assessment of the utility of a diagnostic test or alert is not the same as validation.312 Validation of an alert is usually 
conducted using statistics based on the confusion matrix, such as sensitivity, specificity and the Area Under the Receiver 
Operating Characteristic Curve (AUROC). Assessment of utility is commonly carried out using statistics based on Value 
of Information (VOI) theory.313 
VOI theory is an analysis framework widely used in the fields of decision theory and health economic analysis which 
employs Bayesian statistics to determine utility. The core principle of the theory is that the utility of a test is not a 
property of the test itself but derived from the outcomes of the decisions made as a result of using the test.314 The 
decisions will have both benefits and costs, which may be financial or non-financial (e.g. patient harm). Utility is 
calculated as a ratio between benefits and costs. Applied to monitoring, benefits are improved patient outcomes and 
more efficient use of hospital resources. Costs are adverse patient outcomes and increased use of hospital resources. 
The influence of implementing continuous monitoring on different outcomes can be modelled as a decision tree, as 
shown in Figure 10.2. Each of the circular nodes represents an uncertain outcome and the triangles represent possible 
endpoints. In constructing the tree we have made the following assumptions: 
1. Continuous monitoring will be deployed as an addition to intermittent monitoring, rather than as a 
replacement.  
2. Patient deterioration is always associated with a change in vital signs, which is assumed to be measured with 
100% accuracy 
3. “Significantly earlier” escalation always improves patient outcome. We will discuss how to define “significantly 
earlier” at a later stage. 
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Assumptions 2 and 3, although debatable, are commonly expressed in the literature reporting the derivation and 
validation of Early Warning Scores. 
 
Figure 10.2: A decision tree depicting the possible outcomes from monitoring using intermittent observations according to standard practice or 
continuous monitoring in addition to intermittent observations. Square nodes represent a choice to be made, circular nodes are “chance nodes” which 
represent uncertainties about which path will be taken, triangular nodes are endpoints. Grey endpoints are positive outcomes. Black endpoints are 
negative outcomes. For simplicity we have not represented the case where a patient has multiple episodes of deterioration within the same episode of 
care. 
The utility of continuous monitoring can be calculated assigning a probability to each of the branches of the tree and a 
utility value to each of the outcomes. These can be combined to ascertain the overall utility of using continuous 
monitoring compared with using intermittent observations alone. 
The illustrative model shown in Figure 10.2 predicts utility based using patient outcome as the principal metric of value. 
However, our aim is to assess the utility in terms of information provided to clinicians which might prompt escalation or 
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1. Nurses will routinely record intermittent observations at regular intervals, irrespective of whether the patient is 
wearing a continuous monitor. The timing of observations will be strongly influenced by ward routine and 
nurses’ clinical judgement. This has been demonstrated to be the case in previous research.19 
2. An alert from continuous monitoring is clinically useful if it identifies abnormal vital signs and is significantly in 
advance of an alert from the next scheduled manually recorded observation set. 
3. Alerts which are true but not significantly early do not add utility over intermittent observations. 
4. There may be a time delay (of variable length) before a nurse is able to come to the bedside. When the nurse 
arrives at the bedside if the continuous monitor shows vital signs whose values are below the alerting threshold 
(as might occur with a vital sign fluctuating either side of the alerting threshold) the nurse will assume the alert 
was a false alert and ignore the alert. 
5. False negative alerts have no influence on clinical decision making. 
6. Intermittent observations always accurately record vital signs and never generates any false alerts. 
7. Once a patient’s vital signs have crossed a threshold of deterioration alerting to worsening deviation or 
continued abnormality is of no value. Similarly if a patient is in the recovery phase, early identification of 
recovery is of no value. 
8. If nurses do not respond to alerts then continuous monitoring has no utility. 
The decision tree representing the model which incorporates all these assumptions is shown in Figure 10.3. Black 
endpoints represent negative outcomes, grey endpoints represent positive outcomes and white endpoints represent 
neutral outcomes. For the sake of simplicity we assign a utility value of 1 to a positive outcome, -1 to a negative outcome 
and 0 to a neutral outcome. 
In order to calculate the incremental utility of continuous monitoring over intermittent observations we must estimate 
probabilities for each of the following: 
1. Probability that vital signs are deteriorating (pdet), stable normal  (pnorm) or on a stable abnormal/recovery 
trajectory (1 – pdet + pnorm) 
2. Probability that continuous monitoring will alert given patient deterioration (palert | pdet) 
3. Probability that continuous monitoring will alert given patient vital signs are normal (palert | pnorm) 
4. Probability that an accurate deterioration alert will be significantly early (pearly) 
5. Probability that continuous monitoring will be positive given a significantly early alert (ppersist | pearly) 
6. Probability that continuous monitoring will be positive given an alert which is not significantly early  (ppersist | (1 
– pearly)) 
Chapter 10: Assessing The Advantages of Continuous Monitoring 
 
 163 




Figure 10.3: A decision tree to model nurse perception of the utility of continuous monitoring. Circular nodes are “chance nodes” which represent 
uncertainties about which path will be taken, triangular nodes are endpoints. Grey endpoints are positive outcomes, black endpoints are negative 
outcomes and white endpoints are neutral outcomes. 
10.3 Estimation of Probabilities 
Analysis was conducted using intermittent nurse charted vital signs from the Cardiac Surgery (CS) ward and 
corresponding HR and SpO2 time series recorded using the LISTEN study wearable monitor. For brevity we describe 
the methods with reference to the HR only. However, the same procedure was applied to the SpO2 data. Time series for 
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each vital sign were analysed independently to allow comparison of the utility of continuous HR monitoring and 
continuous SpO2 monitoring. 
10.3.1 Data Selection 
The following criteria were used to select patient data for analysis: 
• Patients had both intermittent and continuous vital sign recordings from the CS Ward. 
• Minimum data capture rate for both ECG and PPG (DCR{E,P}) from continuous monitoring to be 25%. 
• The intermittently-recorded HR/SpO2 time series contained at least one period where the intermittently 
recorded vital signs were abnormal. (Abnormality is defined below.) 
10.3.2 Pre-Processing 
Continuous monitoring data were pre-processed to reduce signal noise and remove gaps. Time series were segmented 
into 15 minute windows. As described in Chapter 3, all HR values were labelled as good quality or bad quality using a 
Signal Quality Indicator (SQI) algorithm. For each window the median of all HR values labelled as “good quality” was 
calculated to provide a HR estimate every 15 minutes. For 15 minute windows with no HR readings the population 
mean was imputed.  
Vital signs from both continuous and intermittent monitoring time series were transformed into measures of patient 
state using the NEWS score thresholds (Figure 10.4). For each vital sign (HR and SpO2) NEWS scores (NEWSHR / 
NEWSSats) of 2 were used as the thresholds of abnormality (Table 10.1). There is no NEWSHR threshold scoring 2 for 
bradycardia, therefore we used ≤40 bpm as the lower threshold for HR. 
 3 2 1 0 1 2 3 
Respiration rate ≤ 8  9 – 11 12 – 20  21 – 24 ≥ 25 
Oxygen saturations ≤ 91 92 – 93 94 – 95 ≥ 96    
Any supplemental 
oxygen 
 Yes  No    
Temperature ≤ 35.0  35.1 – 36.0 36.1 – 38.0 38.1 – 39.0 ≥ 39.1  
Systolic blood pressure ≤ 90 91 – 100 101 – 110 111 – 219   ≥ 220 
Heart rate ≤ 40  41 – 50 51 – 90 91 – 110 111 – 130 ≥ 131 
Level of consciousness    A   V, P or U 
Table 10.1: NEWS Thresholds. Level of consciousness is measured on the AVPU scale. 
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Figure 10.4: Time series of heart rates and associated NEWS values from intermittent observations (top two plots) and concurrent continuous 
monitoring (bottom two plots) 
10.3.3 Estimation of Period Type Probabilities 
The intermittent time series belonging to each patient were segmented into variable length periods whose start and end 
times were the times of consecutive HR measurements from the intermittent observations. Each period was classified as 
belonging to one of four categories: 
• stable normal: NEWSHR is normal (< 2) at the beginning and end of the period. 
• stable abnormal: NEWSHR is abnormal (≥ 2) at the beginning and end of the period. 
• deterioration: NEWSHR is normal at the beginning of the period and abnormal at the end. 
•  recovery: NEWSHR is abnormal at the beginning of the period and normal at the end. 
For a given category, the probability of occurrence was estimated as the proportion of all periods which were of that 
category. 
10.3.4 Estimation of Alert Occurrence Probabilities 
The probability of alerting was only estimated for deterioration and stable normal periods. Periods under 15 minutes or 
over 12 hours in duration were excluded from the analysis. The method of estimating the probabilities was dependent 
on the period category. For deterioration periods, the first NEWSHR score ≥ 2 from continuous monitoring was 
Chapter 10: Assessing The Advantages of Continuous Monitoring 
 
 166 
considered to be an alert. Only one alert per period of deterioration was permitted. The probability of an alert during a 
deterioration period (palert | pdet) was calculated as the proportion of deterioration periods containing an alert. 
For stable normal periods, successive abnormal NEWSHR values (from the 15 minute estimates based upon the 
continuous monitor recordings) were grouped and considered to be a single (false) alert. If the NEWSHR from the 
continuous monitor returned to normal then any subsequent abnormality within the same period was considered to 
represent a new false alert. There were no limits on the number of alerts per stable normal period. The probability of an 
alert occurring during a stable normal period (palert | pnorm) was calculated at the total number of false alerts divided by the 
total duration of all stable normal periods. 
10.3.5 Estimation of Early Alerting Probability 
The amount of advanced warning given by an alert during a deterioration period was calculated as the difference 
between the alert time and the end of the period. Advanced warning of 60 minutes or greater was considered to be 
“significantly early” as treatment within the first hour of onset has been shown to lead to significantly better outcomes in 
a diverse range of conditions such as sepsis,315 stroke,316 and myocardial infarction.317 The overall probability for the 
population (pearly) was estimated as the proportion of deterioration periods with an alert for which the alert occurred ≥ 60 
minutes before the end of the period. 
10.3.6 Estimation of Alert Persistence Probability 
Deterioration periods containing an alert were divided into two sub-groups, periods which contained a significantly 
early alert and periods which contained an alert which was not significantly early. For all periods in both cohorts, the 
alert persistence was calculated as the proportion of NEWSHR values (the 15 minute estimates) from the continuous 
monitoring data which were ≥2. For each sub-group, the probability of a nurse arriving at a random timeo after the 
initial alert and finding the vital sign values to still be above the alerting threshold was given as the average persistence 
for all periods in the sub-group. 
10.3.7 Sensitivity Analysis 
We conducted two sensitivity analyses. The first to determine the sensitivity of the result to a achnage in the incidence of 
deterioration. The second to the weighting of the cost/benefit ratio. For the first analysis we varied the ratio of 
deterioration to stable normal periods. We set the probability of other periods to be twice the probability of 
deterioration. This figure was based on post hoc analysis of the data. For the second analysis the probable costs were 
                                                        
o We assume that sometimes there might be a delay in the nurse arriving at the bedside on account of competing priorities 
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plotted where the cost of a false alert was set at 0.25, 0.5, 0.75  and 1 times of the utility of true alert. All remaining 
probabilities were those calculated as described above. 
10.3.8 Statistics and Data Handling 
Group comparisons were carried out using the Wilcoxon Rank-Sum test. Matlab (Mathworks, Natick, USA) was used 
for data manipulation and to carry out statistical testing. 
10.4 Results 
195 patients wore telemetry on the CS ward. 63 patients had sufficient continuous monitoring data to be included in the 
analysis. The total duration of monitoring was 280 patient days. 1414 complete sets of intermittently-recorded 
observations, which could be combined to make 1351 periods, were recorded during this time. Table 10.2 shows the 
statistics for period count and duration. 
For the HR time series 31 periods were classified as deterioration (pdet = 0.02), 1240 periods as stable normal (pnorm = 
0.92), 32 periods as recovery (prec = 0.02) and 48 periods as stable abnormal (pabnorm = 0.04). Only 15 patients (24%) had 
any deterioration periods. Deterioration periods were clustered within individuals. 48% of the periods of deterioration 
came from the data of only 3 patients (20%). 
For the SpO2 time series 114 periods were classified as deterioration (pdet = 0.08) , 990 periods as stable normal (pnorm = 
0.74), 124 periods as recovery (prec = 0.09) and 123 periods as stable abnormal (pabnorm = 0.09). 46 patient (73%) had at 
least one deterioration period. As with HR, deterioration periods for SpO2  were clustered within individuals and the 
spread was similar. 48% of deterioration periods came from 12 patients (26%).   
Period Type 
Heart Rate SpO2 
Number of periods in the 
dataset  
(Percentage in brackets) 
Median duration  
(mins) 
(IQR in brackets) 
Number of periods in the 
dataset  
(Percentage in brackets) 
Median duration  
(mins) 
(IQR in brackets) 
Deteriorating 31 300 (192 - 413) 114 305 (210 - 486) 
Stable normal 1240 280 (180 - 460) 990 280 (190 - 455) 
Recovering 32 248 (183 - 319) 124 245 (90 - 330) 
Stable abnormal 48 298 (175 - 360) 123 270 (141 - 415) 
Table 10.2: Period counts and durations 
The median duration of all periods, for both HR and SpO2 analyses, was 280 mins (IQR: 180 – 440 mins). There was 
no significant difference between the duration of deteriorating and stable normal windows for the HR time series (z = 
0.3566, p = 0.72) nor for the SpO2 time series (z = 0.82, p = 0.41). 30 periods were under 15 minutes and 34 periods 
were over 12 hours in duration and were excluded from alerting probability analysis. 
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24 out of 30 deterioration periods contained an alert for HR monitoring. palert | pdet = 0.80 for continuous HR 
monitoring. 20 alerts were classified as significantly early (pearly = 0.83). The median duration of advanced warning was 
170 mins (IQR: 43 – 256 mins). The mean persistence (ppersist | pearly) was 0.79 for HR alerts classified as significantly early 
and 0.92 for the remaining HR alerts. 
For SpO2 109 deterioration periods were used in the analysis, 77 of which contained an alert. palert | pdet = 0.71 for 
continuous SpO2 monitoring. 70 alerts were classified as significantly early (pearly = 0.91). The median duration of 
advanced warning was 185 mins (IQR: 41– 315 mins). The mean persistence (ppersist | pearly) was 0.59 for SpO2 alerts 
classified as significantly early and 0.86 for the remaining SpO2 alerts. Figure 10.5 shows the distributions of advanced 
warning for both HR and SpO2 monitoring. 
160 alerts occurred during 1207 stable normal periods in the HR time series giving an estimate for palert | pnorm of 0.13 for 
continuous HR monitoring. The corresponding figures for SpO2 monitoring were 674 alerts, 966 stable normal periods 
and palert | pnorm = 0.70.  
 
Figure 10.5: The distribution of the amount of advanced warning provided by continuous monitoring alerts. The left hand column shows data for 
heart rate monitoring. The right hand column shows data for SpO2 monitoring. The top row shows the advanced warning. The bottom row shows 
advanced warning multiplied by the persistence of each alert. This will penalise fluctuating alerts. 
Figure 10.6 shows the decision tree for our model with the estimated probabilities listed above. Based on these estimates, 
the probability of a nurse perceiving an alert to be useful is 0.01 for continuous HR monitoring and 0.03 for continuous 
SpO2 monitoring, the probability of a neutral outcome is 0.87 for continuous HR monitoring and 0.42 for continuous 
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SpO2 monitoring, and the probability of a nurse perceiving the alert to be a false alert is 0.12 for continuous HR 
monitoring and 0.54 for continuous SpO2 monitoring. 
 
Figure 10.6: Decision tree showing estimated probabilities 
Sensitivity analyses for HR and SpO2 are shown in Figure 10.7 and Figure 10.8 respectively. If four false alerts for every 
true alert is deemed to be acceptable, continuous HR monitoring would be beneficial overall in a population where the 
probability of deterioration was around 6%, three times that of the LISTEN population. However, the probability of 
achieving an outcome better than intermittent observations would only be 3%. At the opposite extreme, if 25% of 
periods were deteriorating periods the potential for benefit over intermittent observations would be 13%. 
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Net benefit for continuous SpO2 monitoring is only achieved if one accepts 4 false alerts for every true alert and the 
probability of deterioration is 23%. Even at this implausibly high deterioration rate, the potential for benefit over 
intermittent observations is no higher than 9%. 
 
Figure 10.7: Sensitivity analysis for continuous HR monitoring. The solid up-sloping line represents the probability of benefit, which increases as the 
probability of deterioration increases. The down-sloping lines represent the probability of incurring a cost on account of false alerts. As shown in the 
legend, each of the four lines represents a different weighting of the cost of a false alert. The bottom dotted line represents the case where the relative 
cost of a false alert is ¼ that of a true alert (i.e. one is willing to accept 4 false alerts for every true alert). The cost-benefit ratio is in favour of 
continuous monitoring where the benefit line lies above the cost line. 
 
Figure 10.8: Sensitivity analysis for continuous SpO2 monitoring. The solid up-sloping line represents the probability of benefit, which increases as the 
probability of deterioration increases. The down-sloping lines represent the probability of incurring a cost on account of false alerts. As shown in the 
legend, each of the four lines represents a different weighting of the cost of a false alert. The bottom dotted line represents the case where the relative 
cost of a false alert is ¼ that of a true alert (i.e. one is willing to accept 4 false alerts for every true alert). The cost-benefit ratio is in favour of 
continuous monitoring where the benefit line lies above the cost line. 




Using data from patients recovering from cardiac surgery we have estimated the likelihood that continuous monitoring 
of HR or SpO2 would provide useful alerts over and above those generated by intermittent monitoring according to 
standard ward practice. Our results show that, in the context of a ward where intermittent observations are typically 
charted every 4-5 hours, the probability of generating a useful alert was 1% for HR monitoring at the cost of a 12% 
probability of generating a false alert. The ratio was worse for SpO2 with the probability of utility being 3% but the 
probability of false alerting being 54%, despite filtering to suppress artefact using both an SQI and a median filter 
applied across 15 minutes windows. 
Continuous monitors were reasonably reliable, identifying abnormal vital signs 80% of the time for HR and 71% of the 
time for SpO2. Alerts were typically 3 hours in advance of intermittent monitoring for both parameters. However, HR 
alerts were markedly more persistent than those from SpO2 (ppersist 0.79 vs. 0.59). 
Some of the high fluctuation in alerts is attributable to the fact that, as described in Chapter 3, continuous pulse 
oximetry is significantly less reliable than ECG monitoring. Gaps in monitoring were imputed with a value that had a 
NEWS score of 0. Therefore in any 15 minute window if the majority of signal was missing the NEWS score for the 
window would be 0. This would cause fluctuations in the alert. We chose this imputation strategy (rather than sample 
and hold) deliberately, in order to penalise less reliable monitors, on the basis that absence of information was as 
unhelpful as erroneous information. 
The principle cause for the low utility was the low incidence of deterioration in HR and SpO2. Patients’ HR readings 
were normal for 92% of periods. SpO2 was normal was 74% of periods. In this population even an alerting system 
which never generates a false alert is unlikely to deliver additional clinical benefit over intermittent monitoring for the 
majority of patients. 
Our model only considers alerts of initial deterioration to be of value. In reality alerts of worsening deterioration are also 
likely to be of clinical utility. Therefore we are likely to have underestimated the benefit. However, in our dataset the 
number of deteriorating periods and stable abnormal periods were approximately the same (145 and 171 respectively). 
Therefore even if every period of stable abnormality contained a useful alert the overall utility would only double and 
would still be outweighed by the costs. Furthermore, we have not included the burden of technical alarms (e.g. lead off) 
therefore the estimate of costs is also likely an underestimate. 
Utility might be improved if the intervention were restricted to a high risk population. It may be that the population in 
our study had a lower rate of deterioration than the overall hospital population. The effects of improved population 
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selection is demonstrated by the sensitivity analysis. For the continuous monitoring to have a 5% probability of utility, 
10% of observations period would be need to be deteriorating for HR monitoring and 13% for SpO2 monitoring. Even 
at this level the number of useful alerts from SpO2 would outweighed by the number of false alerts (which would be 
50%). 
The cost-utility ratio could also be improved by reducing the false alert rate. Examination of the model shows that there 
are three endpoints which result in a false alert but only one which results in a useful alert. Our pre-processing has 
already simulated the effects of alert suppression using artefact detection and annunciation delay, two commonly cited 
strategies, so it is likely that these will not be sufficient in and of themselves. Multivariate alerts based on the dynamical 
properties of the data may provide a solution. 
High false alert rates with continuous SpO2 monitoring have been observed by others.129,292 In one study over 12% of 
SpO2 readings from continuous monitoring on an orthopaedic unit were under 93%.292 In order to achieve an 
acceptable false alert rate the investigators were obliged to set the alerting threshold for SpO2 at 80%. Similar findings 
were observed by two other studies,129,131 which both advocated an SpO2 alerting threshold of 85% when using the 
VisiMobile wearable monitor. The implementation of widespread continuous monitoring to alert only in the event of 
such extreme events (late warning rather than early warning) seems hard to justify, although it does have its 
proponents.2 
It is possible that a proportion of the so-called false alerts are true physiological phenomena. Transient desaturations 
have been observed when continuously monitoring patients’ SpO2 in the post-operative population.287,292 However, it 
remains to be proven that these episodes of desaturation herald deterioration or that patient outcomes are improved by 
responding to these episodes.  
Methodological issues may have caused a bias towards overestimation of the false alert rate for SpO2 monitoring. The 
NEWS scoring bands are much narrower for SpO2 than HR. The absolute difference between scoring 0 and 2 is 3% for 
SpO2 and 11 bpm for HR. According to the manufacturer’s technical specifications, the measurement error of the pulse 
oximetry sensor in the Philips monitor is ±2%. Therefore it is much easier for an alert to be generated from SpO2 
measurement error than HR measurement error. 
10.5.1 Limitations 
An important caveat is that the results are based upon single parameter alerts. Aggregate weighted multiparameter 
alerts have been show to generate more accurate that single parameter alerts. 318 Use of a multiparameter EWS to 
generate alerts might have altered the ratio of useful and false alerts. 
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Our data are based upon continuous monitoring of only two vital signs, HR and SpO2. Respiratory rate is commonly 
held to be the most sensitive marker of clinical deterioration. It may be that the results would be markedly different, had  
different vital signs parameters been monitored. 
The classification of alerts hinges on the definition of deterioration. We used a NEWS threshold of 2 as NEWS is widely 
accepted and is held to be the best EWS for discriminating between patients who have a severe adverse event and those 
who do not.318 It seems unlikely the results would change markedly if the thresholds were adjusted within clinically 
sensible limits, therefore we have not carried out a formal sensitivity analysis to examine this. 
Our methods for estimating the probabilities in the model do not take into account into the fact that the data are not 
independent and identically distributed throughout the population. Those from the same patient are correlated. This 
could be addressed by using bootstrapping to calculate estimates. Alternatively one could forgo empirical estimation of 
probabilities and conduct a Monte Carlo simulation. Rather than using either of these methods we chose to conduct a 
sensitivity analysis on key variables on the basis that accurate estimation of probabilities is less important than 
understanding how the different factors, such as prevalence of deterioration, technical performance of the monitor and 
patient physiology interact the give the final outcome. We judged a sensitivity analysis to be the best method for 
achieving this outcome. 
In our model utility is based on accurate detection of initial deterioration. No other forms of benefit are considered. 
Conversely we have excluded considerations of financial cost, patient comfort and the nursing workload required to 
maintain monitoring. These exclusions are deliberate. However, as shown from our feasibility studies, these continue to 
be significant challenges. Conversely, when interpreting the results it is important to remember that real-time 
measurement of a patient’s physiological state may have other benefits beyond bedside alerting. 
10.6 Conclusions 
Our analysis demonstrates that the use of continuous monitoring of HR and SpO2 to generate alerts based on 
univariate thresholds in a general ward setting is unlikely to deliver significant advantage over intermittent monitoring. 
Further research is needed to identify which patient populations are most likely to benefit from continuous monitoring, 
how the monitor data are best analysed to provide useful alerts and whether the data could be used for alternative 
purposes, thereby increasing the overall benefit of the system. 




11.1 Summary of Thesis Achievements 
Delayed recognition of inpatient deterioration causes significant morbidity and mortality. Experts in the field have 
recommended that continuous monitoring of inpatients on general wards might be useful in addressing the problem. 
Continuous monitoring using fixed bedside monitors is recognised to be suboptimal for patient comfort and freedom to 
mobilise. Wearable monitors have been successfully used to monitor outpatients but have not been trialled extensively in 
a hospital setting. In this thesis we examined the feasibility and effectiveness of wearable monitoring of patients on 
general wards. 
An initial review of the wearable monitors available revealed that there were no monitors capable of monitoring all the 
routinely recorded vital signs. Of all the vital signs, monitoring of HR and SpO2 was the most feasible. We therefore 
decided to focus on monitoring these vital signs but also collected ECG and PPG waveform data to allow secondary 
analyses, including estimation of RR. 
In Chapter 3 we described the comparative evaluation of four wearable monitoring systems for monitoring ECG and 
PPG, some comprising of two separate monitors. The aim of the study was to determine which system might be the 
most suitable for use in a larger scale evaluation and to study the factors which affected implementation success. 
Patients were monitored over a 24 hour period. Even in this short period the reliability of the monitoring systems varied 
widely. Out of the 47 recordings analysed only 14 (30%) spanned the full 24 hour period. One system, the Aingeal ECG 
monitor paired with the WristOx2 3150 pulse oximeter was excluded from further testing when it became apparent that 
all data from the Aingeal was being corrupted by a malfunctioning data logging system. 
Of the remaining systems, the best performing monitoring system comprised, the RP2 ECG patch and the WristOx2 
3150. The RP2 was consistently reliable, recording ECG data for a median of 94% of the intended record periods 
(IQR: 81-97%).By contrast the WristOx2 3150 was considerably less reliable (median data capture rate (DCR): 55%) 
and its performance varied widely between patients (DCR IQR: 16-78%). The other systems tested, based around the 
Dyna-Vision and Equivital EQ-02 monitors were less reliable. 
The principle reasons for failure to record data were inadequate battery life, early removal by patients on account of 
discomfort, software flaws and user error caused by poor usability of hardware and software. Regarding 
implementation, the key finding was that user interactions, both of those of the wearer and of the researcher, have a 
major impact on the functioning of the monitoring systems, the hallmark of a complex intervention. 319 This was further 
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compounded by the immaturity of the systems which meant that most of them were prone to failure and therefore very 
dependent on researcher intervention to periodically restore function. 
Based on the findings of our study we judged that, although some of the individual monitors, notably the RP2 and the 
Equivital EQ-02, showed promise, none of them could be reliably deployed as monitoring systems for monitoring both 
ECG and PPG. In the case of the RP2, a similarly reliable pulse oximeter was required to record PPG. In the case of 
the Equivital redesign of the way the device was worn was required to improve comfort. 
As a result of these findings we opted to trial a more conventional telemetry monitor with a pulse oximeter attachment 
as the basis of the next monitoring system we evaluated. We reported the results of a larger trial, the LISTEN study, 
involving patients who had undergone cardiac surgery. Patients stayed on the Cardiac Surgery (CS) ward for a median 
of 4.8 days. Good quality ECG was captured for 40% of this time and good quality PPG was captured for 15%. 
Simultaneous good quality ECG and PPG were available for 14% of the patients’ stay on the CS ward. The data 
capture rates (DCRs) decreased in a linear fashion with time until day 5.  
The DCRs for the first 24 hours exceeded those of all novel monitors tested in the previous chapter, with the exception 
of the RP2 and had the added advantage over the RP2 of providing full ECG and PPG waveform rather than simply 
the co-ordinates of salient points on the ECG. Furthermore the DCRs in the second study were based on the rates of 
acquisition of good quality data whereas no quality assessment was undertaken in the previous trial. The improved 
system reliability was likely due to a combination of the superior reliability of the technology, the choice of a supportive 
environment where staff were familiar with patient monitoring and improved implementation procedures. 
Analysis on a per patient basis demonstrated a bimodal distribution of DCRs for both ECG and PPG. A possible 
interpretation of this finding is that the study population consisted of two sub-populations, those who strongly disliked 
wearing the monitor and removed it almost instantly and those who were content to wear the monitor for the majority 
of their stay. Analysis of feedback questionnaire results also demonstrated a bimodal distribution, adding further support 
for this hypothesis. Both DCRs and questionnaire results demonstrated that ECG monitoring was better tolerated than 
PPG monitoring. These results are concordant with the findings of the evaluation reported in the previous chapter. 
Patient interviews contained predominantly negative feedback about the experience of wearing the monitor. The most 
common complaints were that the monitor was too heavy and that the leads caused distress or irritation, especially the 
PPG leads. Positive statements related to the benefits of wearing the monitor, an increased feeling of safety and a sense 
of satisfaction at being able to aid research.  
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The system provided a live real-time feed of data which was accessible to patients, ward staff and to researchers in 
remote locations. This provided multiple benefits which likely improved DCRs: some patients were motivated to 
continue wearing the monitor because they could see their data, staff could use the data for clinical care, both staff and 
researchers could rapidly identify non-functioning monitors and anticipate battery depletion. Based on our experiences 
we would suggest that real-time, remotely-viewable data display should be considered to be an essential feature of 
wearable monitoring systems designed for use on hospital wards, even if the monitors are being used solely for collection 
of research data. 
As part of our research we identified a deficiency in the tools available for the assessment of patient acceptance of 
wearable monitors. Chapter 5 described the derivation and piloting of a questionnaire, the CAWT questionnaire, based 
upon the Universal Theory of Acceptance and Use of Technology, a widely cited technology acceptance model. The 
questionnaire was designed to evaluate both the acceptability of the monitor itself and the quality of the study 
intervention. It was piloted on a subset of the LISTEN patients.  
Analysis showed that the CAWT questionnaire had excellent internal consistency and statistically significant correlation 
with early removal of monitoring. We improved upon previous work in that our questionnaire was piloted on a larger 
number of participants than previous studies, evaluated in a clinical setting and patient feedback was based upon 
prolonged monitoring periods rather than brief exposure. The study was unique amongst wearable monitor 
questionnaires in assessing the correlation of the questionnaire score with a measurable endpoint, early removal of 
monitoring.  
In Chapter 6 we proposed a structured framework for the implementation and  evaluation of wearable monitoring 
systems tailored to the needs of clinical investigators. The framework was based upon our own experiences and an 
extensive literature review of over 60 different analysis methods. Advice on best practice from multiple scientific 
domains was synthesised to produce a systematic approach to evaluation and implementation design that balanced 
rigour with pragmatism. The outputs of the evaluation could either be used to design better interventions to implement 
a given wearable monitor or to provide a structured comparison of monitor capabilities. 
In the second half of the thesis we investigated the use of data gathered from continuous monitoring. In Chapters 7 and 
8 we described the principle and practice of deriving RR from the ECG and PPG. Having identified that the existing 
literature, although extensive, is not sufficient rigorous to enable determination of whether existing RR algorithms are 
sufficiently accurate to be clinical usable. We conceived a sequence of investigations and collected a novel dataset in 
laboratory setting, specifically tailored to the needs of RR algorithm validation. We reported the results of the most 
comprehensive evaluation of RR algorithms published in the literature. 
Chapter 11: Conclusions 
 
 177 
Our evaluation identified that, operating in ideal circumstances, the best performing algorithms were more accurate 
than a clinical impedance pneumography monitor. We also identified that algorithms were more accurate when 
operating on ECG than PPG. Further work to evaluate algorithms on clinical data, recorded as part of the LISTEN 
study, is described elsewhere. 179 
In the final chapter we reviewed the evidence for the benefit of continuous monitoring. Currently there is no evidence of 
improvement of clinical outcomes based on the implementation of continuous monitoring, irrespective of the alert type, 
be it single parameter threshold alerts, human-mediated alerting using monitor watchers, or automated multiparameter 
alerts. We argued that this was unsurprising, given the number of confounding factors which might act to mask any 
potential benefits of the technology and proposed that before studying the effect on clinical outcomes, one should first 
establish if continuous monitoring alerted significantly (> 1 hour) earlier than the intermittent nurse-recorded 
observations. 
Using data from the LISTEN study, we conducted a retrospective analysis to determine whether continuous monitoring 
had the potential to provide significant clinical benefit by identifying abnormal vital signs significantly earlier than 
conventional monitoring. Our analysis showed that while continuous monitors were effective in identifying adverse vital 
signs early, the overall benefit at a population level was low because the incidence of deterioration was low. 2% of 
observation pairs showed deterioration between the first HR and the second HR and 8% of observation pairs showed 
deterioration between the first SpO2 and the second. Based upon the assumption that a true:false alert ratio of 1:4 was 
acceptable, the incidence of adverse heart rates would need to triple and the incidence of adverse oxygen saturations 
would need to increase six-fold before the benefit from early alerting outweighed the costs of false alerts. 
Based upon our results we conclude that continuous monitoring of HR and SpO2 in combination with conventional 
single parameter threshold-based alerting is unlikely to provide significant clinical benefit at a population level. 
Furthermore, using current technology, any benefit at an individual level is likely to be outweighed by the high 
incidence of false alerts.  
11.2 Future Work 
Based on our work we conclude that the wearable monitors tested in our study could not be used effectively for 
continuous inpatient monitoring without extensive support being provided to maintain monitoring. Although new 
monitors have been developed subsequent to our work, some of which are technically superior to those evaluated in our 
studies, we would anticipate that many of the findings reported here would be replicated if these new systems were 
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trialled as many of the problems identified are generic to complex systems in the early stages of development. Refining 
complex systems to optimise their performance requires an iterative approach. 320  
In approaching the task of developing wearable monitoring systems, clinical researchers have two important roles. 
Firstly, they need to develop tried and tested approaches to implementing and evaluating systems. The CAWT 
acceptance questionnaire and the implementation framework proposed in this thesis are steps in this direction. Both 
need to be evaluated and developed further in light of the results of the evaluation. 
Secondly, clinicians need to understand the precise nature of the task that a wearable monitoring system is designed to 
accomplish. There are two dimensions to answering this question. The first is physiological, the second relates to process 
innovation.  
11.2.1 Determining the Physiological Requirements 
From the physiological perspective, basic questions such as which vital signs needs to be monitored and at what 
frequency remain unanswered. The most effective methods of modelling patient physiology to identify deterioration also 
remain a subject of debate. If proponents of complexity science are correct and greater predictive power can be afforded 
by modelling patient physiology as a series of interacting dynamic feedback loops289 321 322 then the use of continuous 
data will be an essential input into future risk prediction models. 
Paradoxically, answering these questions requires large datasets of continuously recorded vital signs. The LISTEN 
database provides a starting point for such work but significantly larger databases are required. Collecting such 
databases from ambulatory patients will almost certainly require the use of wearable monitors. Key requirements for 
these monitors are high reliability and a wide range of sensors. The aim being to collect as much data as possible and 
then, through subsequent analysis, narrow down the requirements to exactly what is needed in terms of data types, data 
quality and recording frequency.  
In parallel to the work described in this thesis we have contributed to a study conducted by collaborators designed along 
these lines. Following on from the study in Chapter 3 we provided feedback to the manufacturers of the Equivital EQ-
02. Suggestions included ways of designing a pouch worn around the neck to make wearing the device more 
comfortable, adding an accessory battery pack and improvements to the software. Although comfort issues persisted, the 
redesigned system was used successfully to record data from inpatients for up to 14 days.323  
An alternative approach to collecting such datasets is to use a combination of wearable monitors and non-contact 
monitors, so-called pervasive monitoring systems. For instance one manufacturer has developed a sensor for measuring 
respiratory rate based on a sensor placed under the mattress of a patient’s bed324 and other researchers are developing 
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vital signs sensors based on video cameras.145 As we noted in Chapter 5, a key reason that patients remove wearable 
monitors early is the imbalance between the inconvenience experienced and the benefit gained. In a physiological data 
collection study there is minimal direct benefit to the patient therefore sensors applied must be exceedingly comfortable. 
The widespread acceptance of the RP2 patch demonstrates that this is feasible. We anticipate that in the longer term, 
due to the lower burden placed on the patient, pervasive monitoring systems are a more promising avenue for research 
than systems purely based around wearable monitors.  
Developing such monitoring systems will undoubtedly take time. In the interim, a pragmatic approach is to study the 
data we can collect and determine whether useful alerting systems can be developed based on them. Successful 
completion of the sequence of studies described in Chapter 8 to identify a reliable RR algorithm would make 
continuous monitoring of ECG, RR and SpO2 technically feasible. It may be that a substantial proportion of 
deteriorations can be detected using these three vital signs alone. 
Looking even further ahead, ECG and PPG have been used to calculate pulse transit time (PTT), a surrogate for BP. If 
a reliable PTT algorithm can be developed and validated using a similarly rigorous approach to the one we have outline 
for validating RR algorithms, then it would be possible to measure four vital signs related to the cardiorespiratory 
system based upon two sensors. 
11.2.2 Process Innovation 
Equally important to the successful deployment of a novel monitoring system is understanding why existing processes of 
care fail and what role deployment of a monitoring system might have in addressing the problem. If the problems that 
cause failure to rescue are not predominantly failure to record vital signs but rather delays in escalation, poor 
management plans or delays in the delivery of prescribed treatment then deploying even the most advanced vital signs 
monitors will not affect outcomes. The fact that a multitude of papers have been able to describe the physiological 
derangement that precedes cardiac arrest based on data collected from vital signs charts10 284 283 suggests that data is 
collected in many cases but not acted on appropriately. 
In this thesis we have focused on the data collection aspects of a wearable monitoring system but an equally important 
line of research regards when, where, how and to whom vital signs data should be presented in order to ensure that the 
highest quality decisions regarding patient care are made. Conducting this research requires only that vital signs data 
are available in a digital format. Multiple digital vital signs charting systems are available from commercial vendors, to 
which we have added our own modest contribution.325 




Our work has described in detail the feasibility of using wearable monitoring systems to record vital signs and waveform 
data from inpatients on a general ward. The systems we trialled, which to the best of our knowledge are representative 
of the state of the art at the time of testing, were not sufficiently reliable, usable or acceptable to patients to make routine 
monitoring of large patient cohorts feasible. Further work is required to design wearable monitoring systems adapted to 
the inpatient environment, which offers a set of challenges that are distinct from the outpatient monitoring and fitness 
tracking applications. 
A significant challenge in maintaining high quality monitoring is interference from additional sensors and associated 
cables. The use of signal processing to derive additional vital signs maximises the amount of physiological information 
that can be gained whilst minimising the burden on the patient. In a laboratory setting the accuracy of algorithms to 
estimate RR can exceed current non-invasive monitors and the routine clinical practice of measuring RR based on 
manual observation of chest wall movement. Further work is required to establish whether accuracy is maintained when 
used on data from older patients with multiple co-morbidities. 
A retrospective analysis of the data recorded demonstrated that although using continuous monitoring of HR and SpO2 
to generate alerts based on conventional alerting thresholds provided early warning of abnormal physiology for a few 
individuals, at a population level it would not have conferred benefit over intermittent observations according to 
standard ward practice. The predominant reason was the low incidence of moderately abnormal vital signs at a 
population level. Further work is required to establish whether continuous monitoring can offer unique benefits in 
accurately identifying patient deterioration. 
Finally, to realise the promise of the technological developments in these individual areas, it is necessary to undertake 
research to understand how monitors and their associated data display systems can be designed and implemented in a 
way that integrates with existing processes of care and supports clinical staff to make the best quality decisions about 
delivering care to patients. 
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Appendix A: Literature Review Process Supporting 
Framework Recommendations 
This appendix provides details of the process involved in making the recommendations of techniques to use for the 
various stages of our proposed implementation and evaluation framework. 
A.1 General Approach 
A standardised approach was used to identify the best method for each stage of testing. An initial literature search of the 
academic and grey literature was used to identify official standards, guidelines and review articles discussing assessment 
methodology. These documents were used to compile a long-list of all relevant techniques.  
We specified essential and desirable criteria specific to each dimension of failure being assessed. Techniques on the long-
list were assessed against the essential criteria to create a shortlist of methods that met all essential criteria. Where 
different techniques were very similar with respect to the essential criteria they were grouped into categories for clarity. 
Shortlisted methods were scored against the desirable criteria to identify the techniques most suited to our application. 1 
point was allocated for each criterion fully met and half a point for each partially met criterion. Scoring was based upon 
expert opinion from the literature wherever possible. Inevitably a degree of subjectivity is involved in the judgements. 
Therefore shortlisted techniques are briefly described to allow the reader to understand what they involve. 
We aimed to use the same methodology for selecting methods for all the stages of testing. However, the literature did 
not support this in all cases. Modifications to the general method are detailed below where required. For each stage we 
report the shortlisting criteria, shortlisted methods and the recommended method and practical application. 
A.2 Requirements Analysis Methods 
Requirements analysis is a process of identifying the essential and desirable properties of a technological system. The 
output of the process is a structured document, the System Requirements Specification (SRS). The aim of the 
requirements analysis is to provide: (i) structured description of the monitoring aims, the users and the monitoring 
environment and (ii) objective criteria to define success and failure. 
The descriptions of the aims, users and environment provide definition of the baseline assumptions of testing and 
provide useful data to support later stages of the analysis. The definitions of success and failure may be used as trial 
endpoints. A subset of the requirements can be used to shortlist monitors based on their technical specifications. For 
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instance if the monitoring aim is to record ECG then monitors which do not record ECG can be eliminated from 
consideration. 
A.2.1 Shortlisting criteria 
We could not identify any documents which compared different requirements analysis guidelines. Therefore all 
guidelines and standards documents were assessed against both essential and desirable criteria (Table 11.1). We did not 
include textbooks on requirements analysis in the shortlisting on account of their length. 
Key Requirements Derived Criteria 
Essential 
Meets testing objectives 
 




The document is concise, with a minimum of material irrelevant to this application 
The reader is not required to read other standards documents in order to understand the 
complete process 
The method should be suitable for novice analysts 
 
Guidance is explicit 
The document is easy to read 
Supporting materials or worked examples are available 
Table 11.1: Essential and desirable criteria for requirements analysis guidelines 
A.2.2 Shortlisted methods 
We identified three guidelines matching the essential criterion (Table 11.2): 
1. The International Electronic Engineering (IEEE) 1233-1998 standard212  
2. The ISO/IEC/IEEE 29148:2011 standard326 
3. The ANSI/AAMI/IEC 62366:2007 standard171 
IEEE 1233-1998 provides a description of the requirements analysis process, a recommended structure for the SRS and 
detailed guidance on how to define requirements precisely and measurably. Compliance with the standard results in a 
list of requirements which fully describe a given need. 
ISO 29148:2001 is the current international standard for requirements analysis. In addition to the core guidance from 
IEEE 1233-1998, it contains a revised description of the requirements gathering process and guidance on 
commissioning and system development processes. Many aspects of the guidance refer the reader to other ISO 
standards. 
IEC 62366:2007 describes how manufacturers should analyse, specify, design and verify the usability of medical devices. 
The section on application specification recommends the formation of a usability file, a document very similar to the 
IEEE SRS. Processes for completing some of the sections of the usability file are detailed in a separate standard, ISO 
14971:2007, which is referenced in IEC 62366:2007 but not reproduced.  
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Criteria IEEE 1233-1998 ISO 29148:2001 IEC 62366:2007 
The document is concise, with a 
minimum of material irrelevant to 
this application 
Sections on commercial 
considerations are irrelevant but 





A greater proportion of the 
document pertains to commercial 





There are extensive section on 
medical device design and testing 
practices which are not directly 




The reader is not required to read 
other standards documents in 










No. References ISO 14971:2007 
 
(0) 























Supporting materials or worked 
examples are available 
Yes, both templates and worked 
examples are provided. 
 
(1) 
Yes, both templates and worked 
examples are provided. 
 
(1) 




Total 5 4 2 
Table 11.2: Scoring against desirable criteria 
A.3 Reliability Assessment Methods 
The aim of the reliability assessment is to identify, the hardware and software components most likely to fail the causes 
of failures, and the frequency of failures. These data will be used to predict system performance, develop mitigation 
strategies and improve the empirical testing protocol. 
A.3.1 Documents Used To Create the Long-List 
The military, aerospace and engineering literature was reviewed. Five suitable documents were identified: the US 
Military Electronic Reliability Design Handbook (MIL-HDBK-338B)327, a reliability handbook written for the UK 
Ministry of Defence328, a NASA System Design guidebook329, the IEEE guidance on selection of reliability prediction 
methods209 and a highly-cited textbook.330  
A.3.2 Shortlisting Criteria 
Three key requirements were identified as desirable. Ranked in order of importance: the analysis should be more cost-
effective than field-testing, the chosen method should be suitable for novice analysts and the results should be reliable. 
These are similar to criteria used by experts when selecting a testing method. 
The key requirements were used to derive a set of objective criteria for scoring purposes (Table 11.3). The number of 
criteria per requirement reflects the weighting we assigned to the three requirements. 
Key Requirements Assumptions Derived Criteria 
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Table 11.3: Criteria for selecting techniques 
A.3.3 Shortlisting 
Excluding empirical approaches 9 methods were identified from the guidelines (Table 11.4). These can be grouped into 
human factors methods and statistical techniques. 
Human factors methods are systematic approaches for analysing a system’s design to predict failure. Typically the 
analyst starts by constructing a model of the system components, their functions and their relations. This model is then 
used to reason about the likelihood and consequences of component failures. Results are highly dependent on the skills 
of the analyst. 
Statistical techniques vary widely in their complexity. The simplest models predict failure rates based on the number of 
system components. More complex techniques model system design and external factors to determine the overall failure 
rate. No statistical techniques met our essential criteria as they do not provide a list of failures and their causes. 
Of the 9 methods only two met the essential criteria, Failure Modes Effects Analysis (FMEA) and Fault Tree Analysis 
(FTA). The remaining methods did not provide a list of failure and their causes.  
 
Essential 
Output meets testing 
objectives 
 
The aim of testing is to predict whether a monitor is 
likely to fail within the period of the planned 
monitoring intervention 
The method should provide an estimate of failure incidence 
 
 The secondary aim is to understand why failures 
occur in order to improve the monitor 
design/develop mitigation strategies 
The method should identify which components fail and the 
causes of failure 
 The system will consist of both hardware and software 
components 
Methods should allow analysis of both hardware and 
software failures 
Desirable 
Is cost-effective compared 
with field testing alone 
 
If analysis is lengthy then it will not be cost-effective It is quick to carry out an analysis covering the whole 
system using the method 
 If extensive preparation is required before the analysis 
can start then it will not be cost-effective. Testers have 
access to product manuals and knowledgeable 
technical support engineers working for the 
manufacturer 
The method does not require other time-consuming 
analyses or data collection exercises 
 If analysis is expensive then it will not be cost-effective Testing methods does not require expensive specialist 
equipment or dedicated testing facilities 
The method should be 
suitable for novice analysts 
 
Testers are clinicians with generic research skills, not 
professional ergonomists, reliability engineers or 
statisticians 
Method is easy to learn 
 Testers will have never used any of the testing 
methods before. 
Method is easy to apply 
Reliability Analysis will be used to rule out wearable monitors 
that are likely to fail frequently. 
The cost of false positives (over-estimating failure 
incidence/predicting failures which are not observed 
in practice) is higher than false negatives (under-
estimating failure incidence/missing failures which 
are seen in practice) 
False positives are rare 
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Method Estimates failure incidence Lists failures and their 
causes 
Suitable for hardware and 
software systems 
Meets essential criteria 
Human Factors Methods     
Design Checklists No Can only identify failures 
which are on the checklist 
Yes No 
Event tree analysis (ETA) Yes No Yes No 
FMEA/FMECA Yes Yes Yes Yes 
Fault tree analysis Yes Yes Yes Yes 
Reliability Block Diagrams Yes No Yes No 
Statistical techniques     
Complex models Yes No Yes No 
Petri-Net Analysis Yes No Yes No 
Markov analysis Yes No Yes No 
Simple models (e.g. parts 
count) 
Yes No Yes No 
Table 11.4: Shortlisting of reliability assessment methods 
A.3.4 Recommended Technique and Practical Application 
When assessed against the desirable criteria FME(C)A scored 4.5 points and  FTA (Table 11.5), the difference being 
ease of learning.  The dependence of FME(C)A on the skills of the analyst can be partially mitigated through the use of 
supportive documentation such as checklist and handbooks. The handbook approach has previously been adopted by 
the US military. Each handbook contains a comprehensive list of components, their failure modes and empirically 
determined failure rates which can be used to populate an FMEA. The disadvantage of this approach is the 
considerable expense of maintaining accurate, comprehensive and up to date data. 
Checklists can be considered a simplified form of a handbook. These provide a list of failure modes for generic 
components as oppose to failure modes and failure rates for specific makes and models of component. An example is 
provided in the ANSI HE74 standard171 which provides a list of failure modes for connectors. The advantage of this 
high-level approach is that a checklist is generalisable to wider range devices than a handbook and is less expensive to 
maintain. 
The validity of the FME(C)A can also be improved by empirical testing in a laboratory setting. Two types of testing are 
helpful: ad hoc testing, where the analyst tests equipment using themselves as the subject, and focused laboratory testing. 
Ad hoc testing increases the familiarity of the analyst with the equipment. This is useful in order to estimate the relative 
incidence of common failures. It is also likely to reveal failures that the analyst might have missed. An example of the 
latter is bugs in the timestamps. Three of the six systems we have previously tested had flaws which intermittently 
caused errors in the timestamps. 
Focused testing in controlled conditions is useful to measure the reliability of components whose functioning is critical to 
system function. The obvious example is battery life testing. A subtler example from our previous testing of systems is 
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measurement of recorded signal resolution. When examining recorded waveforms in our previous testing we identified 
that their resolution in practice can be lower than the theoretical maximum, rendering them unsuitable for analysis. 
Methods FME(C)A Fault Tree Analysis 
Cost-effectiveness 2 2 
It is quick to carry out an analysis covering the 
whole system using the method 
Much faster than empirical testing but can be 
time-consuming for complex systems 
 
(0.5) 
Much faster than empirical testing but can be 
time-consuming for complex systems 
 
(0.5) 
The method does not require other time-
consuming analyses or data collection exercises 
Reliability is improved with more detailed 
system schematics  
 
(0.5) 
Reliability is improved with more detailed 
system schematics  
 
(0.5) 
Testing methods should not require expensive 








Suitability for novices 2 1.5 






Experts suggest it is more complex to learn 
than FMEA. (ref MIL_HDBK) Requires skill 
with graphical software to lay out the fault tree. 
 
(0.5) 






Reliability 0.5 0.5 






Total 4.5 4 
Table 11.5: Scoring against desirable criteria 
 
A.4 Usability Assessment 
A.4.1 Documents Used to Create the Long-List 
The human factors, Human-Computer Interaction (HCI) and healthcare literature were searched to identify  review 
articles, guidelines and reports to create a long-list of techniques. The following documents were selected. 
• General Methods Papers 
o Nielsen’s review of usability inspection methods331 
o A review of human factors methods by Salmon, Stanton and Walker332  
o A pair of reviews on human error identification methods by Kirwan226,333 
• Papers focused on healthcare and medical devices 
o Guidelines 
§ National Patient Safety (NPSA) guidelines on user testing of medical devices334 
§ ANSI/AAMI HE75 guideline 172 on the application of human factors to medical devices 
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o Review Articles 
§ A review of usability assessment methods for health technologies by Jaspers335 
§ A review of human reliability analyses in healthcare by Lyons et al.336 
A.4.2 Shortlisting Criteria 
Table 11.6: Shortlisting criteria for usability assessment methods 
Scoring criteria were similar to those used for reliability analysis (Table 11.6). Objectively measuring the reliability and 
validity of usability assessment methods is impossible as usability assessment methods is impossible as usability errors are 
not objective entities. We modified the shortlisting criteria to reflect a preference for structured methods. These seem 
more likely to give reproducible results. 
A.4.3 Shortlisting Results 
There was considerable overlap between the documents. Stanton et al described the majority of the methods in their 
report. A few additional techniques were only listed in Lyon’s review. The other documents did not list any other 
methods. 42 methods, grouped into 12 categories, were identified (Table 9).   
 
  
Key Requirements Assumptions Derived Criteria 
Essential 
Output meets testing 
objectives 
 
The aim of testing is to predict whether a monitor is 
likely to fail within the period of the planned 
monitoring intervention 
The method should provide an estimate of failure incidence 
 
 The secondary aim is to identify usability problems in 
order to improve the monitor design/develop 
mitigation strategies 
The method should provide a list of usability problems 
 It should be possible to generalise findings to different 
user groups 
The method should help identify how errors relate to user 
characteristics 
Desirable 
Is cost-effective compared 
with field testing alone 
 
If analysis is lengthy then it will not be cost-effective It is quick to carry out an analysis covering the whole 
system using the method 
 If extensive preparation is required before the analysis 
can start then it will not be cost-effective. Testers have 
access to product manuals and knowledgeable 
technical support engineers working for the 
manufacturer 
The method does not require other time-consuming 
analyses or data collection exercises 
 If analysis is expensive then it will not be cost-effective Testing methods does not require expensive specialist 
equipment or dedicated testing facilities 
The method should be 
suitable for novice analysts 
 
Testers are clinicians with generic research skills, not 
professional ergonomists, reliability engineers or 
statisticians 
Method is easy to learn 
 Testers will have never used any of the testing 
methods before. 
Method is easy to apply 
Reliability Structured methods help minimise variation in the 
output caused by analyst skill 
The method should be structured 
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Method Class Purpose Estimates the 
probability of failure 
Provides a list of 
usability problems 
Relates usability to 
user characteristics  





Analyses the physical 
properties of the system. The 
output can be combined with 
task-based methods to predict 
errors 
No No No 
Heuristic analysis Analyses interface elements 
and scores them against 
whether they meet 
recommendations for good 
design 
No Yes No 
Performance prediction techniques 
Keystroke level modelling 
Timeline analysis 
Critical path analysis 
Predicts how efficiently users 
will be able to complete tasks 
No No No 
Predominantly Task Centred Methods 




HAZOP, HEIST, HET 
Murphy diagram 
SHERPA, Sneak Analysis, SPEAR 
Task Decomposition 
TAFEI, THEA, TRACEr 
Predicts errors by modelling 
the task. Some methods also 
include the influence of 
external influences (termed 
‘performance shaping 
factors’) 
Yes Yes Yes 
Human Error Prediction 
Absolute Probability Judgement 
ATHEANA, HEART, JHEDI 
Paired comparison 
SLIM-MAUD, TESEO 
Quantitatively estimates the 
probability of error occurring 
Yes No No 
Incident Analysis Techniques 
Change Analysis 
MORT 
Techniques optimised to 
retrospectively evaluate an 
incident which has occurred 
No No No 
Both task and system centred 
Interviews 
Structured (e.g. ACTA) 
Semi-structured (e.g. Critical Decision 
Method) 
Unstructured 
May be used to elicit 
information to aid prediction, 
retrospectively analyse 
incidents or gather 
summative feedback 
No Yes No 
Empirical usability testing 
Think Aloud (also called Verbal 
Protocol Analysis) 
Cognitive Inspection 
Observation without analyst 
intervention 
Techniques for elicitation of 
the users’ cognitive models to 
understand whether these 
match the system design 
Yes Yes No 
Group discussion May be used to elicit 
information to aid prediction, 
retrospectively analyse 
incidents or gather 
summative feedback 
No Yes No 
Questionnaires Specific questionnaires exist 
for assessing global usability 
or specific aspects of usability 




of techniques listed above 
No Yes Yes 
Workload Prediction 
Cognitive Task Load Analysis 
Pro-SWORD, Pro-SWAT 
Predicts how easily users will 
be able to complete tasks 
No No No 
Table 11.7: Shortlisted usability assessment methods 
Methods may be predominantly task-centred, predominantly system-centred or use elements of both approaches. Task-
centred methods, commonly termed Human Reliability Assessment (HRA) methods, consider the causes, consequences 
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and probability of failure to carry out the tasks involved in using a system. System-centred methods consider the 
properties of the system and how they might induce error. 
Of the 42 shortlisted methods only the 13 Human Error Identification (HEI) techniques met the essential criteria. 
A.4.4 Recommended Technique and Practical Application 
The results of scoring against the desirable criteria are shown in Table 11.8  The Enhanced Cognitive Walkthrough 
variant was considered when scoring the Cognitive Walkthrough technique. The highest scoring method was Task 
Decomposition with 6.5 points. Cognitive Walkthrough, HET and Sneak Analysis all scored 6 points. Murphy 
Diagrams and FMEA scored 5.5 points. TAFEI was the lowest rated method with 3 points. 
Although they scored highly, we would not recommend use of HET or Sneak Analysis due to concerns regarding the 
validity of their output. The authors of HET suggest that it should be used with caution outside of an aviation setting. 337 
Sneak Analysis is clearly limited in the types of failures it is capable of predicting. 
Cognitive Walkthrough has the benefit of focusing on the user’s cognitive abilities. In contrast to pilots in an aeroplane 
or operators of a power plant control room, users of wearable monitors vary widely in the capabilities. At one spectrum 
are educated, well-trained, technically clinical staff and at the other are patients who may be cognitively impaired and 
have limited understanding of technology. Both groups of user may be expected to carry out the same tasks. It is likely 
that their performance would vary greatly. Therefore for assessment of wearable monitoring systems an approach which 
models user capabilities, such as Cognitive Walkthrough, is highly desirable. The main disadvantages of Cognitive 
Walkthrough is that it may constrain the analyst’s thinking to only considering failure related to cognition and it may be 
much slower to conduct than Murphy Diagram analysis. 
The strength of the Murphy Diagram is its simplicity. The approach is intuitive and does not burden the analyst with 
many questions at each step. This allows for rapid but systematic assessment, even by a novice user. The trade-off is that 
the analyst is more likely to miss errors, especially if they have already identified one plausible error for a given task step. 
The advantage of Task Decomposition is its flexibility. By careful choice of prompts the advantages of both Murphy 
Diagrams and Cognitive Walkthrough can be incorporated.  
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A.5 Acceptability Testing 
In order to collect data throughout the intended monitoring period the patient must accept to wear the monitor. 
Previous research into the desirable characteristics of a wearable monitor182,189,223,338,339 have used unvalidated 
questionnaires to elicit specific requirements from patients and healthcare professionals.  
While these have some value in highlighting recurrent themes, it is difficult to use these to predict acceptance of a novel 
monitoring system, especially as the original studies are limited in their validity and generalisability. An alternative 
approach is the use of a technology acceptance model. 
Technology acceptance models can be divided into three classes, those which predict acceptance based upon an analysis 
of organisational structure and implementation quality,340 those which predict acceptance based on task-technology 
fit341 and those which predict acceptance based upon the behaviour of individuals. For the purposes of this testing 
framework we solely consider acceptability to patients and therefore have only considered acceptance theories based 
upon the behaviour of individuals. 
A.5.1 Shortlisting Results 
We could only find one comprehensive review of acceptance models. The review, conducted by Venkatesh et al185, 
compared the validity of 8 different models of technology acceptance (Table 11.9) and combined features from the 
different models to create a new model, the Unified Theory of Acceptance and Use of Technology (UTAUT). Their 
paper demonstrates that UTAUT has a higher validity than other models. 
Theory of Reasoned Action (TRA) 
Technology Acceptance Model (TAM) 
Motivational Model (MM) 
Theory of Planned Behaviour (TPB) 
Combined TAM and TPB (C-TAM-B) 
Model of PC Utilisation 
Diffusion of Innovation Theory (DOI) 
Social Cognitive Theory 
Unified Theory of Acceptance and Use of Technology (UTAUT) 
Table 11.9: Technology Acceptance Models reviewed by Venkatesh et al 
We could not identify any other papers which performed a similar comparison to confirm the superiority of UTAUT 
over other models. However, a meta-analysis of empirical studies using UTAUT46 concluded that the constructs were 
valid. It also noted that the UTAUT constructs were generally well correlated with measures of acceptance external to 
the model. Another review comparing UTAUT to TAM and DOI suggested that UTAUT was the best model to use in 
healthcare applications based upon the fact that UTAUT constructs seemed to qualitatively match findings from 
empirical healthcare studies.218  
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A.5.2 Recommendation 
In the absence on contradictory evidence we recommend that UTAUT be used to predict acceptability. In the absence 
of a validated tool to reason about acceptance in the abstract the most reliable method would seem to be gathering 
feedback by interview and questionnaire following empirical testing. The original UTAUT questions are listed in Table 
11.10. These are not well adapted to measuring the acceptance of wearable monitors. A well-validated questionnaire 
currently does not exist. Our efforts to address this situation (the CAWT questionnaire) are described in Chapter 6. 
Until such time as a validated questionnaire exists we leave it to the reader to decide whether to utilise the CAWT 
questionnaire, utilise another questionnaire or  develop their own. Our key recommendation would be that acceptability 
should be measured separately from usability and an underlying theoretical framework should be used when developing 
a questionnaire to maximise the predictive ability of the tool. 
Performance expectancy 
I would find the system useful in my job. 
Using the system enables me to accomplish tasks more quickly. RA5: Using the system increases my productivity. 
If I use the system, I will increase my chances of getting a raise. 
Effort expectancy 
My interaction with the system would be clear and understandable. 
 It would be easy for me to become skilful at using the system. 
I would find the system easy to use 
Learning to operate the system is easy for me. 
Attitude toward using technology 
Using the system is a bad/good idea. 
The system makes work more interesting. AF2: Working with the system is fun. 
I like working with the system. 
Social influence 
People who influence my behaviour think that I should use the system. 
People who are important to me think that I should use the system. 
The senior management of this business has been helpful in the use of the system. 
In general, the organization has supported the use of the system. 
Facilitating conditions 
I have the resources necessary to use the system. 
I have the knowledge necessary to use the system. 
The system is not compatible with other systems I use. 
A specific person (or group) is available for assistance with system difficulties. 
Self-efficacy 
I could complete a job or task using the system if there was no one around to tell me what to do as I go. 
I could complete a job or task using the system if I could call someone for help if I got stuck. 
I could complete a job or task using the system if I had a lot of time to complete the job for which the software was provided. 
I could complete a job or task using the system if I had just the built-in help facility for assistance. 
Anxiety 
I feel apprehensive about using the system. 
It scares me to think that I could lose a lot of information using the system by hitting the wrong key. 
I hesitate to use the system for fear of making mistakes I cannot correct. 
The system is somewhat intimidating to me. 
Behavioural intention to use the system 
I intend to use the system in the next <n> months. 
I predict I would use the system in the next<n>months. 
I plan to use the system in the next<n>months. 
Table 11.10: UTAUT Questions 
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Appendix B: Checklists 
B.1 TIDieR Checklist 
Item 
number Item  
Where 
located  
 BRIEF NAME  
1. Provide the name or a phrase that describes the intervention. p. 49 
 WHY  
2. Describe any rationale, theory, or goal of the elements essential to the intervention. p. 49 
 WHAT  
3. 
Materials: Describe any physical or informational materials used in the intervention, 
including those provided to participants or used in intervention delivery or in training of 
intervention providers. Provide information on where the materials can be accessed (e.g. 
online appendix, URL). 
p. 57 
 
4. Procedures: Describe each of the procedures, activities, and/or processes used in the 
intervention, including any enabling or support activities. p. 59 
 WHO PROVIDED  
5. For each category of intervention provider (e.g. psychologist, nursing assistant), describe 
their expertise, background and any specific training given. p. 60 
 HOW  
6. 
Describe the modes of delivery (e.g. face-to-face or by some other mechanism, such as 
internet or telephone) of the intervention and whether it was provided individually or in a 
group. 
p. 59 
 WHERE  
7. Describe the type(s) of location(s) where the intervention occurred, including any necessary 
infrastructure or relevant features. p. 57 
 WHEN and HOW MUCH  
8. Describe the number of times the intervention was delivered and over what period of time 
including the number of sessions, their schedule, and their duration, intensity or dose. p. 59 
 TAILORING  
9. If the intervention was planned to be personalised, titrated or adapted, then describe what, 
why, when, and how. n/a 
 MODIFICATIONS  
10. If the intervention was modified during the course of the study, describe the changes (what, 
why, when, and how). n/a 
 HOW WELL  
11. Planned: If intervention adherence or fidelity was assessed, describe how and by whom, and 




Actual: If intervention adherence or fidelity was assessed, describe the extent to which the 





B.2 PRISMA Checklist 
 




TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  p. 36 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; objectives; 
data sources; study eligibility criteria, participants, and interventions; study 
appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
p. 36 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  n/a 
Objectives  4 Provide an explicit statement of questions being addressed with reference to 




METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including registration 
number.  
n/a 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as 




7 Describe all information sources (e.g., databases with dates of coverage, contact 
with study authors to identify additional studies) in the search and date last 
searched.  
p. 37 
Search  8 Present full electronic search strategy for at least one database, including any 
limits used, such that it could be repeated.  
p. 38 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in 




10 Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and confirming 
data from investigators.  
p. 38 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made.  
n/a 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including 
specification of whether this was done at the study or outcome level), and how 




13 State the principal summary measures (e.g., risk ratio, difference in means).  n/a 
Synthesis of 
results  
14 Describe the methods of handling data and combining results of studies, if done, 
including measures of consistency (e.g., I2) for each meta-analysis.  
n/a 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence 




16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, 










Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the 




18 For each study, present characteristics for which data were extracted (e.g., study 
size, PICOS, follow-up period) and provide the citations.  
p. 40 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, any outcome level 
assessment (see item 12).  
n/a 
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) 
simple summary data for each intervention group (b) effect estimates and 




21 Present results of each meta-analysis done, including confidence intervals and 
measures of consistency.  
n/a 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  n/a 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, 





24 Summarize the main findings including the strength of evidence for each main 
outcome; consider their relevance to key groups (e.g., healthcare providers, 
users, and policy makers).  
p. 46 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-
level (e.g., incomplete retrieval of identified research, reporting bias).  
p. 46 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, 
and implications for future research.  
p. 48 
FUNDING 
Funding  27 Describe sources of funding for the systematic review and other support (e.g., 
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